1	Viewpoint	NN	O	viewpoint	_	0	SENT_1	[p1l6t153r323b221],
2	|	SYM	O	|	dep	1	SENT_1	[p1l371t6r419b204],

1	The	DT	O	the	det	2	SENT_2	[p1l6t378r113b431],
2	rise	NN	O	rise	_	0	SENT_2	[p1l134t380r230b431],
3	and	CC	O	and	_	0	SENT_2	[p1l247t378r356b431],
4	fall	NN	DATE	fall	conj_and	2	SENT_2	[p1l371t377r459b431],
5	of	IN	O	of	_	0	SENT_2	[p1l478t377r540b431],
6	the	DT	O	the	det	8	SENT_2	[p1l550t378r647b431],
7	antimalarial	JJ	O	antimalarial	amod	8	SENT_2	[p1l664t378r1015b431],
8	Lapdap	NN	O	lapdap	prep_of	4	SENT_2	[p1l1037t378r1263b447],
9	:	:	O	:	_	0	SENT_2	[p1l1037t378r1263b447],
10	a	DT	O	a	det	11	SENT_2	[p1l1282t395r1313b431],
11	lesson	NN	O	lesson	dep	2	SENT_2	[p1l1331t378r1507b431],
12	in	IN	O	in	_	0	SENT_2	[p1l1528t380r1578b430],
13	@	IN	O	@	amod	15	SENT_2	[p1l1821t374r1883b446],
14	g	NN	O	g	nn	15	SENT_2	[p1l1924t396r1956b451],
15	pharmacogenetics	NNS	O	pharmacogenetic	prep_in	11	SENT_2	[p1l26t490r1344b660],

1	Lucio	NNP	PERSON	Lucio	nn	2	SENT_3	[p1l26t780r179b835],
2	Luzzatto	NNP	PERSON	Luzzatto	_	0	SENT_3	[p1l199t780r463b835],

1	The	DT	O	the	det	2	SENT_4	[p1l23t985r166b1053],
2	spread	NN	O	spread	nsubj	13	SENT_4	[p1l270t986r516b1073],
3	of	IN	O	of	_	0	SENT_4	[p1l616t985r699b1053],
4	chloroquine-resistant	JJ	O	chloroquine-resistant	amod	6	SENT_4	[p1l787t985r1592b1073],
5	Plasmodium	NN	LOCATION	plasmodium	nn	6	SENT_4	[p1l1696t985r2142b1053],
6	falciparum	NN	O	falciparum	prep_of	2	SENT_4	[p1l8t1093r414b1182],
7	in	IN	O	in	_	0	SENT_4	[p1l449t1098r523b1160],
8	Africa	NNP	LOCATION	Africa	prep_in	6	SENT_4	[p1l558t1093r785b1161],
9	has	VBZ	O	have	aux	13	SENT_4	[p1l821t1093r946b1161],
10	been	VBN	O	be	cop	13	SENT_4	[p1l984t1093r1164b1161],
11	a	DT	O	a	det	13	SENT_4	[p1l1202t1117r1238b1161],
12	strong	JJ	O	strong	amod	13	SENT_4	[p1l1277t1107r1514b1182],
13	stimulus	NN	O	stimulus	_	0	SENT_4	[p1l1553t1093r1879b1161],
14	to	TO	O	to	_	0	SENT_4	[p1l1917t1107r1986b1161],
15	the	DT	O	the	det	16	SENT_4	[p1l2023t1093r2139b1161],
16	development	NN	O	development	prep_to	13	SENT_4	[p1l25t1202r512b1290],
17	of	IN	O	of	_	0	SENT_4	[p1l583t1202r666b1269],
18	new	JJ	O	new	amod	20	SENT_4	[p1l726t1226r882b1269],
19	antimalarial	JJ	O	antimalarial	amod	20	SENT_4	[p1l953t1202r1406b1269],
20	drugs	NNS	O	drug	prep_of	16	SENT_4	[p1l1479t1202r1711b1291],
21	.	.	O	.	_	0	SENT_4	[p1l1479t1202r1711b1291],

1	Although	IN	O	although	mark	9	SENT_5	[p1l1786t1202r2140b1291],
2	artemisinin	NN	O	artemisinin	nsubj	9	SENT_5	[p1l25t1315r464b1378],
3	and	CC	O	and	_	0	SENT_5	[p1l481t1310r619b1378],
4	related	JJ	O	related	amod	5	SENT_5	[p1l634t1310r890b1378],
5	compounds	NNS	O	compound	nsubj	9	SENT_5	[p1l907t1310r1347b1398],
6	have	VBP	O	have	aux	9	SENT_5	[p1l1365t1310r1535b1378],
7	been	VBN	O	be	cop	9	SENT_5	[p1l1552t1310r1733b1378],
8	promising	JJ	O	promising	amod	9	SENT_5	[p1l1749t1315r2140b1399],
9	therapies	NNS	O	therapy	advcl	22	SENT_5	[p1l23t1418r367b1506],
10	since	IN	O	since	_	0	SENT_5	[p1l397t1422r587b1485],
11	the	DT	O	the	det	13	SENT_5	[p1l612t1418r728b1485],
12	19805	CD	NUMBER	19805	num	13	SENT_5	[p1l757t1423r1003b1495],
13	}	CD	NUMBER	}	prep_since	9	SENT_5	[p1l757t1423r1003b1495],
14	their	PRP$	O	they	poss	16	SENT_5	[p1l1025t1418r1204b1486],
15	low	JJ	O	low	amod	16	SENT_5	[p1l1226t1418r1359b1486],
16	availability	NN	O	availability	nsubj	22	SENT_5	[p1l1383t1418r1784b1507],
17	and	CC	O	and	_	0	SENT_5	[p1l1808t1418r1946b1486],
18	high	JJ	O	high	amod	19	SENT_5	[p1l1969t1418r2140b1507],
19	cost	NN	O	cost	conj_and	16	SENT_5	[p1l25t1540r171b1594],
20	have	VBP	O	have	aux	22	SENT_5	[p1l244t1527r415b1594],
21	greatly	RB	O	greatly	advmod	22	SENT_5	[p1l492t1527r744b1616],
22	delayed	VBN	O	delay	_	0	SENT_5	[p1l817t1527r1099b1615],
23	large-scale	JJ	O	large-scale	amod	24	SENT_5	[p1l1172t1527r1565b1616],
24	use	NN	O	use	dobj	22	SENT_5	[p1l1640t1551r1787b1594],
25	.	.	O	.	_	0	SENT_5	[p1l1640t1551r1787b1594],

1	In	IN	O	in	_	0	SENT_6	[p1l1870t1533r1949b1593],
2	the	DT	O	the	det	3	SENT_6	[p1l2023t1527r2139b1594],
3	meantime	NN	O	meantime	prep_in	8	SENT_6	[p1l24t1639r428b1712],
4	,	,	O	,	_	0	SENT_6	[p1l24t1639r428b1712],
5	a	DT	O	a	det	7	SENT_6	[p1l466t1659r503b1702],
6	logical	JJ	O	logical	amod	7	SENT_6	[p1l535t1634r778b1723],
7	alternative	NN	O	alternative	nsubjpass	18	SENT_6	[p1l814t1634r1204b1702],
8	was	VBD	O	be	_	0	SENT_6	[p1l1237t1659r1376b1702],
9	to	TO	O	to	_	0	SENT_6	[p1l1411t1648r1480b1702],
10	experiment	NN	O	experiment	prep_to	8	SENT_6	[p1l1516t1639r1944b1722],
11	with	IN	O	with	_	0	SENT_6	[p1l1975t1634r2140b1702],
12	existing	VBG	O	exist	amod	13	SENT_6	[p1l25t1747r316b1831],
13	agents	NNS	O	agent	prep_with	8	SENT_6	[p1l351t1756r612b1831],
14	,	,	O	,	_	0	SENT_6	[p1l351t1756r612b1831],
15	and	CC	O	and	_	0	SENT_6	[p1l650t1742r788b1810],
16	there	EX	O	there	expl	18	SENT_6	[p1l820t1742r1011b1810],
17	was	VBD	O	be	auxpass	18	SENT_6	[p1l1044t1766r1183b1810],
18	added	VBN	O	add	conj_and	8	SENT_6	[p1l1220t1742r1444b1810],
19	pressure	NN	O	pressure	dobj	18	SENT_6	[p1l1476t1766r1799b1830],
20	to	TO	O	to	aux	21	SENT_6	[p1l1833t1756r1901b1810],
21	do	VB	O	do	xcomp	18	SENT_6	[p1l1938t1742r2025b1810],
22	so	RB	O	so	advmod	21	SENT_6	[p1l2063t1766r2139b1810],
23	because	IN	O	because	_	0	SENT_6	[p1l22t1851r320b1918],
24	of	IN	O	of	_	0	SENT_6	[p1l372t1851r455b1918],
25	the	DT	O	the	det	27	SENT_6	[p1l492t1851r608b1918],
26	increasing	VBG	O	increase	amod	27	SENT_6	[p1l659t1855r1051b1940],
27	frequency	NN	O	frequency	prep_because_of	21	SENT_6	[p1l1101t1851r1476b1939],
28	of	IN	O	of	_	0	SENT_6	[p1l1525t1851r1608b1918],
29	resistance	NN	O	resistance	prep_of	27	SENT_6	[p1l1646t1855r2020b1918],
30	to	TO	O	to	_	0	SENT_6	[p1l2070t1864r2139b1918],
31	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_to	21	SENT_6	[p1l27t1958r1069b2047],
32	(	CD	NUMBER	(	num	31	SENT_6	[p1l1152t1958r1509b2047],
33	Fansidar	NNP	O	Fansidar	nn	40	SENT_6	[p1l1152t1958r1509b2047],
34	,	,	O	,	_	0	SENT_6	[p1l1152t1958r1509b2047],
35	Roche	NNP	PERSON	Roche	appos	40	SENT_6	[p1l1593t1958r1838b2036],
36	,	,	O	,	_	0	SENT_6	[p1l1593t1958r1838b2036],
37	Basel	NNP	LOCATION	Basel	appos	40	SENT_6	[p1l1922t1958r2137b2036],
38	,	,	O	,	_	0	SENT_6	[p1l1922t1958r2137b2036],
39	Switzerland	NNP	LOCATION	Switzerland	appos	40	SENT_6	[p1l29t2066r518b2155],
40	)	NNP	O	)	tmod	31	SENT_6	[p1l29t2066r518b2155],
41	,	,	O	,	_	0	SENT_6	[p1l29t2066r518b2155],
42	which	WDT	O	which	nsubj	46	SENT_6	[p1l600t2066r829b2134],
43	was	VBD	O	be	cop	46	SENT_6	[p1l906t2090r1045b2133],
44	the	DT	O	the	det	46	SENT_6	[p1l1126t2066r1243b2133],
45	main	JJ	O	main	amod	46	SENT_6	[p1l1324t2070r1519b2133],
46	alternative	NN	O	alternative	rcmod	40	SENT_6	[p1l1599t2066r1990b2133],
47	to	TO	O	to	_	0	SENT_6	[p1l2070t2079r2139b2133],
48	chloroquine	NN	O	chloroquine	prep_to	46	SENT_6	[p1l25t2175r497b2263],
49	.	.	O	.	_	0	SENT_6	[p1l25t2175r497b2263],

1	Therefore	RB	O	therefore	advmod	33	SENT_7	[p1l525t2175r915b2252],
2	,	,	O	,	_	0	SENT_7	[p1l525t2175r915b2252],
3	in	IN	O	in	_	0	SENT_7	[p1l945t2179r1020b2241],
4	the	DT	DATE	the	det	6	SENT_7	[p1l1044t2175r1161b2242],
5	late	JJ	DATE	late	amod	6	SENT_7	[p1l1186t2175r1318b2242],
6	1990s	CD	DATE	1990s	prep_in	33	SENT_7	[p1l1347t2181r1570b2253],
7	,	,	O	,	_	0	SENT_7	[p1l1347t2181r1570b2253],
8	a	DT	O	a	det	9	SENT_7	[p1l1600t2199r1637b2242],
9	combination	NN	O	combination	appos	6	SENT_7	[p1l1664t2175r2140b2242],
10	of	IN	O	of	_	0	SENT_7	[p1l25t2282r108b2350],
11	chlorproguanil	NN	O	chlorproguanil	nn	14	SENT_7	[p1l132t2282r690b2371],
12	(	CD	NUMBER	(	num	14	SENT_7	[p1l731t2282r1162b2371],
13	Lapudrine	NN	O	lapudrine	nn	14	SENT_7	[p1l731t2282r1162b2371],
14	)	NN	O	)	prep_of	9	SENT_7	[p1l731t2282r1162b2371],
15	and	CC	O	and	_	0	SENT_7	[p1l1205t2282r1343b2350],
16	dapsone	NN	O	dapsone	prep_of	9	SENT_7	[p1l1378t2282r1950b2370],
17	—	CD	NUMBER	—	num	16	SENT_7	[p1l1378t2282r1950b2370],
18	both	CC	O	both	dep	9	SENT_7	[p1l1378t2282r1950b2370],
19	lowcost	JJ	O	lowcost	amod	20	SENT_7	[p1l1984t2282r2138b2350, p1l25t2403r171b2457],
20	drugs	NNS	O	drug	conj	9	SENT_7	[p1l261t2390r822b2479],
21	—	RB	O	—	advmod	22	SENT_7	[p1l261t2390r822b2479],
22	known	VBN	O	know	partmod	20	SENT_7	[p1l261t2390r822b2479],
23	as	IN	O	as	_	0	SENT_7	[p1l913t2414r985b2457],
24	Lapdap	NN	O	lapdap	nn	26	SENT_7	[p1l1081t2390r1348b2478],
25	(	CD	NUMBER	(	num	26	SENT_7	[p1l1445t2390r2137b2479],
26	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	prep_as	22	SENT_7	[p1l1445t2390r2137b2479],
27	,	,	O	,	_	0	SENT_7	[p1l1445t2390r2137b2479],
28	London	NNP	LOCATION	London	appos	26	SENT_7	[p1l28t2499r331b2576],
29	,	,	O	,	_	0	SENT_7	[p1l28t2499r331b2576],
30	UK	NNP	LOCATION	UK	nn	31	SENT_7	[p1l367t2505r510b2587],
31	)	NNP	O	)	nsubjpass	33	SENT_7	[p1l367t2505r510b2587],
32	was	VBD	O	be	auxpass	33	SENT_7	[p1l542t2523r681b2566],
33	introduced	VBN	O	introduce	_	0	SENT_7	[p1l712t2498r1166b2566],
34	?	.	O	?	_	0	SENT_7	[p1l712t2498r1166b2566],

1	Chlorproguanil	NNP	O	Chlorproguanil	nsubj	12	SENT_8	[p1l1196t2499r1793b2588],
2	,	,	O	,	_	0	SENT_8	[p1l1196t2499r1793b2588],
3	which	WDT	O	which	nsubj	5	SENT_8	[p1l1823t2499r2052b2566],
4	is	VBZ	O	be	cop	5	SENT_8	[p1l2080t2503r2138b2566],
5	similar	JJ	O	similar	rcmod	1	SENT_8	[p1l27t2606r290b2674],
6	to	TO	O	to	_	0	SENT_8	[p1l315t2620r384b2674],
7	proguanil	NN	O	proguanil	prep_to	5	SENT_8	[p1l412t2606r797b2695],
8	,	,	O	,	_	0	SENT_8	[p1l412t2606r797b2695],
9	is	VBZ	O	be	cop	12	SENT_8	[p1l828t2611r885b2674],
10	a	DT	O	a	det	12	SENT_8	[p1l917t2631r954b2674],
11	very	RB	O	very	advmod	12	SENT_8	[p1l979t2631r1135b2695],
12	effective	JJ	O	effective	_	0	SENT_8	[p1l1162t2607r1469b2674],
13	antimalarial	JJ	O	antimalarial	amod	12	SENT_8	[p1l1499t2606r1971b2684],
14	,	,	O	,	_	0	SENT_8	[p1l1499t2606r1971b2684],
15	and	CC	O	and	_	0	SENT_8	[p1l2003t2606r2141b2674],
16	dapsone	NN	O	dapsone	nsubj	28	SENT_8	[p1l25t2714r355b2802],
17	,	,	O	,	_	0	SENT_8	[p1l25t2714r355b2802],
18	which	WDT	O	which	nsubjpass	21	SENT_8	[p1l402t2714r631b2782],
19	is	VBZ	O	be	auxpass	21	SENT_8	[p1l677t2719r734b2782],
20	chemically	RB	O	chemically	advmod	21	SENT_8	[p1l784t2714r1186b2803],
21	related	VBN	O	relate	rcmod	16	SENT_8	[p1l1230t2714r1485b2782],
22	to	TO	O	to	_	0	SENT_8	[p1l1529t2728r1598b2782],
23	the	DT	O	the	det	24	SENT_8	[p1l1644t2714r1761b2782],
24	sulphonamides	NNS	O	sulphonamide	prep_to	21	SENT_8	[p1l1810t2714r2138b2802, p1l25t2823r314b2901],
25	,	,	O	,	_	0	SENT_8	[p1l1810t2714r2138b2802, p1l25t2823r314b2901],
26	is	VBZ	O	be	cop	28	SENT_8	[p1l385t2827r442b2890],
27	very	RB	O	very	advmod	28	SENT_8	[p1l510t2847r666b2911],
28	effective	JJ	O	effective	conj_and	12	SENT_8	[p1l733t2823r1040b2890],
29	for	IN	O	for	_	0	SENT_8	[p1l1109t2823r1216b2890],
30	treatment	NN	O	treatment	prep_for	28	SENT_8	[p1l1281t2836r1651b2890],
31	of	IN	O	of	_	0	SENT_8	[p1l1718t2823r1801b2890],
32	leprosy	NNP	O	leprosy	prep_of	30	SENT_8	[p1l1855t2823r2136b2911],
33	.	.	O	.	_	0	SENT_8	[p1l1855t2823r2136b2911],

1	Chlorproguanil	NNP	O	Chlorproguanil	nsubj	5	SENT_9	[p1l27t2930r605b3019],
2	and	CC	O	and	_	0	SENT_9	[p1l643t2930r781b2998],
3	dapsone	NN	O	dapsone	conj_and	1	SENT_9	[p1l818t2930r1128b3018],
4	both	CC	O	both	advmod	5	SENT_9	[p1l1165t2930r1334b2998],
5	interfere	VBP	O	interfere	conj_but	5	SENT_9	[p1l1371t2930r1695b2998],
6	with	IN	O	with	_	0	SENT_9	[p1l1731t2930r1897b2998],
7	folate	JJ	O	folate	amod	8	SENT_9	[p1l1934t2930r2139b2998],
8	metabolism	NN	O	metabolism	prep_with	5	SENT_9	[p1l24t3038r470b3105],
9	but	CC	O	but	_	0	SENT_9	[p1l517t3038r642b3105],
10	at	IN	O	at	_	0	SENT_9	[p1l689t3051r754b3105],
11	different	JJ	O	different	amod	13	SENT_9	[p1l802t3038r1126b3105],
12	biosynthetic	JJ	O	biosynthetic	amod	13	SENT_9	[p1l1170t3038r1629b3126],
13	stages	NNS	O	stage	prep_at	5	SENT_9	[p1l1680t3051r1925b3127],
14	,	,	O	,	_	0	SENT_9	[p1l1680t3051r1925b3127],
15	thus	RB	O	thus	advmod	5	SENT_9	[p1l1975t3038r2138b3105],
16	their	PRP$	O	they	poss	18	SENT_9	[p1l23t3147r202b3214],
17	combined	VBN	O	combine	amod	18	SENT_9	[p1l231t3147r606b3214],
18	use	NN	O	use	nsubj	19	SENT_9	[p1l635t3171r763b3214],
19	was	VBD	O	be	ccomp	5	SENT_9	[p1l792t3171r930b3214],
20	in	IN	O	in	_	0	SENT_9	[p1l963t3151r1038b3213],
21	line	NN	O	line	prep_in	19	SENT_9	[p1l1067t3147r1208b3214],
22	with	IN	O	with	_	0	SENT_9	[p1l1237t3147r1403b3214],
23	the	DT	O	the	det	25	SENT_9	[p1l1433t3147r1549b3214],
24	classic	JJ	O	classic	amod	25	SENT_9	[p1l1581t3147r1822b3214],
25	tenet	NN	O	tenet	prep_with	19	SENT_9	[p1l1851t3160r2040b3214],
26	of	IN	O	of	_	0	SENT_9	[p1l2070t3147r2153b3214],
27	antimicrobial	JJ	O	antimicrobial	amod	28	SENT_9	[p1l25t3255r529b3323],
28	therapy	NN	O	therapy	prep_of	25	SENT_9	[p1l569t3255r863b3344],
29	,	,	O	,	_	0	SENT_9	[p1l569t3255r863b3344],
30	which	WDT	O	which	nsubj	31	SENT_9	[p1l905t3255r1134b3323],
31	aims	VBZ	O	aim	rcmod	28	SENT_9	[p1l1176t3260r1352b3323],
32	to	TO	O	to	aux	33	SENT_9	[p1l1395t3269r1464b3323],
33	prevent	VB	O	prevent	xcomp	31	SENT_9	[p1l1506t3269r1790b3343],
34	development	NN	O	development	dobj	33	SENT_9	[p1l1830t3255r2138b3343, p1l24t3376r222b3430],
35	of	IN	O	of	_	0	SENT_9	[p1l248t3363r331b3430],
36	resistant	JJ	O	resistant	amod	37	SENT_9	[p1l345t3367r668b3430],
37	organisms	NNS	O	organism	prep_of	34	SENT_9	[p1l694t3368r1108b3452],
38	.	.	O	.	_	0	SENT_9	[p1l694t3368r1108b3452],

1	At	IN	O	at	advmod	6	SENT_10	[p1l93t3477r174b3539],
2	least	JJS	O	least	pobj	1	SENT_10	[p1l193t3472r362b3539],
3	one	CD	NUMBER	one	num	5	SENT_10	[p1l384t3496r516b3539],
4	potential	JJ	O	potential	amod	5	SENT_10	[p1l539t3471r863b3559],
5	side-eifect	NN	O	side-eifect	nsubj	6	SENT_10	[p1l888t3472r1260b3539],
6	was	VBD	O	be	dep	15	SENT_10	[p1l1279t3496r1415b3539],
7	to	TO	O	to	aux	9	SENT_10	[p1l1440t3485r1508b3539],
8	be	VB	O	be	auxpass	9	SENT_10	[p1l1530t3472r1616b3539],
9	expected	VBN	O	expect	xcomp	6	SENT_10	[p1l1641t3472r1957b3559],
10	with	IN	O	with	_	0	SENT_10	[p1l1977t3472r2140b3539],
11	Lapdap	NN	PERSON	lapdap	prep_with	9	SENT_10	[p1l28t3580r310b3668],
12	,	,	O	,	_	0	SENT_10	[p1l28t3580r310b3668],
13	because	IN	O	because	_	0	SENT_10	[p1l345t3580r637b3648],
14	dapsone	NN	O	dapsone	prep_because	9	SENT_10	[p1l671t3580r976b3668],
15	causes	VBZ	O	cause	_	0	SENT_10	[p1l1011t3604r1249b3648],
16	haemolytic	JJ	O	haemolytic	amod	17	SENT_10	[p1l1283t3580r1688b3669],
17	anaemia	NN	O	anaemia	dobj	15	SENT_10	[p1l1721t3585r2034b3648],
18	in	IN	O	in	_	0	SENT_10	[p1l2067t3585r2141b3647],
19	about	RB	O	about	quantmod	20	SENT_10	[p1l25t3688r231b3755],
20	20	CD	PERCENT	20	num	21	SENT_10	[p1l258t3692r415b3758],
21	%	NN	PERCENT	%	prep_in	15	SENT_10	[p1l258t3692r415b3758],
22	of	IN	O	of	_	0	SENT_10	[p1l443t3688r525b3755],
23	patients	NNS	O	patient	prep_of	21	SENT_10	[p1l538t3692r873b3776],
24	}	CD	NUMBER	}	num	23	SENT_10	[p1l538t3692r873b3776],
25	This	DT	O	this	det	26	SENT_10	[p1l899t3688r1060b3756],
26	side-effect	NN	O	side-effect	nsubj	28	SENT_10	[p1l1091t3688r1463b3756],
27	is	VBZ	O	be	cop	28	SENT_10	[p1l1487t3693r1544b3756],
28	predictable	JJ	O	predictable	rcmod	23	SENT_10	[p1l1572t3688r1977b3776],
29	and	CC	O	and	_	0	SENT_10	[p1l2005t3688r2141b3756],
30	much	RB	O	much	advmod	32	SENT_10	[p2l24t17r239b84],
31	more	RBR	O	more	advmod	32	SENT_10	[p2l290t41r484b84],
32	severe	JJ	O	severe	conj_and	28	SENT_10	[p2l539t41r764b84],
33	in	IN	O	in	_	0	SENT_10	[p2l817t21r891b83],
34	people	NNS	O	people	prep_in	32	SENT_10	[p2l942t17r1184b105],
35	who	WP	O	who	nsubj	36	SENT_10	[p2l1235t17r1390b84],
36	have	VBP	O	have	rcmod	34	SENT_10	[p2l1442t17r1610b84],
37	an	DT	O	a	det	39	SENT_10	[p2l1664t41r1753b84],
38	inherited	VBN	O	inherit	amod	39	SENT_10	[p2l1805t17r2142b84],
39	deﬁciency	NN	O	deﬁciency	dobj	36	SENT_10	[p2l25t124r395b213],
40	of	IN	O	of	_	0	SENT_10	[p2l412t124r494b192],
41	glucose	NN	O	glucose	nn	43	SENT_10	[p2l501t124r776b213],
42	6-phosphate	NN	O	6-phosphate	nn	43	SENT_10	[p2l797t124r1245b212],
43	dehydrogenase	NN	O	dehydrogenase	prep_of	39	SENT_10	[p2l1265t124r1818b213],
44	(	CD	NUMBER	(	num	46	SENT_10	[p2l1844t130r2136b213],
45	G6PD	NN	O	g6pd	nn	46	SENT_10	[p2l1844t130r2136b213],
46	)	NN	O	)	nsubj	15	SENT_10	[p2l1844t130r2136b213],
47	.	.	O	.	_	0	SENT_10	[p2l1844t130r2136b213],

1	G6PD	NN	O	g6pd	nsubj	2	SENT_11	[p2l31t237r251b300],
2	is	VBZ	O	be	_	0	SENT_11	[p2l295t237r352b299],
3	on	IN	O	on	_	0	SENT_11	[p2l400t256r492b299],
4	the	DT	O	the	det	6	SENT_11	[p2l536t232r650b300],
5	X	NN	O	x	nn	6	SENT_11	[p2l695t239r753b298],
6	chromosome	NN	O	chromosome	prep_on	2	SENT_11	[p2l797t232r1302b309],
7	,	,	O	,	_	0	SENT_11	[p2l797t232r1302b309],
8	and	CC	O	and	_	0	SENT_11	[p2l1351t232r1488b300],
9	therefore	RB	O	therefore	advmod	15	SENT_11	[p2l1530t232r1866b300],
10	severe	JJ	O	severe	amod	12	SENT_11	[p2l1914t256r2140b300],
11	G6PD	NN	O	g6pd	nn	12	SENT_11	[p2l27t346r247b408],
12	deﬁciency	NN	O	deﬁciency	nsubj	15	SENT_11	[p2l302t341r671b429],
13	is	VBZ	O	be	cop	15	SENT_11	[p2l720t345r777b408],
14	more	RBR	O	more	advmod	15	SENT_11	[p2l830t365r1023b408],
15	common	JJ	O	common	conj_and	2	SENT_11	[p2l1076t365r1408b408],
16	in	IN	O	in	_	0	SENT_11	[p2l1459t345r1532b407],
17	males	NNS	O	male	prep_in	15	SENT_11	[p2l1583t341r1797b408],
18	than	IN	O	than	prep	15	SENT_11	[p2l1850t341r2016b408],
19	in	IN	O	in	pcomp	18	SENT_11	[p2l2067t345r2140b407],
20	females	NNS	O	female	pobj	19	SENT_11	[p2l24t448r328b516],
21	.	.	O	.	_	0	SENT_11	[p2l24t448r328b516],

1	G6PD-deﬁcient	JJ	O	g6pd-deﬁcient	amod	2	SENT_12	[p2l415t448r985b516],
2	erythrocytes	NNS	O	erythrocyte	nsubj	5	SENT_12	[p2l1065t448r1507b537],
3	are	VBP	O	be	cop	5	SENT_12	[p2l1591t473r1701b516],
4	extremely	RB	O	extremely	advmod	5	SENT_12	[p2l1783t448r2142b537],
5	sensitive	JJ	O	sensitive	_	0	SENT_12	[p2l27t560r342b623],
6	to	TO	O	to	_	0	SENT_12	[p2l373t569r441b623],
7	oxidative	JJ	O	oxidative	amod	8	SENT_12	[p2l474t556r796b623],
8	stress	NN	O	stress	prep_to	5	SENT_12	[p2l830t569r1055b633],
9	,	,	O	,	_	0	SENT_12	[p2l830t569r1055b633],
10	such	JJ	O	such	_	0	SENT_12	[p2l1092t556r1263b623],
11	as	IN	O	as	_	0	SENT_12	[p2l1295t580r1365b623],
12	results	NNS	O	result	prep_such_as	8	SENT_12	[p2l1399t556r1642b623],
13	from	IN	O	from	_	0	SENT_12	[p2l1676t556r1857b623],
14	certain	JJ	O	certain	amod	15	SENT_12	[p2l1889t560r2140b623],
15	infections	NNS	O	infection	prep_from	12	SENT_12	[p2l24t665r407b742],
16	,	,	O	,	_	0	SENT_12	[p2l24t665r407b742],
17	or	CC	O	or	_	0	SENT_12	[p2l437t689r512b732],
18	ingestion	NN	O	ingestion	prep_such_as	8	SENT_12	[p2l537t669r880b754],
19	of	IN	O	of	_	0	SENT_12	[p2l906t665r988b732],
20	fava	NN	O	fava	nn	21	SENT_12	[p2l1000t665r1146b732],
21	beans	NNS	O	bean	prep_of	18	SENT_12	[p2l1169t665r1382b732],
22	or	CC	O	or	_	0	SENT_12	[p2l1410t689r1486b732],
23	various	JJ	O	various	amod	24	SENT_12	[p2l1508t669r1774b732],
24	drugs	NNS	O	drug	conj_or	21	SENT_12	[p2l1803t665r2030b754],
25	.	.	O	.	_	0	SENT_12	[p2l1803t665r2030b754],

1	In	IN	O	in	_	0	SENT_13	[p2l2063t671r2140b731],
2	fact	NN	O	fact	prep_in	8	SENT_13	[p2l24t772r173b850],
3	,	,	O	,	_	0	SENT_13	[p2l24t772r173b850],
4	G6PD	NN	O	g6pd	nn	5	SENT_13	[p2l202t778r423b840],
5	deﬁciency	NN	O	deﬁciency	nsubjpass	8	SENT_13	[p2l449t772r819b861],
6	was	VBD	O	be	auxpass	8	SENT_13	[p2l837t796r974b840],
7	originally	RB	O	originally	advmod	8	SENT_13	[p2l1000t772r1349b861],
8	discovered	VBN	O	discover	_	0	SENT_13	[p2l1371t772r1761b840],
9	in	IN	O	in	_	0	SENT_13	[p2l1782t777r1856b839],
10	1956	CD	DATE	1956	prep_in	8	SENT_13	[p2l1881t777r2043b840],
11	in	IN	O	in	_	0	SENT_13	[p2l2067t777r2141b839],
12	patients	NNS	O	patient	prep_in	8	SENT_13	[p2l24t884r313b968],
13	who	WP	O	who	nsubj	14	SENT_13	[p2l343t880r498b947],
14	developed	VBD	O	develop	rcmod	12	SENT_13	[p2l529t880r897b968],
15	haemolytic	JJ	O	haemolytic	amod	16	SENT_13	[p2l923t880r1329b968],
16	anaemia	NN	O	anaemia	dobj	14	SENT_13	[p2l1358t884r1671b947],
17	after	IN	O	after	_	0	SENT_13	[p2l1700t880r1866b947],
18	having	VBG	O	have	aux	19	SENT_13	[p2l1891t880r2141b969],
19	received	VBN	O	receive	prepc_after	14	SENT_13	[p2l24t988r327b1056],
20	primaquine	NN	O	primaquine	dobj	19	SENT_13	[p2l383t993r817b1076],
21	for	IN	O	for	_	0	SENT_13	[p2l876t988r981b1056],
22	prophylaxis	NN	O	prophylaxis	prep_for	19	SENT_13	[p2l1037t988r1459b1077],
23	or	CC	O	or	_	0	SENT_13	[p2l1520t1013r1596b1056],
24	treatment	NN	O	treatment	conj_or	22	SENT_13	[p2l1650t1002r2014b1056],
25	of	IN	O	of	_	0	SENT_13	[p2l2071t988r2153b1056],
26	malaria	NN	O	malaria	prep_of	22	SENT_13	[p2l24t1096r347b1164],
27	.	.	O	.	_	0	SENT_13	[p2l24t1096r347b1164],

1	“	NN	O	“	nn	3	SENT_14	[p2l24t1096r347b1164],
2	G6PD	NN	O	g6pd	nn	3	SENT_14	[p2l385t1102r605b1164],
3	deﬁciency	NN	O	deﬁciency	nsubj	12	SENT_14	[p2l647t1096r1017b1185],
4	is	VBZ	O	be	cop	6	SENT_14	[p2l1053t1101r1110b1164],
5	more	RBR	O	more	advmod	6	SENT_14	[p2l1150t1121r1344b1164],
6	common	JJ	O	common	rcmod	3	SENT_14	[p2l1383t1121r1715b1164],
7	in	IN	O	in	_	0	SENT_14	[p2l1753t1101r1827b1163],
8	tropical	JJ	O	tropical	amod	11	SENT_14	[p2l1863t1097r2140b1184],
9	and	CC	O	and	_	0	SENT_14	[p2l25t1204r161b1272],
10	subtropical	JJ	O	subtropical	amod	11	SENT_14	[p2l232t1204r639b1292],
11	areas	NNS	O	area	prep_in	6	SENT_14	[p2l709t1208r940b1281],
12	}	VBP	O	}	_	0	SENT_14	[p2l709t1208r940b1281],
13	precisely	RB	O	precisely	advmod	14	SENT_14	[p2l1010t1204r1334b1293],
14	where	WRB	O	where	advmod	19	SENT_14	[p2l1400t1204r1626b1272],
15	antimalarial	JJ	O	antimalarial	amod	16	SENT_14	[p2l1697t1204r2140b1272],
16	treatment	NN	O	treatment	nsubj	19	SENT_14	[p2l23t1326r386b1380],
17	is	VBZ	O	be	cop	19	SENT_14	[p2l435t1317r492b1380],
18	most	RBS	O	most	advmod	19	SENT_14	[p2l544t1326r730b1380],
19	likely	JJ	O	likely	advcl	12	SENT_14	[p2l777t1313r973b1401],
20	to	TO	O	to	aux	22	SENT_14	[p2l1020t1326r1089b1380],
21	be	VB	O	be	auxpass	22	SENT_14	[p2l1138t1313r1224b1380],
22	needed	VBN	O	need	xcomp	19	SENT_14	[p2l1275t1313r1557b1380],
23	.	.	O	.	_	0	SENT_14	[p2l1275t1313r1557b1380],

1	This	DT	O	this	nsubj	8	SENT_15	[p2l1610t1313r1772b1380],
2	is	VBZ	O	be	cop	8	SENT_15	[p2l1824t1317r1881b1380],
3	not	RB	O	not	neg	8	SENT_15	[p2l1933t1326r2054b1380],
4	a	DT	O	a	det	8	SENT_15	[p2l2104t1337r2140b1380],
5	coincidence	NN	O	coincidence	nn	8	SENT_15	[p2l25t1420r460b1488],
6	(	NN	O	(	nn	8	SENT_15	[p2l499t1420r784b1509],
7	ﬁgure	NN	O	ﬁgure	nn	8	SENT_15	[p2l499t1420r784b1509],
8	)	NN	O	)	_	0	SENT_15	[p2l499t1420r784b1509],
9	,	,	O	,	_	0	SENT_15	[p2l499t1420r784b1509],
10	because	IN	O	because	mark	15	SENT_15	[p2l820t1420r1111b1488],
11	G6PD	NN	O	g6pd	nn	12	SENT_15	[p2l1147t1425r1369b1488],
12	deﬁciency	NN	O	deﬁciency	nsubjpass	15	SENT_15	[p2l1405t1420r1774b1509],
13	has	VBZ	O	have	aux	15	SENT_15	[p2l1805t1420r1928b1488],
14	been	VBN	O	be	auxpass	15	SENT_15	[p2l1963t1420r2140b1488],
15	shown	VBN	O	show	advcl	8	SENT_15	[p2l27t1528r267b1596],
16	to	TO	O	to	aux	17	SENT_15	[p2l289t1542r358b1596],
17	confer	VB	O	confer	xcomp	15	SENT_15	[p2l383t1528r617b1596],
18	a	DT	O	a	det	20	SENT_15	[p2l640t1552r677b1596],
19	substantial	JJ	O	substantial	amod	20	SENT_15	[p2l702t1528r1102b1596],
20	resistance	NN	O	resistance	dobj	17	SENT_15	[p2l1125t1533r1491b1596],
21	against	IN	O	against	_	0	SENT_15	[p2l1516t1533r1779b1617],
22	the	DT	O	the	det	24	SENT_15	[p2l1800t1528r1914b1596],
23	lethal	JJ	O	lethal	amod	24	SENT_15	[p2l1938t1528r2140b1596],
24	effects	NNS	O	effect	prep_against	17	SENT_15	[p2l25t1637r257b1704],
25	of	IN	O	of	_	0	SENT_15	[p2l299t1637r381b1704],
26	P	NN	O	p	nn	27	SENT_15	[p2l413t1643r461b1703],
27	falciparum	NN	O	falciparum	prep_of	24	SENT_15	[p2l480t1637r921b1726],
28	.	.	O	.	_	0	SENT_15	[p2l480t1637r921b1726],

1	‘’	NN	O	‘’	nn	2	SENT_16	[p2l480t1637r921b1726],
2	Patients	NNS	O	patient	nsubj	14	SENT_16	[p2l963t1641r1251b1704],
3	with	IN	O	with	_	0	SENT_16	[p2l1290t1637r1453b1704],
4	G6PD	NN	O	g6pd	nn	5	SENT_16	[p2l1495t1642r1716b1704],
5	deﬁciency	NN	O	deﬁciency	prep_with	2	SENT_16	[p2l1758t1637r2137b1725],
6	,	,	O	,	_	0	SENT_16	[p2l1758t1637r2137b1725],
7	which	WDT	O	which	nsubj	9	SENT_16	[p2l22t1744r247b1812],
8	generally	RB	O	generally	advmod	9	SENT_16	[p2l297t1744r631b1833],
9	causes	VBZ	O	cause	rcmod	2	SENT_16	[p2l678t1768r916b1812],
10	no	DT	O	no	det	11	SENT_16	[p2l966t1769r1059b1812],
11	symptoms	NNS	O	symptom	dobj	9	SENT_16	[p2l1110t1758r1511b1833],
12	,	,	O	,	_	0	SENT_16	[p2l1110t1758r1511b1833],
13	can	MD	O	can	aux	14	SENT_16	[p2l1564t1769r1690b1812],
14	become	VB	O	become	_	0	SENT_16	[p2l1736t1744r2023b1812],
15	ill	RB	O	ill	advmod	14	SENT_16	[p2l2072t1744r2141b1811],
16	when	WRB	O	when	advmod	19	SENT_16	[p2l22t1852r226b1920],
17	they	PRP	O	they	nsubjpass	19	SENT_16	[p2l263t1852r420b1941],
18	are	VBP	O	be	auxpass	19	SENT_16	[p2l457t1876r567b1920],
19	given	VBN	O	give	advcl	14	SENT_16	[p2l607t1857r804b1941],
20	certain	JJ	O	certain	amod	21	SENT_16	[p2l843t1857r1094b1920],
21	drugs	NNS	O	drug	iobj	19	SENT_16	[p2l1133t1852r1384b1941],
22	,7	CD	NUMBER	,7	dobj	19	SENT_16	[p2l1133t1852r1384b1941],
23	including	VBG	O	include	_	0	SENT_16	[p2l1421t1852r1774b1941],
24	dapsone	NN	O	dapsone	prep_including	22	SENT_16	[p2l1813t1852r2137b1940],
25	;	:	O	;	_	0	SENT_16	[p2l1813t1852r2137b1940],
26	this	DT	O	this	nsubjpass	29	SENT_16	[p2l23t1961r157b2028],
27	has	VBZ	O	have	aux	29	SENT_16	[p2l183t1961r307b2028],
28	been	VBN	O	be	auxpass	29	SENT_16	[p2l333t1961r511b2028],
29	known	VBN	O	know	parataxis	14	SENT_16	[p2l534t1961r788b2028],
30	for	IN	O	for	_	0	SENT_16	[p2l812t1961r917b2028],
31	more	JJR	DURATION	more	mwe	32	SENT_16	[p2l941t1985r1134b2028],
32	than	IN	DURATION	than	quantmod	33	SENT_16	[p2l1158t1961r1325b2028],
33	40	CD	DURATION	40	num	34	SENT_16	[p2l1348t1967r1430b2028],
34	years	NNS	NUMBER	year	prep_for	29	SENT_16	[p2l1453t1966r1721b2049],
35	.	.	O	.	_	0	SENT_16	[p2l1453t1966r1721b2049],

1	”	NN	O	”	_	0	SENT_17	[p2l1453t1966r1721b2049],

1	Formal	JJ	O	formal	amod	3	SENT_18	[p2l98t2069r366b2136],
2	clinical	JJ	O	clinical	amod	3	SENT_18	[p2l406t2069r676b2136],
3	trials	NNS	O	trial	nsubjpass	7	SENT_18	[p2l715t2068r903b2136],
4	of	IN	O	of	_	0	SENT_18	[p2l947t2068r1030b2136],
5	Lapdap	NN	LOCATION	lapdap	prep_of	3	SENT_18	[p2l1061t2069r1330b2156],
6	were	VBD	O	be	auxpass	7	SENT_18	[p2l1369t2093r1548b2136],
7	undertaken	VBN	O	undertake	_	0	SENT_18	[p2l1588t2068r2026b2136],
8	in	IN	O	in	_	0	SENT_18	[p2l2065t2073r2140b2135],
9	Africa	NNP	LOCATION	Africa	prep_in	7	SENT_18	[p2l23t2176r272b2244],
10	:	:	O	:	_	0	SENT_18	[p2l23t2176r272b2244],
11	no	DT	O	no	det	13	SENT_18	[p2l307t2200r400b2244],
12	G6PD	NN	O	g6pd	nn	13	SENT_18	[p2l435t2181r660b2244],
13	testing	NN	O	testing	nsubjpass	15	SENT_18	[p2l692t2181r951b2265],
14	was	VBD	O	be	auxpass	15	SENT_18	[p2l979t2200r1119b2244],
15	done	VBN	O	do	parataxis	7	SENT_18	[p2l1153t2176r1337b2244],
16	during	IN	O	during	_	0	SENT_18	[p2l1369t2176r1624b2265],
17	a	DT	O	a	det	19	SENT_18	[p2l1656t2200r1693b2244],
18	key	JJ	O	key	amod	19	SENT_18	[p2l1722t2176r1850b2265],
19	study	NN	O	study	prep_during	15	SENT_18	[p2l1882t2176r2141b2265],
20	.	.	O	.	_	0	SENT_18	[p2l1882t2176r2141b2265],

1	”	NN	O	”	nn	2	SENT_19	[p2l1882t2176r2141b2265],
2	I-Iowever	NN	O	i-iowever	nsubj	7	SENT_19	[p2l28t2292r376b2363],
3	,	,	O	,	_	0	SENT_19	[p2l28t2292r376b2363],
4	anaemia	NN	O	anaemia	appos	2	SENT_19	[p2l406t2290r727b2353],
5	was	VBD	O	be	cop	7	SENT_19	[p2l751t2309r890b2353],
6	more	RBR	O	more	advmod	7	SENT_19	[p2l918t2309r1116b2353],
7	common	JJ	O	common	_	0	SENT_19	[p2l1144t2309r1483b2353],
8	in	IN	O	in	_	0	SENT_19	[p2l1508t2290r1583b2351],
9	patients	NNS	O	patient	prep_in	7	SENT_19	[p2l1609t2290r1908b2374],
10	given	VBN	O	give	prep	7	SENT_19	[p2l1938t2290r2140b2375],
11	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	dep	10	SENT_19	[p2l25t2393r954b2482],
12	,	,	O	,	_	0	SENT_19	[p2l25t2393r954b2482],
13	which	WDT	O	which	dobj	16	SENT_19	[p2l976t2393r1207b2461],
14	the	DT	O	the	det	15	SENT_19	[p2l1226t2393r1343b2461],
15	investigators	NNS	O	investigator	nsubj	16	SENT_19	[p2l1364t2398r1847b2482],
16	termed	VBN	O	term	rcmod	11	SENT_19	[p2l1868t2393r2141b2461],
17	as	IN	O	as	_	0	SENT_19	[p2l25t2525r98b2569],
18	a	DT	O	a	det	22	SENT_19	[p2l145t2525r181b2569],
19	possible	JJ	O	possible	amod	22	SENT_19	[p2l223t2501r532b2589],
20	adverse	JJ	O	adverse	amod	22	SENT_19	[p2l577t2501r859b2569],
21	drug	NN	O	drug	nn	22	SENT_19	[p2l904t2501r1080b2590],
22	reaction	NN	O	reaction	prep_as	16	SENT_19	[p2l1124t2506r1450b2569],
23	.	.	O	.	_	0	SENT_19	[p2l1124t2506r1450b2569],

1	In	IN	O	in	dep	6	SENT_20	[p2l1500t2508r1579b2568],
2	a	DT	O	a	det	4	SENT_20	[p2l1623t2525r1660b2569],
3	subsequent	JJ	O	subsequent	amod	4	SENT_20	[p2l1706t2501r2142b2589],
4	study	NN	O	study	pobj	1	SENT_20	[p2l27t2610r282b2698],
5	,	,	O	,	_	0	SENT_20	[p2l27t2610r282b2698],
6	“	CD	NUMBER	“	_	0	SENT_20	[p2l27t2610r282b2698],
7	some	DT	O	some	nsubjpass	12	SENT_20	[p2l336t2634r536b2677],
8	of	IN	O	of	_	0	SENT_20	[p2l591t2610r675b2677],
9	the	DT	O	the	det	10	SENT_20	[p2l714t2610r832b2677],
10	patients	NNS	O	patient	prep_of	7	SENT_20	[p2l886t2614r1185b2698],
11	were	VBD	O	be	auxpass	12	SENT_20	[p2l1239t2634r1419b2677],
12	tested	VBN	O	test	rcmod	6	SENT_20	[p2l1473t2610r1697b2677],
13	for	IN	O	for	_	0	SENT_20	[p2l1750t2610r1857b2677],
14	G6PD	NN	O	g6pd	prep_for	12	SENT_20	[p2l1912t2615r2138b2677],

1	www	NN	O	www	_	0	SENT_21	[p2l22t2877r552b2928],
2	.	.	O	.	_	0	SENT_21	[p2l22t2877r552b2928],

1	the	DT	O	the	det	2	SENT_22	[p2l22t2877r552b2928],
2	|	NN	O	|	_	0	SENT_22	[p2l22t2877r552b2928],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_22	[p2l22t2877r552b2928],
4	Vol	NNP	O	Vol	dep	2	SENT_22	[p2l594t2877r681b2928],
5	376	CD	NUMBER	376	num	4	SENT_22	[p2l700t2876r803b2935],
6	August	NNP	DATE	August	tmod	4	SENT_22	[p2l847t2881r1049b2943],
7	28	CD	DATE	28	num	6	SENT_22	[p2l1067t2876r1152b2937],
8	,	,	DATE	,	_	0	SENT_22	[p2l1067t2876r1152b2937],
9	2010	CD	DATE	2010	num	6	SENT_22	[p2l1171t2883r1310b2928],

1	deﬁciency	NN	O	deﬁciency	_	0	SENT_23	[p2l10t3071r291b3135],
2	,	,	O	,	_	0	SENT_23	[p2l10t3071r291b3135],
3	although	IN	O	although	mark	11	SENT_23	[p2l329t3071r571b3135],
4	the	DT	O	the	det	5	SENT_23	[p2l605t3071r689b3120],
5	results	NNS	O	result	nsubj	11	SENT_23	[p2l725t3071r906b3120],
6	of	IN	O	of	_	0	SENT_23	[p2l943t3071r1003b3120],
7	the	DT	O	the	det	8	SENT_23	[p2l1027t3071r1112b3120],
8	test	NN	O	test	prep_of	5	SENT_23	[p2l1147t3081r1244b3120],
9	were	VBD	O	be	cop	11	SENT_23	[p2l1276t3089r1405b3120],
10	not	RB	O	not	neg	11	SENT_23	[p2l1440t3081r1530b3120],
11	Lancet2o1o	NN	O	lancet2o1o	dep	1	SENT_23	[p2l1591t3082r2060b3122],
12	;	:	O	;	_	0	SENT_23	[p2l1591t3082r2060b3122],
13	376:739	CD	NUMBER	376:739	number	14	SENT_23	[p2l1591t3082r2060b3122],
14	—	CD	NUMBER	—	dep	1	SENT_23	[p2l1591t3082r2060b3122],
15	41	CD	NUMBER	41	dep	14	SENT_23	[p2l1591t3082r2060b3122],
16	known	VBN	O	know	partmod	1	SENT_23	[p2l8t3149r194b3198],
17	to	TO	O	to	_	0	SENT_23	[p2l218t3159r268b3198],
18	doctors	NNS	O	doctor	prep_to	16	SENT_23	[p2l295t3149r491b3198],
19	who	WP	O	who	nsubj	21	SENT_23	[p2l516t3149r630b3198],
20	were	VBD	O	be	aux	21	SENT_23	[p2l654t3166r784b3198],
21	looking	VBG	O	look	rcmod	18	SENT_23	[p2l808t3149r1013b3213],
22	after	IN	O	after	_	0	SENT_23	[p2l1039t3149r1162b3198],
23	the	DT	O	the	det	24	SENT_23	[p2l1185t3149r1269b3198],
24	patients	NNS	O	patient	prep_after	21	SENT_23	[p2l1294t3152r1525b3212],
25	.	.	O	.	_	0	SENT_23	[p2l1294t3152r1525b3212],

1	Published	VBN	O	publish	dep	10	SENT_24	[p2l1593t3164r1761b3198],
2	Online	NNP	O	Online	dep	1	SENT_24	[p2l1773t3164r1892b3198],
3	From	IN	O	from	dep	2	SENT_24	[p2l12t3231r155b3276],
4	retrospective	JJ	O	retrospective	amod	5	SENT_24	[p2l181t3231r530b3291],
5	analysis	NN	O	analysis	pobj	3	SENT_24	[p2l558t3228r772b3291],
6	of	IN	O	of	_	0	SENT_24	[p2l801t3227r861b3276],
7	these	DT	O	these	det	8	SENT_24	[p2l877t3228r1020b3276],
8	data	NNS	O	datum	prep_of	5	SENT_24	[p2l1047t3228r1158b3276],
9	it	PRP	O	it	nsubj	10	SENT_24	[p2l1185t3231r1221b3276],
10	transpired	VBD	O	transpire	_	0	SENT_24	[p2l1246t3228r1529b3291],
11	JU	NNP	O	JU	poss	53	SENT_24	[p2l1587t3227r1793b3271],
12	'	POS	O	'	_	0	SENT_24	[p2l1587t3227r1793b3271],
13	>	JJR	O	>	amod	53	SENT_24	[p2l1587t3227r1793b3271],
14	/	:	O	/	punct	15	SENT_24	[p2l1587t3227r1793b3271],
15	5,2010	CD	NUMBER	5,2010	dep	13	SENT_24	[p2l1587t3227r1793b3271],
16	that	WDT	O	that	dobj	51	SENT_24	[p2l8t3306r114b3354],
17	35	CD	PERCENT	35	num	18	SENT_24	[p2l136t3309r250b3356],
18	%	NN	PERCENT	%	nsubj	51	SENT_24	[p2l136t3309r250b3356],
19	of	IN	O	of	_	0	SENT_24	[p2l272t3305r332b3354],
20	children	NNS	O	child	prep_of	18	SENT_24	[p2l344t3305r570b3354],
21	in	IN	O	in	_	0	SENT_24	[p2l590t3309r644b3353],
22	whom	WP	O	whom	rel	24	SENT_24	[p2l663t3306r835b3354],
23	there	EX	O	there	expl	24	SENT_24	[p2l854t3306r994b3354],
24	was	VBD	O	be	rcmod	20	SENT_24	[p2l1013t3323r1113b3354],
25	a	DT	O	a	det	28	SENT_24	[p2l1136t3323r1163b3354],
26	notable	JJ	O	notable	amod	28	SENT_24	[p2l1183t3305r1383b3354],
27	drop	NN	O	drop	nn	28	SENT_24	[p2l1404t3305r1528b3369],
28	E	NN	O	e	nsubj	24	SENT_24	[p2l1593t3288r1955b3393],
29	;	:	O	;	_	0	SENT_24	[p2l1593t3288r1955b3393],
30	)	CD	NUMBER	)	number	31	SENT_24	[p2l1593t3288r1955b3393],
31	3	CD	NUMBER	3	dep	28	SENT_24	[p2l1593t3288r1955b3393],
32	"	``	O	"	punct	33	SENT_24	[p2l1593t3288r1955b3393],
33	g8	NN	O	g8	dep	31	SENT_24	[p2l1593t3288r1955b3393],
34	‘	CD	NUMBER	‘	num	33	SENT_24	[p2l1593t3288r1955b3393],
35	(	CD	NUMBER	(	num	36	SENT_24	[p2l1593t3288r1955b3393],
36	‘	NN	O	‘	dep	31	SENT_24	[p2l1593t3288r1955b3393],
37	l	NN	O	l	tmod	31	SENT_24	[p2l1593t3288r1955b3393],
38	;	:	O	;	_	0	SENT_24	[p2l1593t3288r1955b3393],
39	;	:	O	;	_	0	SENT_24	[p2l1593t3288r1955b3393],
40	)	CD	NUMBER	)	num	41	SENT_24	[p2l1593t3288r1955b3393],
41	61g	CD	NUMBER	61g	dep	28	SENT_24	[p2l1593t3288r1955b3393],
42	:	:	O	:	_	0	SENT_24	[p2l1593t3288r1955b3393],
43	(	CD	NUMBER	(	dep	41	SENT_24	[p2l1593t3288r1955b3393],
44	:	:	O	:	_	0	SENT_24	[p2l1593t3288r1955b3393],
45	:	:	O	:	_	0	SENT_24	[p2l1593t3288r1955b3393],
46	)	CD	NUMBER	)	num	47	SENT_24	[p2l1593t3288r1955b3393],
47	l0	NN	O	l0	dep	20	SENT_24	[p2l1593t3288r1955b3393],
48	'	''	O	'	_	0	SENT_24	[p2l1593t3288r1955b3393],
49	in	IN	O	in	_	0	SENT_24	[p2l9t3387r63b3432],
50	haemoglobin	NN	O	haemoglobin	prep_in	47	SENT_24	[p2l87t3384r448b3448],
51	were	VBD	O	be	rcmod	15	SENT_24	[p2l472t3401r601b3432],
52	G6PD	NN	O	g6pd	nn	53	SENT_24	[p2l629t3387r791b3432],
53	deﬁcient	NN	O	deﬁcient	dobj	10	SENT_24	[p2l819t3384r1068b3432],
54	.	.	O	.	_	0	SENT_24	[p2l819t3384r1068b3432],

1	There	EX	O	there	expl	3	SENT_25	[p2l1095t3384r1254b3432],
2	were	VBD	O	be	cop	3	SENT_25	[p2l1278t3401r1408b3432],
3	few	JJ	O	few	_	0	SENT_25	[p2l1434t3384r1530b3432],
4	_	NNS	O	_	xcomp	3	SENT_25	[p2l1639t3435r1646b3441],
5	_	VBP	O	_	rcmod	4	SENT_25	[p2l2022t3435r2029b3441],
6	,	,	O	,	_	0	SENT_25	[p2l335t3465r343b3472],
7	,	,	O	,	_	0	SENT_25	[p2l523t3465r530b3472],
8	,	,	O	,	_	0	SENT_25	[p2l1384t3465r1391b3472],
9	,	,	O	,	_	0	SENT_25	[p2l1441t3465r1448b3472],
10	lstitutoToscanoTumorI	NN	O	lstitutotoscanotumorus	dep	3	SENT_25	[p2l1593t3436r2041b3473],
11	,	,	O	,	_	0	SENT_25	[p2l1593t3436r2041b3473],

1	data	NNS	O	datum	_	0	SENT_26	[p2l10t3462r121b3510],
2	for	IN	O	for	_	0	SENT_26	[p2l159t3462r237b3510],
3	this	DT	O	this	det	4	SENT_26	[p2l273t3462r373b3510],
4	section	NN	O	section	prep_for	1	SENT_26	[p2l415t3472r606b3510],
5	of	IN	O	of	_	0	SENT_26	[p2l645t3462r705b3510],
6	the	DT	O	the	det	7	SENT_26	[p2l733t3462r818b3510],
7	study	NN	O	study	prep_of	4	SENT_26	[p2l859t3462r1012b3526],
8	,	,	O	,	_	0	SENT_26	[p2l859t3462r1012b3526],
9	although	IN	O	although	mark	15	SENT_26	[p2l1054t3462r1295b3526],
10	clinical	JJ	O	clinical	amod	12	SENT_26	[p2l1334t3462r1529b3510],
11	Florence	NNP	LOCATION	Florence	nn	12	SENT_26	[p2l1593t3495r1745b3529],
12	Italy	NNP	LOCATION	Italy	nsubjpass	15	SENT_26	[p2l1769t3495r1850b3539],
13	concern	NN	O	concern	dep	12	SENT_26	[p2l10t3558r227b3589],
14	was	VBD	O	be	auxpass	15	SENT_26	[p2l244t3557r344b3589],
15	expressed	VBN	O	express	dep	7	SENT_26	[p2l365t3540r632b3603],
16	in	IN	O	in	_	0	SENT_26	[p2l649t3543r704b3588],
17	the	DT	O	the	det	19	SENT_26	[p2l721t3540r806b3589],
18	Gabon	NNP	LOCATION	Gabon	nn	19	SENT_26	[p2l826t3540r1004b3589],
19	centre	NN	O	centre	prep_in	15	SENT_26	[p2l1023t3550r1190b3589],
20	that	WDT	O	that	dep	34	SENT_26	[p2l1208t3540r1314b3589],
21	serious	JJ	O	serious	amod	28	SENT_26	[p2l1334t3543r1527b3589],
22	(	NN	O	(	nn	28	SENT_26	[p2l1592t3557r1680b3600],
23	Prof	NNP	O	Prof	nn	28	SENT_26	[p2l1592t3557r1680b3600],
24	Lucio	NNP	PERSON	Lucio	nn	28	SENT_26	[p2l1690t3560r1780b3591],
25	Luzzatto	NNP	PERSON	Luzzatto	nn	28	SENT_26	[p2l1793t3561r1941b3591],
26	MD	NN	O	md	nn	28	SENT_26	[p2l1954t3559r2026b3600],
27	)	NN	O	)	nn	28	SENT_26	[p2l1954t3559r2026b3600],
28	haemolysis	NN	O	haemolysis	nsubj	34	SENT_26	[p2l8t3618r313b3682],
29	during	IN	O	during	_	0	SENT_26	[p2l346t3618r529b3682],
30	this	DT	O	this	det	31	SENT_26	[p2l558t3618r658b3666],
31	trial	NN	O	trial	prep_during	28	SENT_26	[p2l689t3618r798b3666],
32	was	VBD	O	be	cop	34	SENT_26	[p2l827t3635r927b3667],
33	more	RBR	O	more	advmod	34	SENT_26	[p2l960t3635r1102b3666],
34	common	JJ	O	common	rcmod	19	SENT_26	[p2l1133t3635r1376b3666],
35	than	IN	O	than	_	0	SENT_26	[p2l1406t3618r1529b3666],
36	correspondenceto	NN	O	correspondenceto	prep_than	34	SENT_26	[p2l1592t3640r1921b3684],
37	;	:	O	;	_	0	SENT_26	[p2l1592t3640r1921b3684],
38	they	PRP	O	they	nsubj	39	SENT_26	[p2l8t3696r124b3759],
39	remembered	VBD	O	remember	parataxis	34	SENT_26	[p2l142t3696r508b3744],
40	_	CD	NUMBER	_	dobj	39	SENT_26	[p2l142t3696r508b3744],
41	Prof	NNP	O	Prof	nn	43	SENT_26	[p2l1593t3701r1664b3735],
42	Lucio	NNP	PERSON	Lucio	nn	43	SENT_26	[p2l1673t3704r1761b3735],
43	Luzzatto	NNP	PERSON	Luzzatto	dep	40	SENT_26	[p2l1773t3704r1925b3741],
44	,	,	O	,	_	0	SENT_26	[p2l1773t3704r1925b3741],

1	WHO	WP	O	who	nsubj	2	SENT_27	[p3l58t22r217b67],
2	held	VBD	O	hold	_	0	SENT_27	[p3l254t18r371b66],
3	a	DT	O	a	det	4	SENT_27	[p3l407t35r434b66],
4	meeting	NN	O	meeting	dobj	2	SENT_27	[p3l470t21r690b82],
5	of	IN	O	of	_	0	SENT_27	[p3l728t18r787b66],
6	experts	NNS	O	expert	prep_of	4	SENT_27	[p3l815t28r1001b81],
7	in	IN	O	in	_	0	SENT_27	[p3l1040t21r1093b66],
8	Iune	NNP	LOCATION	Iune	prep_in	6	SENT_27	[p3l1131t23r1265b80],
9	,	,	O	,	_	0	SENT_27	[p3l1131t23r1265b80],
10	2004	CD	DATE	2004	appos	8	SENT_27	[p3l1306t22r1440b74],
11	,	,	O	,	_	0	SENT_27	[p3l1306t22r1440b74],
12	to	TO	O	to	aux	13	SENT_27	[p3l1478t28r1528b66],
13	w	VB	O	w	xcomp	2	SENT_27	[p3l1590t10r2020b104],
14	?	.	O	?	_	0	SENT_27	[p3l1590t10r2020b104],

1	+	CC	O	+	nsubj	2	SENT_28	[p3l1590t10r2020b104],
2	discuss	VB	O	discuss	_	0	SENT_28	[p3l10t96r202b145],
3	the	DT	O	the	det	4	SENT_28	[p3l220t96r303b145],
4	role	NN	O	role	dobj	2	SENT_28	[p3l321t96r421b145],
5	of	IN	O	of	_	0	SENT_28	[p3l440t96r499b145],
6	Lapdap	NNP	LOCATION	Lapdap	prep_of	4	SENT_28	[p3l510t96r699b160],
7	in	IN	O	in	_	0	SENT_28	[p3l718t99r771b144],
8	the	DT	O	the	det	9	SENT_28	[p3l787t96r870b145],
9	management	NN	O	management	prep_in	2	SENT_28	[p3l888t106r1243b160],
10	of	IN	O	of	_	0	SENT_28	[p3l1260t96r1319b145],
11	malaria	NN	O	malaria	nn	12	SENT_28	[p3l1327t96r1529b145],
12	Florence	NNP	LOCATION	Florence	prep_of	9	SENT_28	[p3l1593t132r1734b166],
13	50139	CD	NUMBER	50139	num	12	SENT_28	[p3l1745t137r1863b172],
14	,	,	O	,	_	0	SENT_28	[p3l1745t137r1863b172],
15	Italy	NNP	LOCATION	Italy	poss	17	SENT_28	[p3l1876t132r1946b176],
16	'	POS	O	'	_	0	SENT_28	[p3l2024t99r2030b109],
17	(	NN	O	(	dobj	2	SENT_28	[p3l13t179r56b238],
18	a	DT	DURATION	a	det	20	SENT_28	[p3l13t179r56b238],
19	few	JJ	DURATION	few	amod	20	SENT_28	[p3l79t174r173b223],
20	months	NNS	DURATION	month	nsubjpass	25	SENT_28	[p3l195t174r399b223],
21	after	IN	O	after	_	0	SENT_28	[p3l424t174r544b223],
22	the	DT	O	the	det	23	SENT_28	[p3l565t174r648b223],
23	drug	NN	O	drug	prep_after	20	SENT_28	[p3l672t174r797b238],
24	was	VBD	O	be	auxpass	25	SENT_28	[p3l818t192r917b223],
25	licensed	VBN	O	license	rcmod	17	SENT_28	[p3l940t174r1160b223],
26	in	IN	O	in	_	0	SENT_28	[p3l1182t178r1235b222],
27	the	DT	O	the	det	28	SENT_28	[p3l1257t174r1340b223],
28	UK	NNP	LOCATION	UK	prep_in	25	SENT_28	[p3l1366t179r1454b223],
29	in	IN	O	in	_	0	SENT_28	[p3l1475t177r1529b222],
30	Iucio,Iuzzatto@ittumorijt	NNP	O	Iucio,Iuzzatto@ittumorijt	nn	31	SENT_28	[p3l1592t194r2069b234],
31	October	NNP	DATE	October	prep_in	25	SENT_28	[p3l11t253r229b309],
32	,	,	DATE	,	_	0	SENT_28	[p3l11t253r229b309],
33	2003	CD	DATE	2003	num	34	SENT_28	[p3l261t258r401b317],
34	)	NN	O	)	appos	31	SENT_28	[p3l261t258r401b317],
35	with	IN	O	with	_	0	SENT_28	[p3l431t253r549b302],
36	special	JJ	O	special	amod	37	SENT_28	[p3l578t253r757b316],
37	regard	NN	O	regard	prep_with	34	SENT_28	[p3l785t253r957b317],
38	to	TO	O	to	_	0	SENT_28	[p3l983t263r1032b302],
39	safety	NN	O	safety	nn	40	SENT_28	[p3l1062t253r1214b317],
40	issues	NNS	O	issue	prep_to	25	SENT_28	[p3l1240t256r1415b302],
41	.	.	O	.	_	0	SENT_28	[p3l1240t256r1415b302],

1	On	IN	O	on	_	0	SENT_29	[p3l1448t257r1529b302],
2	the	DT	O	the	det	3	SENT_29	[p3l8t331r91b379],
3	basis	NN	O	basis	prep_on	11	SENT_29	[p3l109t331r242b379],
4	of	IN	O	of	_	0	SENT_29	[p3l263t331r322b379],
5	the	DT	O	the	det	7	SENT_29	[p3l331t331r414b379],
6	available	JJ	O	available	amod	7	SENT_29	[p3l434t331r662b379],
7	evidence	NN	O	evidence	prep_of	3	SENT_29	[p3l682t331r926b387],
8	,	,	O	,	_	0	SENT_29	[p3l682t331r926b387],
9	the	DT	O	the	det	10	SENT_29	[p3l947t331r1030b379],
10	group	NN	O	group	nsubj	25	SENT_29	[p3l1051t348r1206b395],
11	concluded	VBD	O	conclude	_	0	SENT_29	[p3l1227t331r1528b379],
12	”	RB	O	”	advmod	11	SENT_29	[p3l1227t331r1528b379],
13	that	IN	O	that	complm	17	SENT_29	[p3l8t410r112b458],
14	this	DT	O	this	det	15	SENT_29	[p3l127t410r224b458],
15	drug	NN	O	drug	nsubjpass	17	SENT_29	[p3l244t410r368b474],
16	was	VBD	O	be	auxpass	17	SENT_29	[p3l384t427r483b458],
17	contraindicated	VBN	O	contraindicate	ccomp	11	SENT_29	[p3l502t410r917b458],
18	in	IN	O	in	_	0	SENT_29	[p3l933t413r986b457],
19	patients	NNS	O	patient	prep_in	17	SENT_29	[p3l1003t413r1213b473],
20	with	IN	O	with	_	0	SENT_29	[p3l1230t410r1348b458],
21	G6PD	NN	O	g6pd	nn	22	SENT_29	[p3l1367t413r1527b458],
22	deﬁciency	NN	O	deﬁciency	prep_with	19	SENT_29	[p3l10t487r284b551],
23	,	,	O	,	_	0	SENT_29	[p3l10t487r284b551],
24	and	CC	O	and	_	0	SENT_29	[p3l322t487r420b536],
25	made	VBD	O	make	conj_and	11	SENT_29	[p3l454t487r601b536],
26	several	JJ	O	several	amod	27	SENT_29	[p3l638t487r819b536],
27	recommendations	NNS	O	recommendation	dobj	25	SENT_29	[p3l853t487r1354b536],
28	.	.	O	.	_	0	SENT_29	[p3l853t487r1354b536],

1	First	RB	ORDINAL	first	_	0	SENT_30	[p3l1395t490r1526b543],
2	,	,	O	,	_	0	SENT_30	[p3l1395t490r1526b543],
3	that	IN	O	that	dep	7	SENT_30	[p3l8t565r112b614],
4	Lapdap	NN	PERSON	lapdap	nsubjpass	7	SENT_30	[p3l143t565r332b628],
5	should	MD	O	should	aux	7	SENT_30	[p3l364t565r544b614],
6	be	VB	O	be	auxpass	7	SENT_30	[p3l571t565r633b614],
7	used	VBN	O	use	dep	1	SENT_30	[p3l661t565r788b614],
8	only	RB	O	only	advmod	7	SENT_30	[p3l817t565r931b629],
9	after	IN	O	after	_	0	SENT_30	[p3l959t565r1079b614],
10	severe	JJ	O	severe	amod	11	SENT_30	[p3l1109t582r1272b614],
11	anaemia	NN	O	anaemia	prep_after	7	SENT_30	[p3l1302t568r1529b614],
12	(	CD	NUMBER	(	num	13	SENT_30	[p3l13t644r381b708],
13	haemoglobin	NN	O	haemoglobin	npadvmod	14	SENT_30	[p3l13t644r381b708],
14	<	JJR	O	<	amod	11	SENT_30	[p3l405t647r501b692],
15	50	CD	NUMBER	50	num	16	SENT_30	[p3l405t647r501b692],
16	g	NN	O	g	dep	11	SENT_30	[p3l526t649r579b708],
17	/	:	O	/	punct	1	SENT_30	[p3l526t649r579b708],
18	L	NN	O	l	nn	19	SENT_30	[p3l586t649r631b708],
19	)	NN	O	)	nsubjpass	25	SENT_30	[p3l586t649r631b708],
20	and	CC	O	and	_	0	SENT_30	[p3l659t644r757b692],
21	G6PD	NN	O	g6pd	nn	22	SENT_30	[p3l782t647r941b692],
22	deﬁciency	NN	O	deﬁciency	conj_and	19	SENT_30	[p3l967t644r1234b707],
23	have	VBP	O	have	aux	25	SENT_30	[p3l1255t644r1377b692],
24	been	VBN	O	be	auxpass	25	SENT_30	[p3l1400t644r1529b692],
25	excluded	VBN	O	exclude	dep	1	SENT_30	[p3l10t721r256b770],
26	.	.	O	.	_	0	SENT_30	[p3l10t721r256b770],

1	Second	RB	ORDINAL	second	advmod	22	SENT_31	[p3l290t721r493b777],
2	,	,	O	,	_	0	SENT_31	[p3l290t721r493b777],
3	where	WRB	O	where	advmod	7	SENT_31	[p3l521t721r684b770],
4	G6PD	NN	O	g6pd	nn	5	SENT_31	[p3l714t725r873b770],
5	deﬁciency	NN	O	deﬁciency	nsubj	7	SENT_31	[p3l903t721r1170b785],
6	is	VBZ	O	be	cop	7	SENT_31	[p3l1196t724r1237b770],
7	prevalent	JJ	O	prevalent	advcl	22	SENT_31	[p3l1266t721r1526b784],
8	,	,	O	,	_	0	SENT_31	[p3l1266t721r1526b784],
9	but	CC	O	but	_	0	SENT_31	[p3l8t798r97b846],
10	appropriate	JJ	O	appropriate	amod	11	SENT_31	[p3l133t801r438b861],
11	tests	NNS	O	test	nsubj	14	SENT_31	[p3l474t807r592b846],
12	are	VBP	O	be	cop	14	SENT_31	[p3l631t815r710b846],
13	not	RB	O	not	neg	14	SENT_31	[p3l747t808r834b846],
14	available	JJ	O	available	conj_but	7	SENT_31	[p3l870t798r1112b854],
15	,	,	O	,	_	0	SENT_31	[p3l870t798r1112b854],
16	an	DT	O	a	det	19	SENT_31	[p3l1151t815r1214b846],
17	alternative	JJ	O	alternative	amod	19	SENT_31	[p3l1251t798r1528b846],
18	antimalarial	JJ	O	antimalarial	amod	19	SENT_31	[p3l10t877r331b925],
19	medicine	NN	O	medicine	nsubjpass	22	SENT_31	[p3l363t877r610b925],
20	should	MD	O	should	aux	22	SENT_31	[p3l644t877r824b925],
21	be	VB	O	be	auxpass	22	SENT_31	[p3l854t877r916b925],
22	given	VBN	O	give	_	0	SENT_31	[p3l949t880r1104b941],
23	.	.	O	.	_	0	SENT_31	[p3l949t880r1104b941],

1	Third	NNP	ORDINAL	Third	nn	3	SENT_32	[p3l1138t877r1301b932],
2	,	,	O	,	_	0	SENT_32	[p3l1138t877r1301b932],
3	Lapdap	NNP	PERSON	Lapdap	nsubjpass	6	SENT_32	[p3l1338t877r1528b940],
4	should	MD	O	should	aux	6	SENT_32	[p3l11t953r191b1001],
5	be	VB	O	be	auxpass	6	SENT_32	[p3l208t953r269b1001],
6	used	VBN	O	use	_	0	SENT_32	[p3l288t953r415b1001],
7	When	WRB	O	when	advmod	9	SENT_32	[p3l431t953r579b1001],
8	there	EX	O	there	expl	9	SENT_32	[p3l597t953r733b1001],
9	is	VBZ	O	be	advcl	6	SENT_32	[p3l753t956r794b1001],
10	no	DT	O	no	det	12	SENT_32	[p3l815t971r882b1001],
11	suitable	JJ	O	suitable	amod	12	SENT_32	[p3l903t953r1109b1001],
12	alternative	NN	O	alternative	nsubj	9	SENT_32	[p3l1129t953r1420b1009],
13	,	,	O	,	_	0	SENT_32	[p3l1129t953r1420b1009],
14	but	CC	O	but	_	0	SENT_32	[p3l1440t953r1530b1001],
15	with	IN	O	with	conj_but	6	SENT_32	[p3l8t1031r126b1079],
16	consideration	NN	O	consideration	pobj	15	SENT_32	[p3l144t1031r507b1079],
17	of	IN	O	of	_	0	SENT_32	[p3l526t1031r585b1079],
18	the	DT	O	the	det	20	SENT_32	[p3l593t1031r676b1079],
19	haematological	JJ	O	haematological	amod	20	SENT_32	[p3l694t1031r1099b1095],
20	risks	NNS	O	risk	prep_of	16	SENT_32	[p3l1117t1031r1257b1079],
21	.	.	O	.	_	0	SENT_32	[p3l1117t1031r1257b1079],

1	After	IN	O	after	_	0	SENT_33	[p3l59t1109r192b1158],
2	WI-IO	NN	O	wi-io	poss	4	SENT_33	[p3l208t1114r407b1158],
3	’s	POS	O	’s	_	0	SENT_33	[p3l208t1114r407b1158],
4	meeting	NN	O	meeting	prep_after	7	SENT_33	[p3l427t1113r658b1173],
5	,	,	O	,	_	0	SENT_33	[p3l427t1113r658b1173],
6	Lapdap	NN	PERSON	lapdap	nsubj	7	SENT_33	[p3l681t1109r868b1173],
7	remained	VBD	O	remain	_	0	SENT_33	[p3l887t1109r1141b1158],
8	on	IN	O	on	_	0	SENT_33	[p3l1158t1127r1225b1158],
9	the	DT	O	the	det	10	SENT_33	[p3l1241t1109r1323b1158],
10	market	NN	O	market	prep_on	7	SENT_33	[p3l1341t1109r1529b1158],
11	for	IN	O	for	_	0	SENT_33	[p3l9t1187r84b1236],
12	4	CD	DURATION	4	num	13	SENT_33	[p3l103t1192r133b1235],
13	years	NNS	NUMBER	year	prep_for	10	SENT_33	[p3l150t1204r284b1251],
14	in	IN	O	in	_	0	SENT_33	[p3l306t1190r359b1235],
15	many	JJ	O	many	amod	17	SENT_33	[p3l380t1205r529b1251],
16	African	JJ	LOCATION	african	amod	17	SENT_33	[p3l547t1187r744b1236],
17	countries	NNS	O	country	prep_in	13	SENT_33	[p3l765t1190r1008b1236],
18	until	IN	O	until	_	0	SENT_33	[p3l1030t1187r1155b1236],
19	Feb	NNP	DATE	Feb	prep_until	7	SENT_33	[p3l1178t1187r1269b1236],
20	29	CD	DATE	29	num	19	SENT_33	[p3l1292t1192r1365b1243],
21	,	,	DATE	,	_	0	SENT_33	[p3l1292t1192r1365b1243],
22	2008	CD	DATE	2008	num	19	SENT_33	[p3l1390t1192r1526b1243],
23	,	,	O	,	_	0	SENT_33	[p3l1390t1192r1526b1243],
24	when	WRB	O	when	advmod	27	SENT_33	[p3l8t1264r154b1312],
25	it	PRP	O	it	nsubjpass	27	SENT_33	[p3l180t1267r216b1312],
26	was	VBD	O	be	auxpass	27	SENT_33	[p3l240t1281r338b1312],
27	withdrawn	VBN	O	withdraw	advcl	7	SENT_33	[p3l364t1264r649b1312],
28	by	IN	O	by	_	0	SENT_33	[p3l674t1264r736b1327],
29	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	agent	27	SENT_33	[p3l763t1264r1217b1312],
30	because	IN	O	because	_	0	SENT_33	[p3l1242t1264r1451b1312],
31	of	IN	O	of	_	0	SENT_33	[p3l1479t1264r1538b1312],
32	“	NN	O	“	nn	34	SENT_33	[p3l12t1342r313b1406],
33	signiﬁcant	NN	O	signiﬁcant	nn	34	SENT_33	[p3l12t1342r313b1406],
34	reductions	NNS	O	reduction	prep_because_of	27	SENT_33	[p3l334t1342r612b1391],
35	in	IN	O	in	_	0	SENT_33	[p3l636t1346r689b1390],
36	haemoglobin	NN	O	haemoglobin	nn	37	SENT_33	[p3l710t1342r1059b1406],
37	levels	NNS	O	level	prep_in	34	SENT_33	[p3l1080t1342r1224b1391],
38	of	IN	O	of	_	0	SENT_33	[p3l1248t1342r1307b1391],
39	patients	NNS	O	patient	prep_of	37	SENT_33	[p3l1319t1346r1527b1406],
40	with	IN	O	with	_	0	SENT_33	[p3l8t1420r124b1469],
41	G6PD	NN	O	g6pd	nn	43	SENT_33	[p3l174t1424r332b1469],
42	deﬁciency	NN	O	deﬁciency	nn	43	SENT_33	[p3l382t1420r714b1484],
43	”	NN	O	”	prep_with	39	SENT_33	[p3l382t1420r714b1484],
44	.	.	O	.	_	0	SENT_33	[p3l382t1420r714b1484],

1	“	NN	O	“	ccomp	8	SENT_34	[p3l382t1420r714b1484],
2	Thereafter	RB	O	thereafter	advmod	1	SENT_34	[p3l761t1420r1044b1476],
3	,	,	O	,	_	0	SENT_34	[p3l761t1420r1044b1476],
4	investigators	NNS	O	investigator	nsubj	8	SENT_34	[p3l1094t1424r1427b1484],
5	in	IN	O	in	_	0	SENT_34	[p3l1476t1424r1529b1468],
6	several	JJ	O	several	amod	7	SENT_34	[p3l11t1499r189b1548],
7	studies	NNS	O	study	prep_in	4	SENT_34	[p3l251t1499r434b1548],
8	(	VBP	O	(	dep	33	SENT_34	[p3l499t1504r597b1563],
9	see	VB	O	see	ccomp	8	SENT_34	[p3l499t1504r597b1563],
10	webappendix	JJ	O	webappendix	amod	11	SENT_34	[p3l655t1499r1019b1563],
11	)	NN	O	)	nsubj	12	SENT_34	[p3l655t1499r1019b1563],
12	reported	VBD	O	report	ccomp	9	SENT_34	[p3l1083t1499r1306b1562],
13	severe	JJ	O	severe	nsubj	14	SENT_34	[p3l1367t1516r1528b1548],
14	See	VB	O	see	ccomp	12	SENT_34	[p3l1592t1516r1650b1547],
15	Onlineforwebappendix	NN	O	onlineforwebappendix	nn	17	SENT_34	[p3l1662t1513r2088b1557],
16	haemolytic	JJ	O	haemolytic	amod	17	SENT_34	[p3l8t1578r298b1641],
17	attacks	NNS	O	attack	dobj	14	SENT_34	[p3l318t1578r495b1626],
18	after	IN	O	after	_	0	SENT_34	[p3l518t1578r636b1626],
19	taking	VBG	O	take	prepc_after	14	SENT_34	[p3l655t1578r820b1642],
20	Lapdap	JJ	PERSON	lapdap	dobj	19	SENT_34	[p3l843t1578r1031b1641],
21	mostly	RB	O	mostly	advmod	19	SENT_34	[p3l1052t1578r1229b1641],
22	in	IN	O	in	_	0	SENT_34	[p3l1248t1581r1301b1625],
23	boys	NNS	O	boy	prep_in	19	SENT_34	[p3l1320t1578r1452b1641],
24	,	,	O	,	_	0	SENT_34	[p3l1320t1578r1452b1641],
25	as	IN	O	as	_	0	SENT_34	[p3l1476t1595r1527b1626],
26	expected	VBN	O	expect	amod	27	SENT_34	[p3l10t1654r589b1717],
27	—	NN	O	—	prep_as	19	SENT_34	[p3l10t1654r589b1717],
28	sometimes	RB	O	sometimes	advmod	12	SENT_34	[p3l10t1654r589b1717],
29	these	DT	O	these	det	30	SENT_34	[p3l619t1654r757b1703],
30	attacks	NNS	O	attack	nsubj	33	SENT_34	[p3l788t1654r965b1703],
31	were	VBD	O	be	cop	33	SENT_34	[p3l994t1672r1120b1703],
32	so	RB	O	so	advmod	33	SENT_34	[p3l1151t1671r1205b1703],
33	severe	JJ	O	severe	_	0	SENT_34	[p3l1237t1671r1398b1703],
34	that	IN	O	that	complm	39	SENT_34	[p3l1427t1654r1530b1703],
35	emergency	NN	O	emergency	nn	37	SENT_34	[p3l10t1749r300b1796],
36	blood	NN	O	blood	nn	37	SENT_34	[p3l315t1732r462b1780],
37	transfusion	NN	O	transfusion	nsubj	39	SENT_34	[p3l478t1732r781b1780],
38	was	VBD	O	be	cop	39	SENT_34	[p3l797t1749r895b1780],
39	necessary	JJ	O	necessary	ccomp	33	SENT_34	[p3l914t1749r1176b1796],
40	.	.	O	.	_	0	SENT_34	[p3l914t1749r1176b1796],

1	G6PD	NN	O	g6pd	nn	2	SENT_35	[p3l61t1814r221b1859],
2	deﬁciency	NN	O	deﬁciency	nsubj	13	SENT_35	[p3l252t1811r519b1874],
3	in	IN	O	in	_	0	SENT_35	[p3l547t1814r600b1858],
4	relation	NN	O	relation	prep_in	2	SENT_35	[p3l628t1811r833b1859],
5	to	TO	O	to	_	0	SENT_35	[p3l861t1820r910b1859],
6	the	DT	O	the	det	7	SENT_35	[p3l938t1811r1021b1859],
7	use	NN	O	use	prep_to	4	SENT_35	[p3l1050t1828r1141b1859],
8	of	IN	O	of	_	0	SENT_35	[p3l1171t1811r1230b1859],
9	drugs	NNS	O	drug	prep_of	7	SENT_35	[p3l1250t1811r1400b1875],
10	is	VBZ	O	be	cop	13	SENT_35	[p3l1430t1814r1471b1859],
11	a	DT	O	a	det	13	SENT_35	[p3l1502t1828r1529b1859],
12	classic	JJ	O	classic	amod	13	SENT_35	[p3l10t1888r180b1937],
13	example	NN	O	example	_	0	SENT_35	[p3l195t1888r415b1951],
14	of	IN	O	of	_	0	SENT_35	[p3l431t1888r490b1937],
15	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	13	SENT_35	[p3l494t1888r996b1952],
16	,	,	O	,	_	0	SENT_35	[p3l494t1888r996b1952],
17	and	CC	O	and	_	0	SENT_35	[p3l1013t1888r1111b1937],
18	the	DT	O	the	det	20	SENT_35	[p3l1123t1888r1206b1937],
19	case	NN	O	case	nn	20	SENT_35	[p3l1221t1905r1331b1937],
20	history	NN	O	history	nsubj	28	SENT_35	[p3l1345t1888r1530b1952],
21	of	IN	O	of	_	0	SENT_35	[p3l10t1966r69b2014],
22	Lapdap	NNP	O	Lapdap	prep_of	20	SENT_35	[p3l81t1966r270b2029],
23	for	IN	O	for	_	0	SENT_35	[p3l289t1966r365b2014],
24	malaria	NN	O	malaria	prep_for	22	SENT_35	[p3l382t1966r584b2014],
25	is	VBZ	O	be	cop	28	SENT_35	[p3l602t1969r643b2014],
26	a	DT	O	a	det	28	SENT_35	[p3l664t1983r690b2014],
27	good	JJ	O	good	amod	28	SENT_35	[p3l709t1966r838b2030],
28	example	NN	O	example	conj_and	13	SENT_35	[p3l856t1966r1077b2029],
29	to	TO	O	to	aux	30	SENT_35	[p3l1095t1975r1144b2014],
30	consider	VB	O	consider	infmod	28	SENT_35	[p3l1164t1966r1398b2014],
31	.	.	O	.	_	0	SENT_35	[p3l1164t1966r1398b2014],

1	First	RB	ORDINAL	first	advmod	8	SENT_36	[p3l62t2047r195b2100],
2	,	,	O	,	_	0	SENT_36	[p3l62t2047r195b2100],
3	the	DT	O	the	det	5	SENT_36	[p3l220t2044r303b2093],
4	fundamental	JJ	O	fundamental	amod	5	SENT_36	[p3l327t2044r674b2093],
5	notion	NN	O	notion	nsubj	8	SENT_36	[p3l697t2048r873b2093],
6	of	IN	O	of	_	0	SENT_36	[p3l897t2044r956b2093],
7	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	5	SENT_36	[p3l970t2044r1460b2108],
8	is	VBZ	O	be	_	0	SENT_36	[p3l1485t2048r1526b2093],
9	that	DT	O	that	det	10	SENT_36	[p3l8t2122r113b2171],
10	genes	NNS	O	gene	nsubj	12	SENT_36	[p3l159t2139r311b2186],
11	strongly	RB	O	strongly	advmod	12	SENT_36	[p3l361t2122r578b2186],
12	affect	VBP	O	affect	ccomp	8	SENT_36	[p3l624t2123r769b2171],
13	susceptibility	NN	O	susceptibility	dobj	12	SENT_36	[p3l817t2122r1171b2186],
14	to	TO	O	to	_	0	SENT_36	[p3l1215t2132r1265b2171],
15	a	DT	O	a	det	16	SENT_36	[p3l1313t2140r1340b2171],
16	drug	NN	O	drug	prep_to	12	SENT_36	[p3l1387t2122r1526b2186],
17	,	,	O	,	_	0	SENT_36	[p3l1387t2122r1526b2186],
18	including	VBG	O	include	_	0	SENT_36	[p3l9t2200r267b2264],
19	its	PRP$	O	its	poss	21	SENT_36	[p3l316t2203r376b2248],
20	toxic	JJ	O	toxic	amod	21	SENT_36	[p3l426t2203r551b2248],
21	effects	NNS	O	effect	prep_including	12	SENT_36	[p3l600t2200r784b2248],
22	.	.	O	.	_	0	SENT_36	[p3l600t2200r784b2248],

1	When	WRB	O	when	advmod	5	SENT_37	[p3l835t2200r998b2249],
2	many	JJ	O	many	amod	3	SENT_37	[p3l1046t2217r1197b2264],
3	genes	NNS	O	gene	nsubjpass	5	SENT_37	[p3l1245t2217r1397b2264],
4	are	VBP	O	be	auxpass	5	SENT_37	[p3l1448t2217r1528b2248],
5	involved	VBN	O	involve	advcl	13	SENT_37	[p3l9t2277r247b2333],
6	,	,	O	,	_	0	SENT_37	[p3l9t2277r247b2333],
7	prediction	NN	O	prediction	nsubjpass	13	SENT_37	[p3l289t2277r564b2340],
8	of	IN	O	of	_	0	SENT_37	[p3l605t2277r664b2326],
9	toxic	JJ	O	toxic	amod	10	SENT_37	[p3l694t2281r819b2326],
10	effects	NNS	O	effect	prep_of	7	SENT_37	[p3l859t2278r1029b2326],
11	can	MD	O	can	aux	13	SENT_37	[p3l1071t2295r1163b2326],
12	be	VB	O	be	auxpass	13	SENT_37	[p3l1201t2277r1263b2326],
13	diﬂicult	VBN	O	diﬂicult	_	0	SENT_37	[p3l1305t2277r1525b2326],
14	.	.	O	.	_	0	SENT_37	[p3l1305t2277r1525b2326],

1	However	RB	O	however	advmod	14	SENT_38	[p3l12t2360r258b2411],
2	,	,	O	,	_	0	SENT_38	[p3l12t2360r258b2411],
3	in	IN	O	in	_	0	SENT_38	[p3l278t2358r331b2403],
4	the	DT	O	the	det	5	SENT_38	[p3l347t2355r431b2404],
5	case	NN	O	case	prep_in	14	SENT_38	[p3l450t2372r560b2404],
6	of	IN	O	of	_	0	SENT_38	[p3l579t2355r638b2404],
7	Lapdap	NNP	PERSON	Lapdap	prep_of	5	SENT_38	[p3l649t2355r840b2418],
8	a	DT	O	a	det	10	SENT_38	[p3l859t2373r885b2404],
9	single	JJ	O	single	amod	10	SENT_38	[p3l904t2355r1062b2419],
10	gene	NN	O	gene	nsubj	14	SENT_38	[p3l1080t2372r1220b2419],
11	,	,	O	,	_	0	SENT_38	[p3l1080t2372r1220b2419],
12	G6PD	NN	O	g6pd	appos	10	SENT_38	[p3l1245t2359r1418b2411],
13	,	,	O	,	_	0	SENT_38	[p3l1245t2359r1418b2411],
14	has	VBZ	O	have	_	0	SENT_38	[p3l1437t2355r1527b2404],
15	a	DT	O	a	det	17	SENT_38	[p3l10t2450r36b2481],
16	major	JJ	O	major	amod	17	SENT_38	[p3l63t2436r222b2497],
17	effect	NN	O	effect	dobj	14	SENT_38	[p3l248t2433r393b2481],
18	and	CC	O	and	_	0	SENT_38	[p3l419t2433r518b2481],
19	assay	NN	O	assay	nn	20	SENT_38	[p3l544t2450r685b2496],
20	methods	NNS	O	method	nsubjpass	23	SENT_38	[p3l710t2433r942b2481],
21	are	VBP	O	be	auxpass	23	SENT_38	[p3l971t2450r1051b2481],
22	well	RB	O	well	advmod	23	SENT_38	[p3l1076t2433r1185b2481],
23	established	VBN	O	establish	conj_and	14	SENT_38	[p3l1212t2433r1525b2481],
24	.	.	O	.	_	0	SENT_38	[p3l1212t2433r1525b2481],

1	The	DT	O	the	det	2	SENT_39	[p3l8t2511r111b2560],
2	issue	NN	O	issue	nsubjpass	10	SENT_39	[p3l145t2515r281b2560],
3	of	IN	O	of	_	0	SENT_39	[p3l316t2511r375b2560],
4	testing	NN	O	testing	prep_of	2	SENT_39	[p3l399t2515r581b2575],
5	for	IN	O	for	_	0	SENT_39	[p3l614t2511r691b2560],
6	G6PD	NN	O	g6pd	nn	7	SENT_39	[p3l725t2515r885b2560],
7	deﬁciency	NN	O	deﬁciency	prep_for	4	SENT_39	[p3l921t2511r1190b2575],
8	was	VBD	O	be	auxpass	10	SENT_39	[p3l1221t2529r1320b2560],
9	keenly	RB	O	keenly	advmod	10	SENT_39	[p3l1354t2511r1530b2575],
10	debated	VBN	O	debate	_	0	SENT_39	[p3l10t2589r218b2638],
11	at	IN	O	at	_	0	SENT_39	[p3l247t2599r294b2638],
12	WHO	WP	O	who	nsubj	30	SENT_39	[p3l321t2593r524b2638],
13	’s	POS	O	’s	csubj	30	SENT_39	[p3l321t2593r524b2638],
14	meeting	NN	O	meeting	dep	13	SENT_39	[p3l555t2592r776b2653],
15	in	IN	O	in	mark	22	SENT_39	[p3l805t2592r859b2637],
16	2004	CD	DATE	2004	nsubjpass	22	SENT_39	[p3l890t2593r1025b2645],
17	,	,	O	,	_	0	SENT_39	[p3l890t2593r1025b2645],
18	and	CC	O	and	_	0	SENT_39	[p3l1057t2589r1156b2638],
19	the	DT	O	the	det	20	SENT_39	[p3l1184t2589r1267b2638],
20	fear	NN	O	fear	nsubjpass	22	SENT_39	[p3l1297t2589r1400b2638],
21	was	VBD	O	be	auxpass	22	SENT_39	[p3l1427t2606r1526b2638],
22	expressed	VBN	O	express	dep	14	SENT_39	[p3l10t2667r273b2730],
23	that	IN	O	that	complm	25	SENT_39	[p3l288t2667r392b2715],
24	to	TO	O	to	aux	25	SENT_39	[p3l407t2676r456b2715],
25	dictate	VB	O	dictate	ccomp	22	SENT_39	[p3l475t2667r649b2715],
26	this	DT	O	this	det	27	SENT_39	[p3l666t2667r764b2715],
27	requirement	NN	O	requirement	dobj	25	SENT_39	[p3l783t2670r1122b2730],
28	would	MD	O	would	aux	30	SENT_39	[p3l1136t2667r1302b2715],
29	“	RB	O	“	advmod	30	SENT_39	[p3l1321t2667r1428b2714],
30	kill	VB	O	kill	prepc_at	10	SENT_39	[p3l1321t2667r1428b2714],
31	the	DT	O	the	det	33	SENT_39	[p3l1444t2667r1527b2715],
32	drug	NN	O	drug	nn	33	SENT_39	[p3l10t2744r171b2808],
33	”	NN	O	”	dobj	30	SENT_39	[p3l10t2744r171b2808],
34	.	.	O	.	_	0	SENT_39	[p3l10t2744r171b2808],

1	Whatever	WDT	O	whatever	dep	3	SENT_40	[p3l200t2744r458b2793],
2	the	DT	O	the	det	3	SENT_40	[p3l482t2744r566b2793],
3	merits	NNS	O	merit	dep	10	SENT_40	[p3l593t2748r764b2793],
4	of	IN	O	of	_	0	SENT_40	[p3l793t2744r853b2793],
5	this	DT	O	this	det	6	SENT_40	[p3l869t2744r967b2793],
6	argument	NN	O	argument	prep_of	3	SENT_40	[p3l996t2754r1273b2808],
7	,	,	O	,	_	0	SENT_40	[p3l996t2754r1273b2808],
8	it	PRP	O	it	nsubj	10	SENT_40	[p3l1302t2748r1339b2793],
9	would	MD	O	would	aux	10	SENT_40	[p3l1363t2744r1529b2793],
10	apply	VB	O	apply	_	0	SENT_40	[p3l10t2822r153b2886],
11	to	TO	O	to	_	0	SENT_40	[p3l174t2832r223b2871],
12	clinical	JJ	O	clinical	amod	13	SENT_40	[p3l248t2822r438b2871],
13	usage	NN	O	usage	prep_to	10	SENT_40	[p3l461t2839r628b2886],
14	,	,	O	,	_	0	SENT_40	[p3l461t2839r628b2886],
15	not	RB	O	not	neg	10	SENT_40	[p3l654t2832r742b2871],
16	to	TO	O	to	_	0	SENT_40	[p3l763t2832r813b2871],
17	the	DT	O	the	det	19	SENT_40	[p3l836t2822r919b2871],
18	prelicensing	JJ	O	prelicensing	amod	19	SENT_40	[p3l943t2822r1276b2886],
19	trial	NN	O	trial	prep_to	10	SENT_40	[p3l1298t2822r1419b2878],
20	,	,	O	,	_	0	SENT_40	[p3l1298t2822r1419b2878],
21	the	DT	O	the	det	23	SENT_40	[p3l1444t2822r1527b2871],
22	primary	JJ	O	primary	amod	23	SENT_40	[p3l9t2903r225b2963],
23	aim	NN	O	aim	appos	19	SENT_40	[p3l245t2903r346b2948],
24	of	IN	O	of	_	0	SENT_40	[p3l368t2900r427b2948],
25	which	WDT	O	which	nsubj	26	SENT_40	[p3l437t2900r601b2948],
26	was	VBD	O	be	prep_of	23	SENT_40	[p3l620t2917r719b2948],
27	to	TO	O	to	aux	28	SENT_40	[p3l741t2909r791b2948],
28	assess	VB	O	assess	xcomp	26	SENT_40	[p3l813t2917r976b2948],
29	safety	NN	O	safety	dobj	28	SENT_40	[p3l1000t2900r1153b2963],
30	and	CC	O	and	_	0	SENT_40	[p3l1173t2900r1272b2948],
31	in	IN	O	in	_	0	SENT_40	[p3l1292t2903r1345b2947],
32	which	WDT	O	which	rel	36	SENT_40	[p3l1364t2900r1528b2948],
33	G6PD	NN	O	g6pd	nn	34	SENT_40	[p3l11t2981r171b3026],
34	testing	NN	O	testing	nsubj	36	SENT_40	[p3l206t2980r389b3041],
35	was	VBD	O	be	cop	36	SENT_40	[p3l422t2995r521b3026],
36	essential	JJ	O	essential	prep_of	23	SENT_40	[p3l557t2977r833b3026],
37	.	.	O	.	_	0	SENT_40	[p3l557t2977r833b3026],

1	“	NN	O	“	dep	12	SENT_41	[p3l557t2977r833b3026],
2	Although	IN	O	although	dep	12	SENT_41	[p3l866t2978r1120b3042],
3	several	JJ	O	several	amod	5	SENT_41	[p3l1155t2978r1338b3026],
4	ethics	NNS	O	ethic	nn	5	SENT_41	[p3l1373t2978r1526b3026],
5	committees	NNS	O	committee	nsubj	12	SENT_41	[p3l10t3058r322b3104],
6	assessing	VBG	O	assess	partmod	5	SENT_41	[p3l353t3058r606b3119],
7	Lapdap	NN	PERSON	lapdap	nn	8	SENT_41	[p3l637t3055r827b3118],
8	trials	NNS	O	trial	dobj	6	SENT_41	[p3l855t3055r988b3104],
9	apparently	RB	O	apparently	advmod	6	SENT_41	[p3l1019t3055r1302b3119],
10	did	VBD	O	do	aux	12	SENT_41	[p3l1329t3055r1414b3104],
11	not	RB	O	not	neg	12	SENT_41	[p3l1441t3065r1529b3104],
12	demand	VB	O	demand	advcl	23	SENT_41	[p3l10t3133r229b3182],
13	G6PD	NN	O	g6pd	nn	14	SENT_41	[p3l283t3137r443b3182],
14	testing	NN	O	testing	dobj	12	SENT_41	[p3l496t3136r692b3197],
15	,	,	O	,	_	0	SENT_41	[p3l496t3136r692b3197],
16	the	DT	O	the	det	18	SENT_41	[p3l746t3133r830b3182],
17	Ghanaian	NNP	ORGANIZATION	Ghanaian	nn	18	SENT_41	[p3l885t3133r1145b3182],
18	Ministry	NNP	ORGANIZATION	Ministry	nsubj	23	SENT_41	[p3l1199t3136r1426b3197],
19	of	IN	ORGANIZATION	of	_	0	SENT_41	[p3l1478t3133r1537b3182],
20	Health	NNP	ORGANIZATION	Health	poss	22	SENT_41	[p3l12t3212r230b3260],
21	’s	POS	O	’s	_	0	SENT_41	[p3l12t3212r230b3260],
22	committee	NN	O	committee	prep_of	18	SENT_41	[p3l251t3215r538b3260],
23	did	VBD	O	do	_	0	SENT_41	[p3l558t3212r688b3260],
24	.	.	O	.	_	0	SENT_41	[p3l558t3212r688b3260],

1	“	NN	O	“	_	0	SENT_42	[p3l558t3212r688b3260],

1	I	PRP	O	I	_	0	SENT_43	[p3l6t3500r54b3698],
2	Viewpoint	NN	O	viewpoint	dep	1	SENT_43	[p3l101t3664r312b3710],

1	Primaquine	NN	O	primaquine	dep	5	SENT_44	[p4l1242t203r1439b243],
2	or	CC	O	or	_	0	SENT_44	[p4l1449t211r1484b233],
3	dapsone	NN	O	dapsone	dep	5	SENT_44	[p4l1494t200r1639b243],
4	(	CD	NUMBER	(	dep	5	SENT_44	[p4l1241t255r1352b297],
5	redox	NN	O	redox	dep	7	SENT_44	[p4l1241t255r1352b297],
6	agents	NNS	O	agent	dep	5	SENT_44	[p4l1362t256r1490b298],
7	)	CD	NUMBER	)	_	0	SENT_44	[p4l1362t256r1490b298],
8	given	VBN	O	give	partmod	7	SENT_44	[p4l1502t257r1594b298],

1	With	IN	O	with	_	0	SENT_45	[p4l218t346r300b379],
2	no	DT	O	no	det	3	SENT_45	[p4l315t357r356b379],
3	malaria	NN	O	malaria	prep_with	11	SENT_45	[p4l370t346r504b385],
4	,	,	O	,	_	0	SENT_45	[p4l370t346r504b385],
5	G6PD	NN	O	g6pd	nn	6	SENT_45	[p4l219t400r313b434],
6	deﬁciency	NN	O	deﬁciency	nsubj	11	SENT_45	[p4l323t400r495b444],
7	remains	VBZ	O	remain	cop	11	SENT_45	[p4l220t458r356b489],
8	rare	JJ	O	rare	amod	11	SENT_45	[p4l369t467r432b489],
9	Oxidative	JJ	O	oxidative	amod	11	SENT_45	[p4l1638t448r1802b481],
10	stress	NN	O	stress	nn	11	SENT_45	[p4l1813t454r1909b481],
11	Antimalarial	NN	O	antimalarial	_	0	SENT_45	[p4l1048t500r1259b533],
12	on	IN	O	on	_	0	SENT_45	[p4l1637t514r1680b536],
13	erythrocytes	NNS	O	erythrocyte	nn	14	SENT_45	[p4l1692t502r1907b546],
14	activity	NN	O	activity	prep_on	11	SENT_45	[p4l1048t558r1175b598],

1	E	NN	O	e	_	0	SENT_46	[p4l395t829r633b922],
2	°	SYM	O	°	dep	1	SENT_46	[p4l846t851r872b879],

1	Spontaneous	JJ	O	spontaneous	amod	4	SENT_47	[p4l142t889r369b930],
2	. . .	NN	O	. . .	nn	4	SENT_47	[p4l1232t912r1258b941],[p4l648t916r674b945],
3	o	NN	O	o	nn	4	SENT_47	[p4l1382t887r1408b915],
4	mutation	NN	O	mutation	_	0	SENT_47	[p4l143t944r303b975],
5	of	IN	O	of	_	0	SENT_47	[p4l315t941r352b975],
6	G6PD	NN	O	g6pd	nn	7	SENT_47	[p4l361t941r454b975],
7	W	NN	O	w	prep_of	4	SENT_47	[p4l704t907r761b1005],
8	.	.	O	.	_	0	SENT_47	[p4l790t928r816b957],

1	O	NN	O	o	nn	2	SENT_48	[p4l1101t947r1127b976],
2	W	NN	O	w	_	0	SENT_48	[p4l1366t917r1423b1015],

1	W	NNP	O	W	nn	2	SENT_49	[p4l632t946r690b1044],
2	W	NNP	O	W	nsubj	3	SENT_49	[p4l775t958r832b1056],
3	\	VBD	O	\	_	0	SENT_49	[p4l902t954r1044b1043],
4	\	CD	NUMBER	\	number	5	SENT_49	[p4l902t954r1044b1043],
5	_	CD	NUMBER	_	dobj	3	SENT_49	[p4l902t954r1044b1043],
6	v	LS	O	v	prep	3	SENT_49	[p4l902t954r1044b1043],
7	w	NN	O	w	dep	6	SENT_49	[p4l1086t977r1143b1076],
8	.	.	O	.	_	0	SENT_49	[p4l1275t1001r1301b1029],

1	Selective	JJ	O	selective	amod	2	SENT_50	[p4l1734t979r1884b1012],
2	haemolysis	NN	O	haemolysis	_	0	SENT_50	[p4l1897t979r2087b1022],
3	.	.	O	.	_	0	SENT_50	[p4l1018t1063r1044b1092],
4	'	''	O	'	_	0	SENT_50	[p4l1385t1026r1411b1055],

1	of	IN	O	of	_	0	SENT_51	[p4l1733t1033r1770b1067],
2	G6PD	NN	O	g6pd	nn	4	SENT_51	[p4l1779t1033r2040b1067],
3	—	CD	NUMBER	—	num	4	SENT_51	[p4l1779t1033r2040b1067],
4	deﬁcient	NN	O	deﬁcient	pobj	1	SENT_51	[p4l1779t1033r2040b1067],

1	Large	JJ	O	large	amod	2	SENT_52	[p4l412t1090r503b1131],
2	numbers	NNS	O	number	dep	7	SENT_52	[p4l516t1087r667b1120],
3	of	IN	O	of	_	0	SENT_52	[p4l677t1087r714b1120],
4	W	NN	O	w	nn	6	SENT_52	[p4l1369t1057r1426b1155],
5	erythrocytes	NNS	O	erythrocyte	nn	6	SENT_52	[p4l1733t1088r1948b1132],
6	people	NNS	O	people	prep_of	2	SENT_52	[p4l410t1142r525b1185],
7	infected	JJ	O	infected	_	0	SENT_52	[p4l538t1141r677b1175],
8	W	NNP	O	W	nn	10	SENT_52	[p4l1003t1093r1060b1192],
9	W	NNP	O	W	nn	10	SENT_52	[p4l1228t1140r1286b1239],
10	W	NNP	O	W	dep	11	SENT_52	[p4l1313t1091r1374b1222],
11	“	IN	O	“	dep	7	SENT_52	[p4l1830t1174r1922b1266],

1	6	CD	NUMBER	6	num	3	SENT_53	[p4l647t1211r666b1385],
2	<	JJR	O	<	amod	3	SENT_53	[p4l702t1211r729b1385],
3	K	NN	O	k	_	0	SENT_53	[p4l751t1211r794b1385],
4	In	IN	O	in	dep	3	SENT_53	[p4l1028t1259r1056b1288],
5	areas	NNS	O	area	pobj	4	SENT_53	[p4l1068t1267r1156b1289],
6	of	IN	O	of	_	0	SENT_53	[p4l1166t1255r1203b1289],
7	endemic	JJ	O	endemic	amod	8	SENT_53	[p4l1211t1255r1359b1289],
8	malaria	NN	O	malaria	prep_of	5	SENT_53	[p4l1372t1255r1506b1294],
9	,	,	O	,	_	0	SENT_53	[p4l1372t1255r1506b1294],
10	pI	NN	O	pi	prep_of	5	SENT_53	[p4l1607t1192r1847b1360],
11	+	CC	O	+	_	0	SENT_53	[p4l1607t1192r1847b1360],
12	o	NN	O	o	conj_+	8	SENT_53	[p4l1941t1209r2033b1300],

1	Plasmodium	NN	O	plasmodium	nn	2	SENT_54	[p4l1026t1310r1229b1343],
2	falciparum	NN	O	falciparum	nsubj	4	SENT_54	[p4l1240t1310r1414b1354],
3	has	VBZ	O	have	aux	4	SENT_54	[p4l1027t1365r1083b1398],
4	selected	VBN	O	select	_	0	SENT_54	[p4l1094t1365r1232b1398],
5	for	IN	O	for	mark	7	SENT_54	[p4l1242t1365r1293b1398],
6	people	NNS	O	people	nsubj	7	SENT_54	[p4l1303t1365r1418b1408],
7	‘	VBP	O	‘	advcl	4	SENT_54	[p4l1676t1327r1768b1418],
8	D	NN	O	d	dobj	7	SENT_54	[p4l1808t1360r1899b1451],

1	Plasmodium	NN	O	plasmodium	nn	2	SENT_55	[p4l532t1399r734b1433],
2	falciparum	NN	O	falciparum	_	0	SENT_55	[p4l745t1399r920b1443],
3	with	IN	O	with	_	0	SENT_55	[p4l1025t1420r1101b1453],
4	G6PD	NN	O	g6pd	nn	5	SENT_55	[p4l1114t1419r1208b1453],
5	deﬁciency	NN	O	deﬁciency	prep_with	2	SENT_55	[p4l1219t1419r1391b1463],

1	@	IN	O	@	dep	11	SENT_56	[p4l59t1521r150b1613],
2	Ma	NNP	O	Ma	nn	9	SENT_56	[p4l176t1546r458b1580],
3	|	CD	NUMBER	|	num	4	SENT_56	[p4l176t1546r458b1580],
4	aria	NN	O	aria	dep	5	SENT_56	[p4l176t1546r458b1580],
5	—	RB	O	—	amod	9	SENT_56	[p4l176t1546r458b1580],
6	infected	JJ	O	infected	amod	9	SENT_56	[p4l176t1546r458b1580],
7	erythrocyte	NN	O	erythrocyte	nn	9	SENT_56	[p4l470t1546r667b1590],
8	W	NN	O	w	nn	9	SENT_56	[p4l859t1550r916b1648],
9	G6PD_norma	NN	O	g6pd_norma	pobj	1	SENT_56	[p4l941t1568r1303b1611],
10	|	CD	NUMBER	|	num	11	SENT_56	[p4l941t1568r1303b1611],
11	perSOn	NN	O	person	_	0	SENT_56	[p4l941t1568r1303b1611],
12	©	CD	NUMBER	©	num	14	SENT_56	[p4l58t1624r149b1716],
13	G6PD	NN	O	g6pd	nn	14	SENT_56	[p4l175t1651r436b1685],
14	—	NN	O	—	nn	16	SENT_56	[p4l175t1651r436b1685],
15	deﬁcient	JJ	O	deﬁcient	amod	16	SENT_56	[p4l175t1651r436b1685],
16	erythrocyte	NN	O	erythrocyte	dep	11	SENT_56	[p4l447t1652r645b1695],

1	Q	NNP	O	Q	_	0	SENT_57	[p4l855t1656r915b1787],
2	?	.	O	?	_	0	SENT_57	[p4l855t1656r915b1787],

1	G6PD	NN	O	g6pd	_	0	SENT_58	[p4l941t1701r1329b1745],
2	—	CD	NUMBER	—	num	3	SENT_58	[p4l941t1701r1329b1745],
3	deﬁcientperson	NN	O	deﬁcientperson	dep	1	SENT_58	[p4l941t1701r1329b1745],

1	o	NN	O	o	nn	2	SENT_59	[p4l58t1727r149b1819],
2	G6PD	NN	O	g6pd	_	0	SENT_59	[p4l174t1756r408b1790],
3	—	CD	NUMBER	—	num	4	SENT_59	[p4l174t1756r408b1790],
4	norma	NN	O	norma	dep	2	SENT_59	[p4l174t1756r408b1790],
5	|	NN	O	|	nn	6	SENT_59	[p4l174t1756r408b1790],
6	erythrocyte	NN	O	erythrocyte	dep	2	SENT_59	[p4l421t1757r619b1800],

1	Figure	NN	O	figure	_	0	SENT_60	[p4l8t1888r133b1934],
2	:	:	O	:	_	0	SENT_60	[p4l8t1888r133b1934],
3	Pharmacogenetics	NNS	O	pharmacogenetic	dep	1	SENT_60	[p4l146t1887r518b1934],
4	,	,	O	,	_	0	SENT_60	[p4l146t1887r518b1934],
5	G6PD	NN	O	g6pd	nn	6	SENT_60	[p4l530t1887r634b1923],
6	deﬁciency	NN	O	deﬁciency	dep	1	SENT_60	[p4l645t1887r852b1934],
7	,	,	O	,	_	0	SENT_60	[p4l645t1887r852b1934],
8	and	CC	O	and	_	0	SENT_60	[p4l864t1887r938b1923],
9	malaria	NN	O	malaria	nn	10	SENT_60	[p4l951t1887r1095b1923],
10	selection	NN	O	selection	conj_and	3	SENT_60	[p4l1106t1887r1280b1923],
11	Spontaneous	JJ	O	spontaneous	amod	13	SENT_60	[p4l9t1951r254b1995],
12	mutation	NN	O	mutation	nn	13	SENT_60	[p4l268t1951r441b1984],
13	ofG6PD	NN	O	ofg6pd	nsubj	14	SENT_60	[p4l453t1948r606b1984],
14	leads	VBZ	O	lead	rcmod	10	SENT_60	[p4l620t1948r711b1984],
15	to	TO	O	to	_	0	SENT_60	[p4l720t1955r760b1984],
16	G6PD	NN	O	g6pd	nn	17	SENT_60	[p4l772t1948r876b1984],
17	deﬁciency	NN	O	deﬁciency	prep_to	14	SENT_60	[p4l888t1948r1073b1995],
18	(	CD	NUMBER	(	dobj	14	SENT_60	[p4l1086t1948r1221b1993],
19	shown	VBN	O	show	partmod	18	SENT_60	[p4l1086t1948r1221b1993],
20	in	IN	O	in	_	0	SENT_60	[p4l1236t1951r1267b1983],
21	light	JJ	O	light	amod	23	SENT_60	[p4l1282t1948r1365b1995],
22	pink	JJ	O	pink	amod	23	SENT_60	[p4l1377t1948r1481b1995],
23	)	NN	O	)	prep_in	19	SENT_60	[p4l1377t1948r1481b1995],
24	.	.	O	.	_	0	SENT_60	[p4l1377t1948r1481b1995],

1	Because	IN	O	because	mark	6	SENT_61	[p4l1496t1951r1642b1984],
2	erythrocytes	NNS	O	erythrocyte	nsubj	6	SENT_61	[p4l1654t1948r1885b1995],
3	with	IN	O	with	_	0	SENT_61	[p4l1895t1948r1978b1984],
4	G6PD	NN	O	g6pd	nn	5	SENT_61	[p4l1991t1948r2095b1984],
5	deﬁciency	NN	O	deﬁciency	prep_with	2	SENT_61	[p4l9t2008r194b2054],
6	confer	VBP	O	confer	advcl	19	SENT_61	[p4l205t2008r323b2044],
7	protection	NN	O	protection	dobj	6	SENT_61	[p4l333t2011r528b2054],
8	against	IN	O	against	_	0	SENT_61	[p4l541t2011r676b2055],
9	Plasmodium	NN	O	plasmodium	nn	10	SENT_61	[p4l688t2008r907b2044],
10	falciparum	NN	O	falciparum	prep_against	7	SENT_61	[p4l918t2008r1117b2055],
11	,	,	O	,	_	0	SENT_61	[p4l918t2008r1117b2055],
12	positive	JJ	O	positive	amod	13	SENT_61	[p4l1130t2011r1276b2054],
13	selection	NN	O	selection	nsubj	19	SENT_61	[p4l1288t2008r1451b2044],
14	for	IN	O	for	_	0	SENT_61	[p4l1463t2008r1518b2044],
15	people	NNS	O	people	prep_for	13	SENT_61	[p4l1528t2008r1653b2054],
16	with	IN	O	with	_	0	SENT_61	[p4l1663t2008r1746b2043],
17	G6PD	NN	O	g6pd	nn	18	SENT_61	[p4l1759t2008r1863b2044],
18	deﬁciency	NN	O	deﬁciency	prep_with	15	SENT_61	[p4l1875t2008r2060b2054],
19	takes	VBZ	O	take	_	0	SENT_61	[p4l7t2068r104b2104],
20	place	NN	O	place	dobj	19	SENT_61	[p4l116t2068r210b2114],
21	in	IN	O	in	_	0	SENT_61	[p4l223t2071r254b2103],
22	regions	NNS	O	region	prep_in	19	SENT_61	[p4l269t2071r404b2115],
23	of	IN	O	of	_	0	SENT_61	[p4l415t2068r455b2104],
24	endemic	JJ	O	endemic	amod	25	SENT_61	[p4l464t2068r623b2104],
25	malaria	NN	O	malaria	prep_of	22	SENT_61	[p4l636t2068r781b2104],
26	.	.	O	.	_	0	SENT_61	[p4l636t2068r781b2104],

1	Use	NN	O	use	nsubj	10	SENT_62	[p4l795t2071r859b2104],
2	of	IN	O	of	_	0	SENT_62	[p4l870t2068r910b2104],
3	potent	JJ	O	potent	amod	4	SENT_62	[p4l918t2075r1045b2114],
4	antimalarials	NNS	O	antimalarial	prep_of	1	SENT_62	[p4l1057t2068r1296b2104],
5	such	JJ	O	such	_	0	SENT_62	[p4l1308t2068r1390b2104],
6	as	IN	O	as	_	0	SENT_62	[p4l1403t2080r1439b2104],
7	primaquine	NN	O	primaquine	prep_such_as	4	SENT_62	[p4l1451t2071r1666b2114],
8	or	CC	O	or	_	0	SENT_62	[p4l1677t2080r1715b2104],
9	dapsone	NN	O	dapsone	prep_such_as	4	SENT_62	[p4l1725t2068r1882b2114],
10	causes	VBZ	O	cause	_	0	SENT_62	[p4l1894t2080r2012b2104],
11	oxidative	JJ	O	oxidative	amod	12	SENT_62	[p4l9t2128r180b2163],
12	stress	NN	O	stress	dobj	10	SENT_62	[p4l191t2134r295b2163],
13	and	CC	O	and	_	0	SENT_62	[p4l306t2128r375b2163],
14	a	DT	O	a	det	16	SENT_62	[p4l387t2140r406b2163],
15	high	JJ	O	high	amod	16	SENT_62	[p4l419t2128r498b2175],
16	frequency	NN	O	frequency	conj_and	12	SENT_62	[p4l511t2127r696b2174],
17	of	IN	O	of	_	0	SENT_62	[p4l707t2127r746b2163],
18	haemolytic	JJ	O	haemolytic	amod	19	SENT_62	[p4l757t2128r962b2174],
19	episodes	NNS	O	episode	prep_of	16	SENT_62	[p4l974t2128r1134b2174],
20	in	IN	O	in	_	0	SENT_62	[p4l1147t2131r1178b2163],
21	populations	NNS	O	population	prep_in	10	SENT_62	[p4l1191t2128r1414b2174],
22	where	WRB	O	where	advmod	26	SENT_62	[p4l1424t2128r1538b2163],
23	G6PD	NN	O	g6pd	nn	24	SENT_62	[p4l1550t2127r1654b2163],
24	deﬁciency	NN	O	deﬁciency	nsubj	26	SENT_62	[p4l1666t2127r1851b2174],
25	is	VBZ	O	be	cop	26	SENT_62	[p4l1864t2131r1888b2163],
26	common	JJ	O	common	rcmod	21	SENT_62	[p4l1900t2140r2078b2170],
27	,	,	O	,	_	0	SENT_62	[p4l1900t2140r2078b2170],
28	precisely	RB	O	precisely	advmod	29	SENT_62	[p4l8t2188r168b2234],
29	where	WRB	O	where	advmod	34	SENT_62	[p4l177t2188r292b2223],
30	these	DT	O	these	det	31	SENT_62	[p4l301t2188r401b2223],
31	drugs	NNS	O	drug	nsubjpass	34	SENT_62	[p4l412t2188r515b2235],
32	are	VBP	O	be	auxpass	34	SENT_62	[p4l527t2200r583b2223],
33	most	RBS	O	most	advmod	34	SENT_62	[p4l596t2194r690b2223],
34	required	VBN	O	require	advcl	10	SENT_62	[p4l704t2188r865b2234],
35	.	.	O	.	_	0	SENT_62	[p4l704t2188r865b2234],

1	Second	RB	ORDINAL	second	advmod	8	SENT_63	[p4l698t2343r897b2398],
2	,	,	O	,	_	0	SENT_63	[p4l698t2343r897b2398],
3	another	DT	O	another	det	5	SENT_63	[p4l924t2343r1127b2390],
4	classic	JJ	O	classic	amod	5	SENT_63	[p4l1150t2343r1318b2390],
5	teaching	NN	O	teaching	nsubj	8	SENT_63	[p4l1340t2343r1565b2406],
6	of	IN	O	of	_	0	SENT_63	[p4l1589t2343r1648b2390],
7	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	5	SENT_63	[p4l1661t2343r2141b2406],
8	is	VBZ	O	be	_	0	SENT_63	[p4l644t2421r685b2466],
9	that	IN	O	that	complm	20	SENT_63	[p4l721t2418r835b2473],
10	,	,	O	,	_	0	SENT_63	[p4l721t2418r835b2473],
11	because	IN	O	because	mark	12	SENT_63	[p4l872t2418r1080b2466],
12	of	IN	O	of	parataxis	20	SENT_63	[p4l1116t2418r1174b2466],
13	genetic	JJ	O	genetic	amod	14	SENT_63	[p4l1201t2421r1389b2481],
14	differences	NNS	O	difference	pobj	12	SENT_63	[p4l1425t2418r1728b2473],
15	,	,	O	,	_	0	SENT_63	[p4l1425t2418r1728b2473],
16	side-eﬁlects	NNS	O	side-eﬁlects	nsubj	20	SENT_63	[p4l1767t2418r2056b2466],
17	of	IN	O	of	_	0	SENT_63	[p4l2093t2418r2152b2466],
18	drugs	NNS	O	drug	prep_of	16	SENT_63	[p4l645t2494r792b2557],
19	can	MD	O	can	aux	20	SENT_63	[p4l812t2511r902b2542],
20	Vary	VB	O	vary	ccomp	8	SENT_63	[p4l918t2511r1027b2557],
21	in	IN	O	in	_	0	SENT_63	[p4l1043t2497r1096b2541],
22	different	JJ	O	different	amod	23	SENT_63	[p4l1114t2494r1341b2542],
23	populations	NNS	O	population	prep_in	20	SENT_63	[p4l1357t2494r1681b2556],
24	.	.	O	.	_	0	SENT_63	[p4l1357t2494r1681b2556],

1	G6PD	NN	O	g6pd	nn	2	SENT_64	[p4l1703t2498r1860b2542],
2	deﬁciency	NN	O	deﬁciency	nsubjpass	4	SENT_64	[p4l1881t2494r2144b2557],
3	was	VBD	O	be	auxpass	4	SENT_64	[p4l643t2588r740b2618],
4	known	VBN	O	know	_	0	SENT_64	[p4l763t2571r944b2618],
5	to	TO	O	to	aux	6	SENT_64	[p4l965t2580r1014b2618],
6	exist	VB	O	exist	xcomp	4	SENT_64	[p4l1038t2574r1156b2618],
7	in	IN	O	in	_	0	SENT_64	[p4l1177t2574r1229b2617],
8	10-25	CD	PERCENT	10-25	num	9	SENT_64	[p4l1253t2574r1454b2621],
9	%	NN	PERCENT	%	prep_in	6	SENT_64	[p4l1253t2574r1454b2621],
10	of	IN	O	of	_	0	SENT_64	[p4l1478t2571r1536b2618],
11	the	DT	O	the	det	12	SENT_64	[p4l1548t2571r1630b2618],
12	population	NN	O	population	prep_of	9	SENT_64	[p4l1653t2571r1938b2633],
13	of	IN	O	of	_	0	SENT_64	[p4l1961t2571r2019b2618],
14	subSaharan	NNP	O	subSaharan	nn	15	SENT_64	[p4l2034t2571r2142b2618, p4l648t2646r859b2694],
15	Africa	NNP	LOCATION	Africa	prep_of	12	SENT_64	[p4l876t2646r1066b2701],
16	,	,	O	,	_	0	SENT_64	[p4l876t2646r1066b2701],
17	-	:	O	-	_	0	SENT_64	[p4l876t2646r1066b2701],
18	*	NN	O	*	nsubjpass	31	SENT_64	[p4l876t2646r1066b2701],
19	7	CD	NUMBER	7	num	18	SENT_64	[p4l876t2646r1066b2701],
20	which	WDT	O	which	nsubj	25	SENT_64	[p4l1082t2646r1243b2694],
21	is	VBZ	O	be	cop	25	SENT_64	[p4l1260t2650r1301b2694],
22	at	IN	O	at	quantmod	24	SENT_64	[p4l1321t2656r1366b2694],
23	least	JJS	O	least	mwe	22	SENT_64	[p4l1382t2646r1502b2694],
24	one	CD	NUMBER	one	num	25	SENT_64	[p4l1519t2663r1614b2694],
25	order	NN	O	order	rcmod	18	SENT_64	[p4l1632t2646r1773b2694],
26	of	IN	O	of	_	0	SENT_64	[p4l1790t2646r1848b2694],
27	magnitude	NN	O	magnitude	prep_of	25	SENT_64	[p4l1856t2646r2142b2709],
28	higher	JJR	O	higher	dep	29	SENT_64	[p4l643t2722r818b2785],
29	than	IN	O	than	advmod	25	SENT_64	[p4l844t2722r963b2770],
30	is	VBZ	O	be	auxpass	31	SENT_64	[p4l992t2725r1032b2770],
31	reported	VBN	O	report	parataxis	4	SENT_64	[p4l1063t2722r1285b2784],
32	in	IN	O	in	_	0	SENT_64	[p4l1313t2725r1365b2769],
33	the	DT	O	the	det	34	SENT_64	[p4l1393t2722r1475b2770],
34	UK	NNP	LOCATION	UK	prep_in	31	SENT_64	[p4l1507t2727r1606b2777],
35	,	,	O	,	_	0	SENT_64	[p4l1507t2727r1606b2777],
36	where	WRB	O	where	advmod	40	SENT_64	[p4l1636t2722r1797b2770],
37	Lapdap	NNP	PERSON	Lapdap	nsubj	40	SENT_64	[p4l1829t2722r2016b2784],
38	was	VBD	O	be	cop	40	SENT_64	[p4l2044t2739r2141b2770],
39	licensed	JJ	O	licensed	amod	40	SENT_64	[p4l643t2799r860b2846],
40	(	NN	O	(	rcmod	34	SENT_64	[p4l881t2799r1131b2862],
41	although	IN	O	although	mark	43	SENT_64	[p4l881t2799r1131b2862],
42	not	RB	O	not	neg	43	SENT_64	[p4l1148t2808r1235b2846],
43	marketed	VBN	O	market	dep	40	SENT_64	[p4l1251t2799r1533b2862],
44	)	NN	O	)	dobj	43	SENT_64	[p4l1251t2799r1533b2862],
45	.	.	O	.	_	0	SENT_64	[p4l1251t2799r1533b2862],

1	Third	NNP	ORDINAL	Third	nsubj	10	SENT_65	[p4l693t2874r854b2929],
2	,	,	O	,	_	0	SENT_65	[p4l693t2874r854b2929],
3	drug-induced	JJ	O	drug-induced	amod	4	SENT_65	[p4l877t2874r1231b2937],
4	haemolysis	NN	O	haemolysis	appos	1	SENT_65	[p4l1250t2874r1544b2937],
5	in	IN	O	in	_	0	SENT_65	[p4l1565t2877r1618b2921],
6	G6PD	NN	O	g6pd	nn	7	SENT_65	[p4l1639t2878r1796b2922],
7	deﬁciency	NN	O	deﬁciency	prep_in	4	SENT_65	[p4l1819t2874r2082b2937],
8	is	VBZ	O	be	cop	10	SENT_65	[p4l2101t2877r2141b2922],
9	dose	NN	O	dose	dep	10	SENT_65	[p4l645t2950r763b2997],
10	dependent	JJ	O	dependent	_	0	SENT_65	[p4l821t2950r1112b3012],
11	,	,	O	,	_	0	SENT_65	[p4l821t2950r1112b3012],
12	and	CC	O	and	_	0	SENT_65	[p4l1173t2950r1269b2997],
13	this	DT	O	this	det	14	SENT_65	[p4l1325t2950r1421b2997],
14	dependency	NN	O	dependency	nsubj	15	SENT_65	[p4l1481t2950r1796b3012],
15	applies	VBZ	O	apply	conj_and	10	SENT_65	[p4l1853t2950r2035b3012],
16	to	TO	O	to	_	0	SENT_65	[p4l2094t2959r2142b2997],
17	dapsone	NN	O	dapsone	prep_to	15	SENT_65	[p4l645t3027r930b3089],
18	.	.	O	.	_	0	SENT_65	[p4l645t3027r930b3089],

1	”	NN	O	”	nsubjpass	24	SENT_66	[p4l645t3027r930b3089],
2	The	DT	O	the	det	4	SENT_66	[p4l968t3027r1069b3074],
3	daily	JJ	SET	daily	amod	4	SENT_66	[p4l1108t3027r1232b3089],
4	dose	NN	O	dose	nsubj	14	SENT_66	[p4l1270t3027r1387b3074],
5	of	IN	O	of	_	0	SENT_66	[p4l1427t3027r1485b3074],
6	dapsone	NN	O	dapsone	prep_of	4	SENT_66	[p4l1515t3027r1732b3089],
7	for	IN	O	for	_	0	SENT_66	[p4l1771t3027r1846b3074],
8	long-term	JJ	O	long-term	amod	9	SENT_66	[p4l1882t3027r2143b3090],
9	treatment	NN	O	treatment	prep_for	6	SENT_66	[p4l644t3112r903b3150],
10	of	IN	O	of	_	0	SENT_66	[p4l920t3102r978b3150],
11	leprosy	NNP	O	leprosy	prep_of	9	SENT_66	[p4l986t3102r1176b3165],
12	is	VBZ	O	be	cop	14	SENT_66	[p4l1192t3105r1232b3150],
13	1-2	CD	NUMBER	1-2	num	14	SENT_66	[p4l1253t3107r1336b3149],
14	mg/kg	NN	O	mg/kg	rcmod	1	SENT_66	[p4l1355t3102r1544b3165],
15	,	,	O	,	_	0	SENT_66	[p4l1355t3102r1544b3165],
16	but	CC	O	but	cc	14	SENT_66	[p4l1562t3102r1650b3150],
17	much	RB	O	much	advmod	14	SENT_66	[p4l1666t3102r1819b3150],
18	lower	JJR	O	lower	amod	19	SENT_66	[p4l1835t3102r1981b3150],
19	doses	NNS	O	dose	dep	14	SENT_66	[p4l1998t3102r2141b3150],
20	than	IN	O	than	_	0	SENT_66	[p4l644t3178r763b3226],
21	this	DT	O	this	prep_than	19	SENT_66	[p4l782t3178r878b3226],
22	are	VBP	O	be	auxpass	24	SENT_66	[p4l901t3195r979b3226],
23	generally	RB	O	generally	advmod	24	SENT_66	[p4l1002t3178r1241b3241],
24	given	VBN	O	give	_	0	SENT_66	[p4l1261t3181r1414b3241],
25	.	.	O	.	_	0	SENT_66	[p4l1261t3181r1414b3241],

1	A	DT	O	a	det	2	SENT_67	[p4l1437t3181r1479b3225],
2	combination	NN	O	combination	nsubjpass	18	SENT_67	[p4l1500t3178r1833b3226],
3	of	IN	O	of	_	0	SENT_67	[p4l1855t3178r1913b3226],
4	dapsone	NN	O	dapsone	prep_of	2	SENT_67	[p4l1925t3178r2142b3240],
5	and	CC	O	and	_	0	SENT_67	[p4l645t3255r742b3302],
6	pyrimethamine	NN	O	pyrimethamine	nsubjpass	18	SENT_67	[p4l816t3255r1224b3317],
7	(	CD	NUMBER	(	num	6	SENT_67	[p4l1304t3255r1594b3318],
8	Maloprim	NNP	O	Maloprim	nn	15	SENT_67	[p4l1304t3255r1594b3318],
9	,	,	O	,	_	0	SENT_67	[p4l1304t3255r1594b3318],
10	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	appos	15	SENT_67	[p4l1674t3255r2140b3310],
11	,	,	O	,	_	0	SENT_67	[p4l1674t3255r2140b3310],
12	London	NNP	LOCATION	London	appos	15	SENT_67	[p4l647t3330r860b3385],
13	,	,	O	,	_	0	SENT_67	[p4l647t3330r860b3385],
14	UK	NNP	LOCATION	UK	appos	15	SENT_67	[p4l889t3335r990b3393],
15	)	NNP	O	)	dep	6	SENT_67	[p4l889t3335r990b3393],
16	has	VBZ	O	have	aux	18	SENT_67	[p4l1018t3330r1106b3378],
17	been	VBN	O	be	auxpass	18	SENT_67	[p4l1131t3330r1258b3378],
18	used	VBN	O	use	_	0	SENT_67	[p4l1281t3330r1406b3378],
19	with	IN	O	with	_	0	SENT_67	[p4l1428t3330r1545b3378],
20	a	DT	O	a	det	21	SENT_67	[p4l1569t3347r1596b3378],
21	dose	NN	O	dose	prep_with	18	SENT_67	[p4l1621t3330r1738b3378],
22	of	IN	O	of	_	0	SENT_67	[p4l1764t3330r1822b3378],
23	1-5	CD	NUMBER	1-5	num	24	SENT_67	[p4l1840t3333r1921b3378],
24	mg	NN	O	mg	prep_of	21	SENT_67	[p4l1948t3347r2034b3393],
25	per	IN	O	per	_	0	SENT_67	[p4l2058t3347r2144b3392],
26	week	NN	DURATION	week	prep_per	24	SENT_67	[p4l643t3406r778b3453],
27	for	IN	O	for	_	0	SENT_67	[p4l807t3406r882b3453],
28	prevention	NN	O	prevention	prep_for	18	SENT_67	[p4l910t3409r1194b3468],
29	of	IN	O	of	_	0	SENT_67	[p4l1225t3406r1283b3453],
30	malaria	NN	O	malaria	prep_of	28	SENT_67	[p4l1304t3406r1547b3461],
31	,	,	O	,	_	0	SENT_67	[p4l1304t3406r1547b3461],
32	“	NN	O	“	appos	30	SENT_67	[p4l1304t3406r1547b3461],
33	and	CC	O	and	_	0	SENT_67	[p4l1577t3406r1674b3454],
34	there	EX	O	there	expl	39	SENT_67	[p4l1702t3406r1837b3454],
35	have	VBP	O	have	aux	39	SENT_67	[p4l1867t3406r1986b3454],
36	been	VBN	O	be	cop	39	SENT_67	[p4l2016t3406r2143b3454],
37	only	RB	O	only	advmod	39	SENT_67	[p4l645t3483r757b3545],
38	occasional	JJ	O	occasional	amod	39	SENT_67	[p4l780t3483r1051b3530],
39	reports	NNS	O	report	conj_and	18	SENT_67	[p4l1075t3492r1258b3545],
40	of	IN	O	of	_	0	SENT_67	[p4l1285t3483r1343b3530],
41	serious	JJ	O	serious	amod	42	SENT_67	[p4l1360t3486r1546b3530],
42	haemolysis	NN	O	haemolysis	prep_of	39	SENT_67	[p4l1570t3483r1910b3545],
43	.	.	O	.	_	0	SENT_67	[p4l1570t3483r1910b3545],

1	”	NN	O	”	nsubjpass	24	SENT_68	[p4l1570t3483r1910b3545],
2	Instead	RB	O	instead	advmod	1	SENT_68	[p4l1935t3483r2140b3537],
3	,	,	O	,	_	0	SENT_68	[p4l1935t3483r2140b3537],
4	in	IN	O	in	_	0	SENT_68	[p4l644t3561r697b3605],
5	the	DT	O	the	det	7	SENT_68	[p4l714t3558r796b3606],
6	clinical	JJ	O	clinical	amod	7	SENT_68	[p4l815t3558r1001b3606],
7	trials	NNS	O	trial	prep_in	24	SENT_68	[p4l1018t3558r1148b3606],
8	of	IN	O	of	_	0	SENT_68	[p4l1168t3558r1227b3606],
9	Lapdap	NNP	LOCATION	Lapdap	prep_of	7	SENT_68	[p4l1239t3558r1426b3620],
10	a	DT	O	a	det	11	SENT_68	[p4l1445t3575r1471b3606],
11	dose	NN	O	dose	nsubjpass	24	SENT_68	[p4l1490t3558r1607b3606],
12	of	IN	O	of	prep	11	SENT_68	[p4l1627t3558r1685b3606],
13	about	IN	O	about	pcomp	12	SENT_68	[p4l1695t3558r1842b3606],
14	2-5	CD	NUMBER	2-5	dep	13	SENT_68	[p4l1861t3561r1947b3606],
15	mg	NN	O	mg	dep	14	SENT_68	[p4l1967t3575r2053b3621],
16	/	:	O	/	punct	14	SENT_68	[p4l2057t3558r2143b3621],
17	kg	NN	O	kg	dep	14	SENT_68	[p4l2057t3558r2143b3621],
18	per	IN	O	per	_	0	SENT_68	[p4l644t3651r730b3696],
19	day	NN	DURATION	day	prep_per	17	SENT_68	[p4l748t3634r837b3697],
20	for	IN	O	for	_	0	SENT_68	[p4l853t3634r928b3682],
21	3	CD	DURATION	3	num	22	SENT_68	[p4l948t3639r972b3682],
22	days	NNS	NUMBER	day	prep_for	17	SENT_68	[p4l993t3634r1105b3697],
23	was	VBD	O	be	auxpass	24	SENT_68	[p4l1123t3651r1221b3682],
24	used	VBN	O	use	_	0	SENT_68	[p4l1240t3634r1377b3682],
25	.	.	O	.	_	0	SENT_68	[p4l1240t3634r1377b3682],

1	Finally	RB	O	finally	advmod	23	SENT_69	[p4l697t3711r879b3773],
2	,	,	O	,	_	0	SENT_69	[p4l697t3711r879b3773],
3	although	IN	O	although	mark	8	SENT_69	[p4l940t3711r1173b3774],
4	anaemia	NN	O	anaemia	nsubjpass	8	SENT_69	[p4l1231t3714r1454b3758],
5	and	CC	O	and	_	0	SENT_69	[p4l1512t3711r1609b3758],
6	haemolysis	NN	O	haemolysis	conj_and	4	SENT_69	[p4l1665t3711r1959b3773],
7	were	VBD	O	be	auxpass	8	SENT_69	[p4l2017t3728r2142b3758],
8	recorded	VBN	O	record	advcl	23	SENT_69	[p5l644t13r875b61],
9	in	IN	O	in	_	0	SENT_69	[p5l909t16r961b60],
10	early	JJ	O	early	amod	11	SENT_69	[p5l996t13r1121b76],
11	trials	NNS	O	trial	prep_in	8	SENT_69	[p5l1154t13r1283b61],
12	(	VBP	O	(	dep	11	SENT_69	[p5l1324t13r1718b76],
13	webappendix	JJ	O	webappendix	amod	14	SENT_69	[p5l1324t13r1718b76],
14	)	NN	O	)	dobj	12	SENT_69	[p5l1324t13r1718b76],
15	,	,	O	,	_	0	SENT_69	[p5l1324t13r1718b76],
16	analysis	NN	O	analysis	nsubj	23	SENT_69	[p5l1756t13r1961b76],
17	of	IN	O	of	_	0	SENT_69	[p5l1999t13r2057b61],
18	all	DT	O	all	det	19	SENT_69	[p5l2083t13r2143b61],
19	patients	NNS	O	patient	prep_of	16	SENT_69	[p5l644t92r851b151],
20	as	IN	O	as	_	0	SENT_69	[p5l881t106r931b137],
21	one	CD	NUMBER	one	num	22	SENT_69	[p5l961t106r1055b137],
22	group	NN	O	group	prep_as	19	SENT_69	[p5l1084t106r1238b152],
23	obscured	VBD	O	obscure	_	0	SENT_69	[p5l1266t89r1505b137],
24	the	DT	O	the	det	25	SENT_69	[p5l1531t89r1613b137],
25	frequency	NN	O	frequency	dobj	23	SENT_69	[p5l1640t89r1903b152],
26	of	IN	O	of	_	0	SENT_69	[p5l1929t89r1987b137],
27	these	DT	O	these	det	28	SENT_69	[p5l2005t89r2142b137],
28	events	NNS	O	event	prep_of	25	SENT_69	[p5l645t175r808b213],
29	in	IN	O	in	_	0	SENT_69	[p5l825t169r878b212],
30	the	DT	O	the	det	31	SENT_69	[p5l891t166r973b213],
31	subset	NN	O	subset	prep_in	23	SENT_69	[p5l991t166r1158b213],
32	of	IN	O	of	_	0	SENT_69	[p5l1173t166r1231b213],
33	patients	NNS	O	patient	prep_of	31	SENT_69	[p5l1237t169r1444b228],
34	who	WP	O	who	nsubj	37	SENT_69	[p5l1459t166r1570b213],
35	were	VBD	O	be	cop	37	SENT_69	[p5l1584t183r1709b213],
36	G6PD	NN	O	g6pd	nn	37	SENT_69	[p5l1726t169r1884b213],
37	deﬁcient	NN	O	deﬁcient	rcmod	33	SENT_69	[p5l1901t166r2140b213],
38	.	.	O	.	_	0	SENT_69	[p5l1901t166r2140b213],

1	Surprisingly	RB	O	surprisingly	advmod	24	SENT_70	[p5l648t241r977b304],
2	,	,	O	,	_	0	SENT_70	[p5l648t241r977b304],
3	despite	IN	O	despite	_	0	SENT_70	[p5l1039t241r1225b303],
4	previous	JJ	O	previous	amod	6	SENT_70	[p5l1284t244r1507b303],
5	published	VBN	O	publish	amod	6	SENT_70	[p5l1568t241r1829b303],
6	work	NN	O	work	prep_despite	24	SENT_70	[p5l1886t241r2019b289],
7	on	IN	O	on	_	0	SENT_70	[p5l2077t258r2143b289],
8	dapsone	NN	O	dapsone	prep_on	6	SENT_70	[p5l645t317r876b379],
9	,	,	O	,	_	0	SENT_70	[p5l645t317r876b379],
10	a	DT	O	a	det	11	SENT_70	[p5l892t334r919b364],
11	link	NN	O	link	nsubjpass	24	SENT_70	[p5l931t317r1034b364],
12	between	IN	O	between	_	0	SENT_70	[p5l1045t317r1264b364],
13	Lapdap	NNP	PERSON	Lapdap	prep_between	11	SENT_70	[p5l1280t317r1481b379],
14	,	,	O	,	_	0	SENT_70	[p5l1280t317r1481b379],
15	exacerbation	NN	O	exacerbation	prep_between	11	SENT_70	[p5l1497t317r1827b364],
16	of	IN	O	of	_	0	SENT_70	[p5l1841t317r1900b364],
17	anaemia	NN	O	anaemia	prep_of	15	SENT_70	[p5l1904t320r2140b372],
18	,	,	O	,	_	0	SENT_70	[p5l1904t320r2140b372],
19	and	CC	O	and	_	0	SENT_70	[p5l645t393r742b441],
20	G6PD	NN	O	g6pd	nn	21	SENT_70	[p5l786t397r943b441],
21	deﬁciency	NN	O	deﬁciency	prep_between	11	SENT_70	[p5l989t393r1253b456],
22	was	VBD	O	be	auxpass	24	SENT_70	[p5l1293t410r1390b441],
23	not	RB	O	not	neg	24	SENT_70	[p5l1435t403r1521b441],
24	identiﬁed	VBN	O	identiﬁed	_	0	SENT_70	[p5l1563t393r1815b441],
25	even	RB	O	even	advmod	24	SENT_70	[p5l1858t410r1978b441],
26	in	IN	O	in	_	0	SENT_70	[p5l2021t397r2073b440],
27	a	DT	O	a	det	29	SENT_70	[p5l2117t410r2143b441],
28	Cochrane	NNP	O	Cochrane	nn	29	SENT_70	[p5l646t469r895b517],
29	review	NN	O	review	prep_in	24	SENT_70	[p5l933t472r1143b517],
30	.	.	O	.	_	0	SENT_70	[p5l933t472r1143b517],

1	“	NN	O	“	nsubj	65	SENT_71	[p5l933t472r1143b517],
2	When	WRB	O	when	advmod	6	SENT_71	[p5l1180t469r1340b517],
3	the	DT	O	the	det	4	SENT_71	[p5l1376t469r1458b517],
4	data	NNS	O	datum	nsubjpass	6	SENT_71	[p5l1497t469r1605b517],
5	are	VBP	O	be	auxpass	6	SENT_71	[p5l1643t486r1721b517],
6	split	VBN	O	split	dep	1	SENT_71	[p5l1761t469r1872b531],
7	into	IN	O	into	_	0	SENT_71	[p5l1909t473r2011b517],
8	two	CD	NUMBER	two	num	9	SENT_71	[p5l2049t479r2142b517],
9	subsets	NNS	O	subset	prep_into	6	SENT_71	[p5l646t545r837b593],
10	(	CD	NUMBER	(	num	11	SENT_71	[p5l863t548r1085b608],
11	patients	NNS	O	patient	dep	9	SENT_71	[p5l863t548r1085b608],
12	with	IN	O	with	_	0	SENT_71	[p5l1106t545r1222b593],
13	normal	JJ	O	normal	amod	14	SENT_71	[p5l1242t545r1434b593],
14	G6PD	NN	O	g6pd	prep_with	6	SENT_71	[p5l1455t548r1613b593],
15	vs	CC	O	vs	_	0	SENT_71	[p5l1635t562r1681b592],
16	G6PD	NN	O	g6pd	nn	18	SENT_71	[p5l1702t548r1859b593],
17	deﬁcient	JJ	O	deﬁcient	amod	18	SENT_71	[p5l1882t545r2140b608],
18	)	NN	O	)	prep_with	6	SENT_71	[p5l1882t545r2140b608],
19	,	,	O	,	_	0	SENT_71	[p5l1882t545r2140b608],
20	not	RB	O	not	dep	21	SENT_71	[p5l644t631r731b669],
21	only	RB	O	only	advmod	24	SENT_71	[p5l775t622r886b684],
22	is	VBZ	O	be	cop	24	SENT_71	[p5l929t625r970b669],
23	a	DT	O	a	det	24	SENT_71	[p5l1017t639r1043b669],
24	difference	NN	O	difference	dep	6	SENT_71	[p5l1088t622r1350b669],
25	in	IN	O	in	_	0	SENT_71	[p5l1395t625r1448b668],
26	the	DT	O	the	det	27	SENT_71	[p5l1491t622r1573b669],
27	rate	NN	O	rate	prep_in	24	SENT_71	[p5l1618t631r1716b669],
28	of	IN	O	of	_	0	SENT_71	[p5l1761t622r1820b669],
29	haemolytic	JJ	O	haemolytic	amod	30	SENT_71	[p5l1854t622r2143b684],
30	complications	NNS	O	complication	prep_of	27	SENT_71	[p5l9t1025r530b1114],
31	apparent	JJ	O	apparent	amod	30	SENT_71	[p5l590t1039r937b1114],
32	,	,	O	,	_	0	SENT_71	[p5l590t1039r937b1114],
33	but	CC	O	but	_	0	SENT_71	[p5l994t1026r1119b1094],
34	also	RB	O	also	_	0	SENT_71	[p5l1174t1026r1317b1094],
35	the	DT	O	the	det	37	SENT_71	[p5l1371t1025r1488b1094],
36	time	NN	O	time	nn	37	SENT_71	[p5l1543t1030r1713b1094],
37	course	NN	O	course	dep	6	SENT_71	[p5l1770t1050r2013b1094],
38	of	IN	O	of	_	0	SENT_71	[p5l2070t1025r2153b1094],
39	haemoglobin	NN	O	haemoglobin	prep_of	37	SENT_71	[p5l7t1134r503b1224],
40	is	VBZ	O	be	cop	41	SENT_71	[p5l549t1139r607b1202],
41	different	JJ	O	different	rcmod	39	SENT_71	[p5l657t1134r1098b1202],
42	.19	CD	NUMBER	.19	num	45	SENT_71	[p5l657t1134r1098b1202],
43	’	NN	O	’	nn	45	SENT_71	[p5l657t1134r1098b1202],
44	2	CD	NUMBER	2	num	45	SENT_71	[p5l657t1134r1098b1202],
45	°	NN	O	°	nsubj	24	SENT_71	[p5l657t1134r1098b1202],
46	For	IN	O	for	_	0	SENT_71	[p5l1149t1139r1270b1202],
47	the	DT	O	the	det	49	SENT_71	[p5l1314t1134r1430b1202],
48	Lapdap	NN	MISC	lapdap	nn	49	SENT_71	[p5l1481t1134r1747b1223],
49	trials	NNS	O	trial	prep_for	24	SENT_71	[p5l1794t1134r2000b1212],
50	,	,	O	,	_	0	SENT_71	[p5l1794t1134r2000b1212],
51	an	DT	O	a	det	53	SENT_71	[p5l2051t1159r2140b1202],
52	abrupt	JJ	O	abrupt	amod	53	SENT_71	[p5l9t1244r255b1333],
53	fall	NN	DATE	fall	appos	1	SENT_71	[p5l276t1244r390b1312],
54	in	IN	O	in	_	0	SENT_71	[p5l412t1248r487b1310],
55	haemoglobin	NN	O	haemoglobin	prep_in	53	SENT_71	[p5l507t1244r1022b1334],
56	,	,	O	,	_	0	SENT_71	[p5l507t1244r1022b1334],
57	classiﬁed	VBN	O	classiﬁed	partmod	1	SENT_71	[p5l1048t1244r1391b1312],
58	as	IN	O	as	_	0	SENT_71	[p5l1413t1268r1485b1311],
59	a	DT	O	a	det	62	SENT_71	[p5l1510t1268r1547b1311],
60	serious	JJ	O	serious	amod	62	SENT_71	[p5l1571t1248r1836b1312],
61	adverse	JJ	O	adverse	amod	62	SENT_71	[p5l1862t1244r2139b1312],
62	event	NN	O	event	prep_as	57	SENT_71	[p5l9t1367r226b1432],
63	,	,	O	,	_	0	SENT_71	[p5l9t1367r226b1432],
64	was	VBD	O	be	cop	65	SENT_71	[p5l273t1378r411b1422],
65	predictable	JJ	O	predictable	_	0	SENT_71	[p5l459t1353r870b1442],
66	in	IN	O	in	_	0	SENT_71	[p5l917t1358r991b1421],
67	children	NNS	O	child	prep_in	65	SENT_71	[p5l1037t1353r1348b1422],
68	deﬁcient	JJ	O	deﬁcient	amod	67	SENT_71	[p5l1394t1353r1717b1422],
69	for	IN	O	for	_	0	SENT_71	[p5l1760t1353r1867b1422],
70	G6PD	NN	O	g6pd	prep_for	68	SENT_71	[p5l1914t1359r2138b1422],
71	who	WP	O	who	nsubjpass	73	SENT_71	[p5l7t1464r164b1532],
72	were	VBD	O	be	auxpass	73	SENT_71	[p5l189t1489r367b1532],
73	given	VBN	O	give	rcmod	70	SENT_71	[p5l395t1469r594b1554],
74	a	DT	O	a	det	77	SENT_71	[p5l621t1489r657b1532],
75	potent	JJ	O	potent	amod	77	SENT_71	[p5l683t1478r922b1553],
76	haemolytic	JJ	O	haemolytic	amod	77	SENT_71	[p5l945t1464r1356b1554],
77	agent	NN	O	agent	dobj	73	SENT_71	[p5l1382t1478r1604b1554],
78	.	.	O	.	_	0	SENT_71	[p5l1382t1478r1604b1554],

1	In	IN	O	in	_	0	SENT_72	[p5l83t1608r163b1668],
2	conclusion	NN	O	conclusion	prep_in	9	SENT_72	[p5l205t1602r641b1680],
3	,	,	O	,	_	0	SENT_72	[p5l205t1602r641b1680],
4	Lapdap	NN	PERSON	lapdap	nsubj	9	SENT_72	[p5l690t1602r961b1691],
5	was	VBD	O	be	cop	9	SENT_72	[p5l1003t1626r1143b1670],
6	a	DT	O	a	det	9	SENT_72	[p5l1188t1626r1225b1669],
7	promising	JJ	O	promising	amod	9	SENT_72	[p5l1266t1606r1665b1692],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_72	[p5l1705t1602r2140b1691],
9	option	NN	O	option	_	0	SENT_72	[p5l9t1716r254b1800],
10	when	WRB	O	when	advmod	13	SENT_72	[p5l279t1711r489b1780],
11	it	PRP	O	it	nsubjpass	13	SENT_72	[p5l517t1716r568b1779],
12	was	VBD	O	be	auxpass	13	SENT_72	[p5l592t1736r732b1780],
13	developed	VBN	O	develop	dep	9	SENT_72	[p5l763t1711r1164b1800],
14	.	.	O	.	_	0	SENT_72	[p5l763t1711r1164b1800],

1	Alone	RB	O	alone	ccomp	9	SENT_73	[p5l1194t1711r1419b1780],
2	or	CC	O	or	_	0	SENT_73	[p5l1448t1736r1526b1780],
3	in	IN	O	in	ccomp	9	SENT_73	[p5l1551t1716r1627b1779],
4	combination	NN	O	combination	pobj	3	SENT_73	[p5l1655t1711r2140b1780],
5	with	IN	O	with	_	0	SENT_73	[p5l7t1821r175b1889],
6	artesunate	NN	O	artesunate	prep_with	4	SENT_73	[p5l238t1834r657b1899],
7	,	,	O	,	_	0	SENT_73	[p5l238t1834r657b1899],
8	Lapdap	NN	PERSON	lapdap	nsubj	9	SENT_73	[p5l726t1821r998b1910],
9	proved	VBD	O	prove	_	0	SENT_73	[p5l1060t1821r1320b1910],
10	very	RB	O	very	advmod	11	SENT_73	[p5l1380t1845r1538b1910],
11	efﬁcacious	JJ	O	efﬁcacious	acomp	9	SENT_73	[p5l1599t1821r2000b1889],
12	in	IN	O	in	_	0	SENT_73	[p5l2064t1826r2140b1888],
13	several	JJ	O	several	amod	14	SENT_73	[p5l11t1931r271b1999],
14	trials	NNS	O	trial	prep_in	9	SENT_73	[p5l331t1931r543b2009],
15	,	,	O	,	_	0	SENT_73	[p5l331t1931r543b2009],
16	although	IN	O	although	mark	18	SENT_73	[p5l609t1931r949b2021],
17	not	RB	O	not	dep	18	SENT_73	[p5l1010t1944r1135b1999],
18	in	IN	O	in	advcl	9	SENT_73	[p5l1195t1935r1270b1997],
19	Thailand	NNP	LOCATION	Thailand	pobj	18	SENT_73	[p5l1330t1931r1739b1998],
20	.	.	O	.	_	0	SENT_73	[p5l1330t1931r1739b1998],

1	“	NN	O	“	npadvmod	7	SENT_74	[p5l1330t1931r1739b1998],
2	In	IN	O	in	_	0	SENT_74	[p5l1802t1937r1882b1997],
3	2007	CD	DATE	2007	prep_in	7	SENT_74	[p5l1946t1935r2136b2009],
4	,	,	O	,	_	0	SENT_74	[p5l1946t1935r2136b2009],
5	Lapdap	NNP	PERSON	Lapdap	nsubjpass	7	SENT_74	[p5l13t2040r284b2129],
6	was	VBD	O	be	auxpass	7	SENT_74	[p5l327t2065r468b2109],
7	presented	VBN	O	present	_	0	SENT_74	[p5l514t2040r937b2129],
8	”	RB	O	”	advmod	7	SENT_74	[p5l514t2040r937b2129],
9	as	IN	O	as	_	0	SENT_74	[p5l982t2065r1056b2109],
10	a	DT	O	a	det	12	SENT_74	[p5l1104t2065r1141b2109],
11	successful	JJ	O	successful	amod	12	SENT_74	[p5l1187t2040r1579b2109],
12	example	NN	O	example	prep_as	7	SENT_74	[p5l1624t2041r1940b2129],
13	of	IN	O	of	_	0	SENT_74	[p5l1986t2040r2071b2109],
14	a	DT	O	a	det	16	SENT_74	[p5l2103t2065r2140b2109],
15	public-private	JJ	O	public-private	amod	16	SENT_74	[p5l8t2150r534b2239],
16	partnership	NN	O	partnership	prep_of	12	SENT_74	[p5l578t2150r1025b2239],
17	of	IN	O	of	_	0	SENT_74	[p5l1070t2150r1155b2219],
18	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	nn	20	SENT_74	[p5l1187t2150r1867b2228],
19	,	,	O	,	_	0	SENT_74	[p5l1187t2150r1867b2228],
20	WI-IO	NNP	O	WI-IO	prep_of	16	SENT_74	[p5l1913t2156r2138b2219],
21	Special	JJ	O	special	amod	22	SENT_74	[p5l14t2260r281b2349],
22	Programme	NNP	O	Programme	dep	16	SENT_74	[p5l358t2266r812b2350],
23	in	IN	O	in	_	0	SENT_74	[p5l886t2264r962b2326],
24	Research	NNP	O	Research	prep_in	22	SENT_74	[p5l1039t2260r1381b2328],
25	and	CC	O	and	_	0	SENT_74	[p5l1455t2260r1595b2327],
26	Training	NNP	O	Training	prep_in	22	SENT_74	[p5l1666t2264r1992b2350],
27	in	IN	O	in	_	0	SENT_74	[p5l2064t2264r2140b2326],
28	Tropical	JJ	O	tropical	amod	29	SENT_74	[p5l7t2369r315b2458],
29	Diseases	NNS	O	disease	prep_in	22	SENT_74	[p5l404t2374r753b2448],
30	,	,	O	,	_	0	SENT_74	[p5l404t2374r753b2448],
31	and	CC	O	and	_	0	SENT_74	[p5l843t2369r983b2438],
32	the	DT	O	the	det	34	SENT_74	[p5l1066t2369r1185b2438],
33	UK	NNP	ORGANIZATION	UK	nn	34	SENT_74	[p5l1275t2376r1400b2438],
34	Department	NNP	ORGANIZATION	Department	conj_and	16	SENT_74	[p5l1487t2376r1949b2458],
35	for	IN	ORGANIZATION	for	_	0	SENT_74	[p5l2033t2369r2141b2438],
36	International	NNP	ORGANIZATION	International	nn	37	SENT_74	[p5l13t2479r514b2547],
37	Development	NNP	ORGANIZATION	Development	prep_for	34	SENT_74	[p5l570t2479r1100b2568],
38	,	,	O	,	_	0	SENT_74	[p5l570t2479r1100b2568],
39	with	IN	O	with	_	0	SENT_74	[p5l1153t2479r1322b2547],
40	scientists	NNS	O	scientist	prep_with	7	SENT_74	[p5l1376t2484r1727b2547],
41	from	IN	O	from	_	0	SENT_74	[p5l1782t2479r1970b2547],
42	the	DT	O	the	det	43	SENT_74	[p5l2020t2479r2139b2547],
43	University	NNP	ORGANIZATION	University	prep_from	40	SENT_74	[p5l13t2593r409b2678],
44	of	IN	ORGANIZATION	of	_	0	SENT_74	[p5l439t2589r523b2656],
45	Liverpool	NNP	ORGANIZATION	Liverpool	prep_of	43	SENT_74	[p5l545t2589r918b2678],
46	,	,	O	,	_	0	SENT_74	[p5l545t2589r918b2678],
47	the	DT	O	the	det	49	SENT_74	[p5l951t2589r1070b2657],
48	London	NNP	ORGANIZATION	London	nn	49	SENT_74	[p5l1105t2589r1394b2657],
49	School	NNP	ORGANIZATION	School	conj_and	43	SENT_74	[p5l1431t2589r1682b2657],
50	of	IN	ORGANIZATION	of	_	0	SENT_74	[p5l1714t2589r1798b2657],
51	Hygiene	NNP	ORGANIZATION	Hygiene	prep_of	49	SENT_74	[p5l1820t2593r2139b2679],
52	and	CC	ORGANIZATION	and	_	0	SENT_74	[p5l9t2698r150b2767],
53	Tropical	NNP	ORGANIZATION	Tropical	nn	54	SENT_74	[p5l232t2698r539b2787],
54	Medicine	NNP	ORGANIZATION	Medicine	conj_and	43	SENT_74	[p5l626t2698r998b2777],
55	,	,	O	,	_	0	SENT_74	[p5l626t2698r998b2777],
56	African	NNP	MISC	African	nn	57	SENT_74	[p5l1084t2698r1369b2767],
57	Researchers	NNP	O	Researchers	conj_and	43	SENT_74	[p5l1457t2698r1913b2767],
58	and	CC	O	and	_	0	SENT_74	[p5l2001t2698r2141b2767],
59	clinicians	NNS	O	clinician	conj_and	43	SENT_74	[p5l9t2808r395b2886],
60	,	,	O	,	_	0	SENT_74	[p5l9t2808r395b2886],
61	and	CC	O	and	_	0	SENT_74	[p5l467t2808r607b2876],
62	the	DT	O	the	det	64	SENT_74	[p5l672t2808r791b2876],
63	Wellcome	NNP	ORGANIZATION	Wellcome	nn	64	SENT_74	[p5l858t2808r1235b2877],
64	Trust	NNP	ORGANIZATION	Trust	conj_and	54	SENT_74	[p5l1302t2812r1519b2876],
65	.	.	O	.	_	0	SENT_74	[p5l1302t2812r1519b2876],

1	Public	NNP	O	Public	nsubjpass	7	SENT_75	[p5l1594t2808r2139b2897],
2	—	CD	NUMBER	—	num	4	SENT_75	[p5l1594t2808r2139b2897],
3	private	JJ	O	private	amod	4	SENT_75	[p5l1594t2808r2139b2897],
4	partnerships	NNS	O	partnership	dep	1	SENT_75	[p5l8t2918r492b3006],
5	should	MD	O	should	aux	7	SENT_75	[p5l528t2917r785b2986],
6	be	VB	O	be	auxpass	7	SENT_75	[p5l814t2917r901b2986],
7	encouraged	VBN	O	encourage	_	0	SENT_75	[p5l933t2917r1378b3007],
8	in	IN	O	in	_	0	SENT_75	[p5l1407t2922r1483b2984],
9	principle	NN	O	principle	prep_in	7	SENT_75	[p5l1513t2917r1876b3006],
10	,	,	O	,	_	0	SENT_75	[p5l1513t2917r1876b3006],
11	but	CC	O	but	_	0	SENT_75	[p5l1909t2917r2036b2986],
12	in	IN	O	in	_	0	SENT_75	[p5l2064t2922r2140b2984],
13	this	DT	O	this	det	14	SENT_75	[p5l7t3026r147b3095],
14	case	NN	O	case	prep_in	18	SENT_75	[p5l214t3051r371b3095],
15	a	DT	O	a	det	16	SENT_75	[p5l435t3051r472b3095],
16	drug	NN	O	drug	nsubjpass	22	SENT_75	[p5l536t3026r713b3116],
17	was	VBD	O	be	auxpass	18	SENT_75	[p5l774t3051r915b3095],
18	presented	VBN	O	present	conj_but	7	SENT_75	[p5l980t3026r1357b3115],
19	as	IN	O	as	_	0	SENT_75	[p5l1420t3051r1494b3095],
20	successful	JJ	O	successful	prep_as	18	SENT_75	[p5l1562t3026r1953b3095],
21	but	CC	O	but	_	0	SENT_75	[p5l2014t3026r2141b3095],
22	withdrawn	VBN	O	withdraw	conj_but	7	SENT_75	[p5l7t3135r419b3203],
23	after	IN	O	after	_	0	SENT_75	[p5l456t3135r628b3203],
24	only	RB	O	only	quantmod	26	SENT_75	[p5l663t3135r826b3224],
25	a	DT	DURATION	a	quantmod	26	SENT_75	[p5l860t3159r898b3203],
26	few	JJ	DURATION	few	num	27	SENT_75	[p5l933t3135r1068b3203],
27	months	NNS	DURATION	month	prep_after	22	SENT_75	[p5l1102t3135r1416b3203],
28	.	.	O	.	_	0	SENT_75	[p5l1102t3135r1416b3203],

1	The	DT	O	the	det	3	SENT_76	[p5l1455t3135r1600b3203],
2	Lapdap	NN	MISC	lapdap	nn	3	SENT_76	[p5l1641t3135r1912b3224],
3	trials	NNS	O	trial	nsubj	5	SENT_76	[p5l1948t3135r2138b3203],
4	have	VBP	O	have	aux	5	SENT_76	[p5l7t3245r181b3313],
5	included	VBN	O	include	_	0	SENT_76	[p5l247t3244r582b3313],
6	the	DT	O	the	det	8	SENT_76	[p5l645t3244r764b3313],
7	largest	JJS	O	largest	amod	8	SENT_76	[p5l829t3245r1086b3334],
8	number	NN	O	number	dobj	5	SENT_76	[p5l1150t3245r1459b3313],
9	of	IN	O	of	_	0	SENT_76	[p5l1525t3244r1609b3313],
10	documented	VBN	O	document	dep	11	SENT_76	[p5l1663t3244r2141b3313],
11	G6PD-related	JJ	O	g6pd-related	amod	13	SENT_76	[p5l11t3353r531b3421],
12	haemolytic	JJ	O	haemolytic	amod	13	SENT_76	[p5l567t3353r987b3443],
13	attacks	NNS	O	attack	prep_of	8	SENT_76	[p5l1026t3353r1283b3421],
14	from	IN	O	from	_	0	SENT_76	[p5l1323t3353r1511b3421],
15	one	CD	NUMBER	one	num	16	SENT_76	[p5l1550t3378r1685b3421],
16	drug	NN	O	drug	prep_from	5	SENT_76	[p5l1726t3353r1903b3443],
17	other	JJ	O	other	dep	16	SENT_76	[p5l1942t3353r2141b3421],
18	than	IN	O	than	_	0	SENT_76	[p5l7t3462r180b3530],
19	primaquine	JJ	O	primaquine	amod	22	SENT_76	[p5l204t3467r655b3551],
20	(	NN	O	(	nn	22	SENT_76	[p5l687t3462r1261b3552],
21	webappendix	NN	O	webappendix	nn	22	SENT_76	[p5l687t3462r1261b3552],
22	)	NN	O	)	prep_than	16	SENT_76	[p5l687t3462r1261b3552],
23	;	:	O	;	_	0	SENT_76	[p5l687t3462r1261b3552],
24	many	JJ	O	many	amod	25	SENT_76	[p5l1290t3486r1504b3552],
25	people	NNS	O	people	nsubj	26	SENT_76	[p5l1527t3462r1777b3551],
26	suffered	VBD	O	suffer	parataxis	5	SENT_76	[p5l1806t3462r2136b3540],
27	,	,	O	,	_	0	SENT_76	[p5l1806t3462r2136b3540],
28	and	CC	O	and	_	0	SENT_76	[p5l9t3572r150b3641],
29	the	DT	O	the	det	30	SENT_76	[p5l195t3573r313b3641],
30	number	NN	O	number	nsubj	40	SENT_76	[p5l361t3573r670b3641],
31	of	IN	O	of	_	0	SENT_76	[p5l718t3572r802b3641],
32	events	NNS	O	event	prep_of	30	SENT_76	[p5l837t3586r1075b3641],
33	that	WDT	O	that	nsubj	34	SENT_76	[p5l1124t3573r1272b3641],
34	happened	VBD	O	happen	rcmod	32	SENT_76	[p5l1317t3572r1695b3661],
35	outside	IN	O	outside	_	0	SENT_76	[p5l1742t3573r2019b3641],
36	of	IN	O	of	_	0	SENT_76	[p5l2069t3572r2153b3641],
37	controlled	JJ	O	controlled	amod	38	SENT_76	[p5l9t3681r395b3749],
38	trials	NNS	O	trial	prep_outside_of	34	SENT_76	[p5l427t3681r617b3749],
39	is	VBZ	O	be	cop	40	SENT_76	[p5l654t3686r712b3749],
40	unknown	JJ	O	unknown	parataxis	5	SENT_76	[p5l748t3681r1134b3749],
41	.	.	O	.	_	0	SENT_76	[p5l748t3681r1134b3749],

1	At	IN	O	at	advmod	29	SENT_77	[p5l1171t3686r1253b3749],
2	least	JJS	O	least	pobj	1	SENT_77	[p5l1285t3681r1478b3759],
3	,	,	O	,	_	0	SENT_77	[p5l1285t3681r1478b3759],
4	we	PRP	O	we	nsubj	6	SENT_77	[p5l1514t3706r1618b3749],
5	should	MD	O	should	aux	6	SENT_77	[p5l1656t3681r1913b3749],
6	learn	VB	O	learn	parataxis	29	SENT_77	[p5l1945t3681r2140b3749],
7	as	RB	O	as	advmod	8	SENT_77	[p6l9t47r83b90],
8	much	JJ	O	much	advmod	6	SENT_77	[p6l149t23r370b91],
9	as	IN	O	as	mark	15	SENT_77	[p6l435t47r509b90],
10	possible	JJ	O	possible	nsubj	15	SENT_77	[p6l575t23r886b112],
11	from	IN	O	from	_	0	SENT_77	[p6l951t23r1139b90],
12	the	DT	O	the	det	14	SENT_77	[p6l1201t23r1320b91],
13	available	JJ	O	available	amod	14	SENT_77	[p6l1387t23r1715b91],
14	data	NNS	O	datum	prep_from	10	SENT_77	[p6l1781t23r2136b113],
15	—	VBP	O	—	ccomp	8	SENT_77	[p6l1781t23r2136b113],
16	eg	FW	O	eg	dobj	15	SENT_77	[p6l1781t23r2136b113],
17	,	,	O	,	_	0	SENT_77	[p6l1781t23r2136b113],
18	haemolysis	NN	O	haemolysis	nsubj	29	SENT_77	[p6l7t132r435b221],
19	with	IN	O	with	_	0	SENT_77	[p6l464t131r633b200],
20	the	DT	O	the	det	23	SENT_77	[p6l659t131r778b200],
21	A	NN	O	a	nn	23	SENT_77	[p6l806t137r912b198],
22	—	NN	O	—	nn	23	SENT_77	[p6l806t137r912b198],
23	type	NN	O	type	prep_with	18	SENT_77	[p6l937t145r1094b221],
24	of	IN	O	of	_	0	SENT_77	[p6l1124t131r1208b200],
25	G6PD	NN	O	g6pd	nn	26	SENT_77	[p6l1226t137r1453b200],
26	deﬁciency	NN	O	deﬁciency	prep_of	23	SENT_77	[p6l1485t131r1868b221],
27	can	MD	O	can	aux	29	SENT_77	[p6l1896t156r2025b200],
28	be	VB	O	be	cop	29	SENT_77	[p6l2052t131r2139b200],
29	life-threatening	JJ	O	life-threatening	_	0	SENT_77	[p6l7t240r622b330],
30	.	.	O	.	_	0	SENT_77	[p6l7t240r622b330],

1	Regrettably	RB	O	regrettably	advmod	9	SENT_78	[p6l700t240r1140b330],
2	,	,	O	,	_	0	SENT_78	[p6l700t240r1140b330],
3	not	RB	O	not	nsubj	9	SENT_78	[p6l1212t254r1337b308],
4	testing	VBG	O	test	amod	3	SENT_78	[p6l1403t245r1664b330],
5	for	IN	O	for	_	0	SENT_78	[p6l1732t240r1841b308],
6	G6PD	NN	O	g6pd	nn	7	SENT_78	[p6l1910t245r2138b308],
7	deﬁciency	NN	O	deﬁciency	prep_for	3	SENT_78	[p6l9t350r393b439],
8	was	VBD	O	be	cop	9	SENT_78	[p6l421t374r562b418],
9	wrong	JJ	O	wrong	_	0	SENT_78	[p6l595t374r839b440],
10	in	IN	O	in	_	0	SENT_78	[p6l871t354r946b416],
11	the	DT	O	the	det	12	SENT_78	[p6l977t350r1096b417],
12	case	NN	O	case	prep_in	9	SENT_78	[p6l1130t374r1287b418],
13	of	IN	O	of	_	0	SENT_78	[p6l1321t350r1405b417],
14	Lapdap	NNP	LOCATION	Lapdap	prep_of	12	SENT_78	[p6l1429t350r1721b439],
15	,	,	O	,	_	0	SENT_78	[p6l1429t350r1721b439],
16	and	CC	O	and	_	0	SENT_78	[p6l1758t350r1897b417],
17	was	VBD	O	be	cop	20	SENT_78	[p6l1927t374r2067b418],
18	a	DT	O	a	det	20	SENT_78	[p6l2103t374r2140b417],
19	surprising	JJ	O	surprising	amod	20	SENT_78	[p6l11t463r406b548],
20	departure	NN	O	departure	conj_and	9	SENT_78	[p6l434t458r803b547],
21	for	IN	O	for	_	0	SENT_78	[p6l831t458r940b527],
22	clinical	JJ	O	clinical	amod	23	SENT_78	[p6l967t458r1239b527],
23	investigators	NNS	O	investigator	prep_for	20	SENT_78	[p6l1266t463r1752b548],
24	who	WP	O	who	nsubj	25	SENT_78	[p6l1779t458r1939b527],
25	have	VBP	O	have	rcmod	23	SENT_78	[p6l1966t458r2139b527],
26	an	DT	O	a	det	28	SENT_78	[p6l9t592r100b635],
27	outstanding	JJ	O	outstanding	amod	28	SENT_78	[p6l131t567r590b657],
28	record	NN	O	record	dobj	25	SENT_78	[p6l620t567r864b635],
29	not	RB	O	not	neg	30	SENT_78	[p6l893t581r1017b635],
30	only	RB	O	only	preconj	25	SENT_78	[p6l1047t567r1210b657],
31	in	IN	O	in	_	0	SENT_78	[p6l1238t572r1313b634],
32	malaria	NN	O	malaria	nn	33	SENT_78	[p6l1344t567r1632b635],
33	research	NN	O	research	prep_in	25	SENT_78	[p6l1662t567r1986b635],
34	but	CC	O	but	_	0	SENT_78	[p6l2014t567r2141b635],
35	also	RB	O	also	advmod	25	SENT_78	[p6l9t677r156b745],
36	in	IN	O	in	_	0	SENT_78	[p6l180t681r256b743],
37	their	PRP$	O	they	poss	39	SENT_78	[p6l279t677r461b744],
38	life-long	JJ	O	life-long	amod	39	SENT_78	[p6l482t677r800b767],
39	concern	NN	O	concern	conj_but	33	SENT_78	[p6l824t701r1129b745],
40	for	IN	O	for	_	0	SENT_78	[p6l1153t677r1262b744],
41	the	DT	O	the	det	42	SENT_78	[p6l1283t677r1401b745],
42	care	NN	O	care	prep_for	39	SENT_78	[p6l1427t701r1580b745],
43	of	IN	O	of	_	0	SENT_78	[p6l1606t677r1690b745],
44	all	DT	O	all	det	45	SENT_78	[p6l1702t677r1789b744],
45	patients	NNS	O	patient	prep_of	42	SENT_78	[p6l1812t681r2136b766],
46	.	.	O	.	_	0	SENT_78	[p6l1812t681r2136b766],

1	Because	IN	O	because	_	0	SENT_79	[p6l13t792r319b854],
2	of	IN	O	of	_	0	SENT_79	[p6l373t785r457b854],
3	the	DT	O	the	det	5	SENT_79	[p6l494t785r613b854],
4	increased	VBN	O	increase	amod	5	SENT_79	[p6l665t785r1031b854],
5	availability	NN	O	availability	prep_because_of	59	SENT_79	[p6l1083t785r1493b875],
6	of	IN	O	of	dep	5	SENT_79	[p6l1544t785r1628b854],
7	artemisininbased	JJ	O	artemisininbased	amod	8	SENT_79	[p6l1667t790r2138b854, p6l7t894r226b962],
8	agents	NNS	O	agent	pobj	6	SENT_79	[p6l258t907r524b984],
9	,	,	O	,	_	0	SENT_79	[p6l258t907r524b984],
10	and	CC	O	and	_	0	SENT_79	[p6l561t894r701b962],
11	because	IN	O	because	mark	19	SENT_79	[p6l731t894r1033b962],
12	the	DT	O	the	det	15	SENT_79	[p6l1065t894r1184b962],
13	malaria	NN	O	malaria	nn	15	SENT_79	[p6l1217t894r1506b962],
14	cure	NN	O	cure	nn	15	SENT_79	[p6l1539t918r1702b962],
15	rate	NN	O	rate	nsubj	19	SENT_79	[p6l1735t907r1878b962],
16	might	MD	O	might	aux	19	SENT_79	[p6l1911t894r2141b984],
17	not	RB	O	not	neg	19	SENT_79	[p6l8t1018r133b1073],
18	be	VB	O	be	cop	19	SENT_79	[p6l183t1005r269b1073],
19	satisfactory	JJ	O	satisfactory	conj_and	6	SENT_79	[p6l325t1005r756b1094],
20	today	NN	DATE	today	tmod	19	SENT_79	[p6l804t1005r1010b1094],
21	in	IN	O	in	_	0	SENT_79	[p6l1059t1009r1135b1072],
22	all	DT	O	all	det	23	SENT_79	[p6l1188t1005r1275b1073],
23	parts	NNS	O	part	prep_in	19	SENT_79	[p6l1326t1018r1513b1094],
24	of	IN	O	of	_	0	SENT_79	[p6l1568t1005r1652b1073],
25	Africa	NNP	LOCATION	Africa	prep_of	23	SENT_79	[p6l1690t1005r1922b1073],
26	with	IN	O	with	_	0	SENT_79	[p6l1971t1005r2140b1073],
27	Lapdap	NNP	PERSON	Lapdap	prep_with	19	SENT_79	[p6l13t1113r354b1202],
28	,	,	O	,	_	0	SENT_79	[p6l13t1113r354b1202],
29	”	CD	NUMBER	”	nsubj	59	SENT_79	[p6l13t1113r354b1202],
30	this	DT	O	this	det	31	SENT_79	[p6l380t1114r519b1182],
31	agent	NN	O	agent	nsubj	35	SENT_79	[p6l550t1127r759b1204],
32	will	MD	O	will	aux	35	SENT_79	[p6l782t1114r921b1182],
33	probably	RB	O	probably	advmod	35	SENT_79	[p6l948t1114r1281b1203],
34	never	RB	O	never	neg	35	SENT_79	[p6l1306t1138r1517b1182],
35	recover	VB	O	recover	rcmod	29	SENT_79	[p6l1543t1138r1837b1182],
36	:	:	O	:	_	0	SENT_79	[p6l1543t1138r1837b1182],
37	despite	IN	O	despite	dep	35	SENT_79	[p6l1869t1114r2139b1203],
38	the	DT	O	the	det	39	SENT_79	[p6l7t1222r126b1291],
39	fact	NN	O	fact	pobj	37	SENT_79	[p6l173t1222r310b1291],
40	that	IN	O	that	dep	45	SENT_79	[p6l354t1222r521b1301],
41	,	,	O	,	_	0	SENT_79	[p6l354t1222r521b1301],
42	paradoxically	RB	O	paradoxically	advmod	45	SENT_79	[p6l570t1222r1082b1312],
43	,	,	O	,	_	0	SENT_79	[p6l570t1222r1082b1312],
44	it	PRP	O	it	nsubj	45	SENT_79	[p6l1132t1227r1184b1290],
45	has	VBZ	O	have	ccomp	37	SENT_79	[p6l1228t1222r1355b1291],
46	an	DT	O	a	det	49	SENT_79	[p6l1405t1247r1495b1291],
47	excellent	JJ	O	excellent	amod	49	SENT_79	[p6l1542t1222r1877b1291],
48	safety	NN	O	safety	nn	49	SENT_79	[p6l1924t1222r2142b1312],
49	record	NN	O	record	dobj	45	SENT_79	[p6l8t1331r253b1399],
50	and	CC	O	and	_	0	SENT_79	[p6l287t1331r426b1399],
51	is	VBZ	O	be	cop	53	SENT_79	[p6l459t1336r518b1399],
52	good	JJ	O	good	amod	53	SENT_79	[p6l556t1331r740b1421],
53	value	NN	O	value	ccomp	37	SENT_79	[p6l770t1331r970b1399],
54	for	IN	O	for	_	0	SENT_79	[p6l1005t1331r1113b1399],
55	money	NN	O	money	prep_for	53	SENT_79	[p6l1146t1356r1407b1421],
56	for	IN	O	for	_	0	SENT_79	[p6l1439t1331r1548b1399],
57	those	DT	O	those	det	58	SENT_79	[p6l1579t1331r1782b1399],
58	Africans	NNS	MISC	african	prep_for	55	SENT_79	[p6l1816t1331r2137b1399],
59	(	VBP	O	(	_	0	SENT_79	[p6l14t1441r154b1531],
60	the	DT	O	the	det	63	SENT_79	[p6l14t1441r154b1531],
61	large	JJ	O	large	amod	63	SENT_79	[p6l202t1441r389b1531],
62	majority	NN	O	majority	nn	63	SENT_79	[p6l438t1445r781b1531],
63	)	NN	O	)	dobj	59	SENT_79	[p6l438t1445r781b1531],
64	who	WP	O	who	nsubj	68	SENT_79	[p6l833t1441r992b1509],
65	are	VBP	O	be	cop	68	SENT_79	[p6l1042t1465r1156b1509],
66	not	RB	O	not	neg	68	SENT_79	[p6l1204t1454r1329b1508],
67	G6PD	JJ	O	g6pd	amod	68	SENT_79	[p6l1378t1446r1605b1509],
68	deﬁcient	NN	O	deﬁcient	rcmod	63	SENT_79	[p6l1656t1441r2005b1509],
69	.	.	O	.	_	0	SENT_79	[p6l1656t1441r2005b1509],

1	In	IN	O	in	_	0	SENT_80	[p6l2061t1447r2140b1507],
2	future	NN	DATE	future	pobj	1	SENT_80	[p6l8t1549r264b1628],
3	,	,	O	,	_	0	SENT_80	[p6l8t1549r264b1628],
4	in	IN	O	in	_	0	SENT_80	[p6l302t1554r378b1616],
5	circumstances	NNS	O	circumstance	prep_in	2	SENT_80	[p6l414t1554r962b1617],
6	similar	JJ	O	similar	amod	5	SENT_80	[p6l1002t1549r1271b1617],
7	to	TO	O	to	_	0	SENT_80	[p6l1303t1563r1373b1617],
8	those	DT	O	those	prep_to	6	SENT_80	[p6l1408t1549r1612b1617],
9	under	IN	O	under	_	0	SENT_80	[p6l1646t1549r1877b1617],
10	which	WDT	O	which	prep_under	8	SENT_80	[p6l1908t1549r2140b1617],

1	Lapdap	NN	PERSON	lapdap	nsubjpass	3	SENT_81	[p6l13t1659r284b1748],
2	was	VBD	O	be	auxpass	3	SENT_81	[p6l308t1683r449b1727],
3	tested	VBN	O	test	_	0	SENT_81	[p6l476t1659r722b1737],
4	,	,	O	,	_	0	SENT_81	[p6l476t1659r722b1737],
5	a	DT	O	a	det	7	SENT_81	[p6l752t1683r789b1727],
6	wise	JJ	O	wise	amod	7	SENT_81	[p6l812t1664r981b1727],
7	approach	NN	O	approach	nsubj	9	SENT_81	[p6l1009t1659r1360b1748],
8	would	MD	O	would	aux	9	SENT_81	[p6l1383t1659r1619b1727],
9	be	VB	O	be	parataxis	3	SENT_81	[p6l1642t1659r1729b1727],
10	to	TO	O	to	aux	11	SENT_81	[p6l1754t1672r1824b1727],
11	invest	VB	O	invest	xcomp	9	SENT_81	[p6l1851t1664r2078b1727],
12	a	DT	O	a	det	14	SENT_81	[p6l2103t1683r2140b1727],
13	small	JJ	O	small	amod	14	SENT_81	[p6l11t1769r216b1836],
14	fraction	NN	O	fraction	dobj	11	SENT_81	[p6l250t1769r547b1837],
15	of	IN	O	of	_	0	SENT_81	[p6l582t1769r666b1836],
16	the	DT	O	the	det	18	SENT_81	[p6l687t1769r805b1836],
17	development	NN	O	development	nn	18	SENT_81	[p6l842t1769r1337b1858],
18	costs	NNS	O	cost	prep_of	14	SENT_81	[p6l1371t1782r1555b1836],
19	of	IN	O	of	_	0	SENT_81	[p6l1593t1769r1677b1836],
20	a	DT	O	a	det	22	SENT_81	[p6l1700t1793r1737b1836],
21	new	JJ	O	new	amod	22	SENT_81	[p6l1771t1793r1929b1837],
22	drug	NN	O	drug	prep_of	18	SENT_81	[p6l1963t1769r2140b1859],
23	in	IN	O	in	_	0	SENT_81	[p6l8t1882r84b1944],
24	an	DT	O	a	det	26	SENT_81	[p6l131t1902r222b1946],
25	ultra-simple	JJ	O	ultra-simple	amod	26	SENT_81	[p6l267t1877r734b1966],
26	test	NN	O	test	prep_in	11	SENT_81	[p6l780t1891r915b1946],
27	for	IN	O	for	_	0	SENT_81	[p6l961t1877r1069b1946],
28	G6PD	NN	O	g6pd	nn	29	SENT_81	[p6l1116t1883r1343b1946],
29	deﬁciency	NN	O	deﬁciency	prep_for	26	SENT_81	[p6l1394t1877r1788b1967],
30	,	,	O	,	_	0	SENT_81	[p6l1394t1877r1788b1967],
31	such	JJ	O	such	prep	3	SENT_81	[p6l1841t1877r2017b1946],
32	as	IN	O	as	mark	35	SENT_81	[p6l2064t1902r2137b1946],
33	have	VBP	O	have	aux	35	SENT_81	[p6l7t1986r181b2054],
34	been	VBN	O	be	auxpass	35	SENT_81	[p6l204t1986r388b2054],
35	developed	VBN	O	develop	dep	3	SENT_81	[p6l413t1986r795b2075],
36	and	CC	O	and	_	0	SENT_81	[p6l819t1986r959b2054],
37	ﬁeld-tested	VBN	O	ﬁeld-test	dep	3	SENT_81	[p6l982t1986r1472b2064],
38	,	,	O	,	_	0	SENT_81	[p6l982t1986r1472b2064],
39	“	NN	O	“	dep	3	SENT_81	[p6l982t1986r1472b2064],
40	and	CC	O	and	_	0	SENT_81	[p6l1494t1986r1634b2054],
41	which	WDT	O	which	nsubjpass	45	SENT_81	[p6l1655t1986r1887b2054],
42	might	MD	O	might	aux	45	SENT_81	[p6l1911t1986r2141b2076],
43	still	RB	O	still	advmod	45	SENT_81	[p6l11t2097r148b2165],
44	be	VB	O	be	auxpass	45	SENT_81	[p6l174t2097r261b2165],
45	improved	VBN	O	improve	dep	3	SENT_81	[p6l289t2097r674b2186],
46	.	.	O	.	_	0	SENT_81	[p6l289t2097r674b2186],

1	Acknowledgments	NNS	O	acknowledgment	nsubj	5	SENT_82	[p6l8t2244r537b2311],
2	I	PRP	O	I	nsubj	5	SENT_82	[p6l11t2317r29b2364],
3	am	VBP	O	be	cop	5	SENT_82	[p6l52t2330r143b2364],
4	very	RB	O	very	advmod	5	SENT_82	[p6l161t2330r282b2381],
5	grateful	JJ	O	grateful	conj_and	5	SENT_82	[p6l301t2311r526b2382],
6	to	TO	O	to	_	0	SENT_82	[p6l544t2322r598b2364],
7	Adetokunbo	NNP	PERSON	Adetokunbo	nn	8	SENT_82	[p6l618t2311r974b2364],
8	Lucas	NNP	PERSON	Lucas	prep_to	5	SENT_82	[p6l998t2317r1157b2364],
9	for	IN	O	for	_	0	SENT_82	[p6l1180t2311r1263b2364],
10	our	PRP$	O	we	poss	12	SENT_82	[p6l1282t2330r1381b2364],
11	long-time	JJ	O	long-time	amod	12	SENT_82	[p6l1399t2311r1680b2382],
12	association	NN	O	association	prep_for	8	SENT_82	[p6l1702t2315r2022b2364],
13	and	CC	O	and	cc	5	SENT_82	[p6l9t2382r116b2435],
14	for	IN	O	for	_	0	SENT_82	[p6l135t2382r218b2435],
15	valuable	JJ	O	valuable	amod	16	SENT_82	[p6l235t2382r474b2435],
16	input	NN	O	input	prep_for	5	SENT_82	[p6l495t2386r665b2452],
17	;	:	O	;	_	0	SENT_82	[p6l495t2386r665b2452],
18	and	CC	O	and	_	0	SENT_82	[p6l689t2382r796b2435],
19	to	TO	O	to	_	0	SENT_82	[p6l815t2393r868b2435],
20	Piero	NNP	PERSON	Piero	nn	21	SENT_82	[p6l892t2386r1039b2435],
21	Dolara	NNP	PERSON	Dolara	prep_to	5	SENT_82	[p6l1064t2382r1268b2443],
22	,	,	O	,	_	0	SENT_82	[p6l1064t2382r1268b2443],
23	Giorgio	NNP	PERSON	Giorgio	nn	24	SENT_82	[p6l1293t2386r1509b2453],
24	Sirugo	NNP	PERSON	Sirugo	conj_and	21	SENT_82	[p6l1534t2386r1736b2453],
25	,	,	O	,	_	0	SENT_82	[p6l1534t2386r1736b2453],
26	and	CC	O	and	_	0	SENT_82	[p6l1759t2382r1867b2435],
27	Rosario	NNP	PERSON	Rosario	nn	28	SENT_82	[p6l11t2457r226b2506],
28	Notaro	NNP	PERSON	Notaro	conj_and	21	SENT_82	[p6l250t2459r444b2506],
29	for	IN	O	for	_	0	SENT_82	[p6l464t2453r547b2506],
30	helpful	JJ	O	helpful	amod	31	SENT_82	[p6l565t2453r773b2523],
31	suggestions	NNS	O	suggestion	prep_for	5	SENT_82	[p6l794t2457r1136b2524],
32	about	IN	O	about	_	0	SENT_82	[p6l1158t2453r1321b2506],
33	the	DT	O	the	det	34	SENT_82	[p6l1338t2453r1429b2506],
34	paper	NN	O	paper	prep_about	31	SENT_82	[p6l1449t2472r1621b2523],
35	.	.	O	.	_	0	SENT_82	[p6l1449t2472r1621b2523],

1	Conﬂicts	NNS	O	conﬂicts	nsubj	12	SENT_83	[p6l9t2545r253b2595],
2	of	IN	O	of	_	0	SENT_83	[p6l268t2545r328b2595],
3	interest	NN	O	interest	prep_of	1	SENT_83	[p6l342t2547r559b2595],
4	I	PRP	O	I	nsubj	7	SENT_83	[p6l11t2616r29b2662],
5	was	VBD	O	be	cop	7	SENT_83	[p6l50t2629r158b2663],
6	a	DT	O	a	det	7	SENT_83	[p6l180t2629r209b2663],
7	member	NN	O	member	rcmod	3	SENT_83	[p6l229t2610r479b2663],
8	of	IN	O	of	_	0	SENT_83	[p6l498t2610r563b2663],
9	the	DT	O	the	det	11	SENT_83	[p6l572t2610r662b2663],
10	Expert	NNP	O	Expert	nn	11	SENT_83	[p6l685t2614r869b2679],
11	Panel	NNP	O	Panel	prep_of	7	SENT_83	[p6l891t2610r1049b2663],
12	summoned	VBD	O	summon	_	0	SENT_83	[p6l1071t2610r1405b2663],
13	by	IN	O	by	_	0	SENT_83	[p6l1423t2610r1490b2679],
14	WHO	WP	ORGANIZATION	who	prep_by	12	SENT_83	[p6l1508t2615r1680b2664],
15	in	IN	O	in	_	0	SENT_83	[p6l1702t2614r1761b2662],
16	Geneva	NNP	LOCATION	Geneva	prep_in	12	SENT_83	[p6l1782t2614r1996b2663],
17	in	IN	O	in	_	0	SENT_83	[p6l2015t2614r2074b2662],
18	]	CD	NUMBER	]	prep_in	12	SENT_83	[p6l10t2685r141b2748],
19	une	JJ	O	une	amod	18	SENT_83	[p6l10t2685r141b2748],
20	2004	CD	DATE	2004	tmod	19	SENT_83	[p6l163t2684r309b2732],
21	.	.	O	.	_	0	SENT_83	[p6l163t2684r309b2732],

1	I	PRP	O	I	nsubj	2	SENT_84	[p6l335t2685r353b2732],
2	declare	VBP	O	declare	_	0	SENT_84	[p6l377t2679r581b2732],
3	that	IN	O	that	complm	5	SENT_84	[p6l600t2679r713b2732],
4	I	PRP	O	I	nsubj	5	SENT_84	[p6l735t2685r753b2732],
5	have	VBP	O	have	ccomp	2	SENT_84	[p6l774t2679r907b2732],
6	no	DT	O	no	det	7	SENT_84	[p6l927t2698r1000b2732],
7	conﬂicts	NNS	O	conﬂicts	dobj	5	SENT_84	[p6l1022t2679r1263b2732],
8	of	IN	O	of	_	0	SENT_84	[p6l1285t2679r1350b2732],
9	interest	NN	O	interest	prep_of	7	SENT_84	[p6l1360t2683r1581b2732],
10	in	IN	O	in	_	0	SENT_84	[p6l1600t2683r1658b2732],
11	writing	VBG	O	write	prepc_in	5	SENT_84	[p6l1676t2683r1887b2750],
12	this	DT	O	this	det	13	SENT_84	[p6l1906t2679r2012b2732],
13	Viewpoint	NN	O	viewpoint	dobj	11	SENT_84	[p6l7t2750r318b2816],
14	.	.	O	.	_	0	SENT_84	[p6l7t2750r318b2816],

1	References	NNS	O	reference	_	0	SENT_85	[p6l12t2837r307b2888],
2	1	CD	NUMBER	1	num	4	SENT_85	[p6l10t2913r34b2961],
3	Bruce-Chwatt	NN	O	bruce-chwatt	nn	4	SENT_85	[p6l153t2908r549b2961],
4	L	NN	O	l	dep	1	SENT_85	[p6l571t2914r643b2976],
5	]	CD	NUMBER	]	dep	4	SENT_85	[p6l571t2914r643b2976],
6	.	.	O	.	_	0	SENT_85	[p6l571t2914r643b2976],

1	Qinghaosu	NNP	O	Qinghaosu	_	0	SENT_86	[p6l668t2908r1002b2979],
2	:	:	O	:	_	0	SENT_86	[p6l668t2908r1002b2979],
3	a	DT	O	a	det	5	SENT_86	[p6l1026t2927r1054b2961],
4	new	JJ	O	new	amod	5	SENT_86	[p6l1074t2927r1196b2961],
5	antimalarial	JJ	O	antimalarial	dep	1	SENT_86	[p6l1215t2908r1580b2961],
6	.	.	O	.	_	0	SENT_86	[p6l1215t2908r1580b2961],

1	Br	NNP	O	Br	nsubj	2	SENT_87	[p6l154t2994r221b3040],
2	Med	VBD	O	med	_	0	SENT_87	[p6l238t2989r403b3058],
3	]	CD	NUMBER	]	num	7	SENT_87	[p6l238t2989r403b3058],
4	(	CD	NUMBER	(	num	7	SENT_87	[p6l428t2989r567b3058],
5	Clin	NNP	PERSON	Clin	nn	7	SENT_87	[p6l428t2989r567b3058],
6	Res	NNP	PERSON	Res	nn	7	SENT_87	[p6l590t2994r681b3041],
7	Ed	NNP	PERSON	Ed	dobj	2	SENT_87	[p6l703t2989r796b3058],
8	)	CD	NUMBER	)	num	9	SENT_87	[p6l703t2989r796b3058],
9	1982	CD	DATE	1982	dep	7	SENT_87	[p6l822t2994r965b3050],
10	;	:	O	;	_	0	SENT_87	[p6l822t2994r965b3050],
11	284	CD	NUMBER	284	num	13	SENT_87	[p6l989t2993r1105b3041],
12	:	:	O	:	_	0	SENT_87	[p6l989t2993r1105b3041],
13	767-68	CD	NUMBER	767-68	dep	7	SENT_87	[p6l1126t2992r1338b3044],
14	.	.	O	.	_	0	SENT_87	[p6l1126t2992r1338b3044],

1	2	CD	NUMBER	2	num	4	SENT_88	[p6l10t3068r38b3115],
2	Winstanley	NNP	PERSON	Winstanley	nn	4	SENT_88	[p6l148t3062r476b3133],
3	P.	NNP	PERSON	P.	nn	4	SENT_88	[p6l498t3068r548b3115],
4	Chlorproguanil-dapsone	NN	PERSON	chlorproguanil-dapsone	_	0	SENT_88	[p6l573t3062r1283b3133],
5	(	CD	NUMBER	(	num	7	SENT_88	[p6l1308t3067r1606b3133],
6	LAPDAP	NN	O	lapdap	nn	7	SENT_88	[p6l1308t3067r1606b3133],
7	)	NN	O	)	dep	4	SENT_88	[p6l1308t3067r1606b3133],
8	for	IN	O	for	_	0	SENT_88	[p6l1630t3062r1714b3116],
9	uncomplicated	JJ	O	uncomplicated	amod	11	SENT_88	[p6l148t3137r583b3206],
10	falciparum	NN	O	falciparum	nn	11	SENT_88	[p6l602t3137r920b3206],
11	malaria	NN	O	malaria	prep_for	7	SENT_88	[p6l940t3137r1174b3190],
12	.	.	O	.	_	0	SENT_88	[p6l940t3137r1174b3190],

1	Trop	NNP	O	Trop	nn	4	SENT_89	[p6l1202t3140r1319b3206],
2	Med	NNP	O	Med	nn	4	SENT_89	[p6l1341t3137r1460b3189],
3	Int	NNP	O	Int	nn	4	SENT_89	[p6l1482t3142r1562b3189],
4	Health	NNP	O	Health	_	0	SENT_89	[p6l1585t3137r1771b3190],
5	2001	CD	DATE	2001	num	4	SENT_89	[p6l1792t3142r1935b3198],
6	;	:	O	;	_	0	SENT_89	[p6l1792t3142r1935b3198],
7	6	CD	NUMBER	6	num	9	SENT_89	[p6l151t3221r197b3269],
8	:	:	O	:	_	0	SENT_89	[p6l151t3221r197b3269],
9	952-54	CD	NUMBER	952-54	dep	4	SENT_89	[p6l221t3219r437b3269],
10	.	.	O	.	_	0	SENT_89	[p6l221t3219r437b3269],

1	Viewpoint	NN	O	viewpoint	nn	2	SENT_90	[p6l6t3755r217b3801],
2	I	NN	O	i	_	0	SENT_90	[p6l265t3591r313b3789],

1	vwvw	NN	O	vwvw	_	0	SENT_91	[p6l814t3450r1347b3501],
2	.	.	O	.	_	0	SENT_91	[p6l814t3450r1347b3501],

1	the	DT	O	the	det	2	SENT_92	[p6l814t3450r1347b3501],
2	|	NN	O	|	_	0	SENT_92	[p6l814t3450r1347b3501],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_92	[p6l814t3450r1347b3501],
4	Vol	NNP	O	Vol	dep	2	SENT_92	[p6l1389t3450r1477b3501],
5	376	CD	NUMBER	376	num	4	SENT_92	[p6l1497t3449r1600b3508],
6	August	NNP	DATE	August	tmod	4	SENT_92	[p6l1644t3454r1848b3516],
7	28	CD	DATE	28	num	6	SENT_92	[p6l1866t3449r1951b3510],
8	,	,	DATE	,	_	0	SENT_92	[p6l1866t3449r1951b3510],
9	2010	CD	DATE	2010	num	6	SENT_92	[p6l1971t3456r2111b3501],

1	Puavilai	NNP	LOCATION	Puavilai	nn	2	SENT_93	[p7l141t236r350b285],
2	S	NNP	LOCATION	S	_	0	SENT_93	[p7l372t240r416b293],
3	,	,	O	,	_	0	SENT_93	[p7l372t240r416b293],
4	Chutha	NNP	PERSON	Chutha	nn	5	SENT_93	[p7l438t236r636b285],
5	S	NNP	PERSON	S	appos	2	SENT_93	[p7l657t240r701b293],
6	,	,	O	,	_	0	SENT_93	[p7l657t240r701b293],
7	Polnikorn	NNP	O	Polnikorn	nn	8	SENT_93	[p7l724t236r987b285],
8	N	NNP	O	N	appos	2	SENT_93	[p7l1007t241r1064b293],
9	,	,	O	,	_	0	SENT_93	[p7l1007t241r1064b293],
10	et	FW	O	et	nn	11	SENT_93	[p7l1085t246r1132b285],
11	al.	FW	O	al.	appos	2	SENT_93	[p7l1150t236r1206b285],
12	.	.	O	.	_	0	SENT_93	[p7l1150t236r1206b285],

1	Incidence	NN	O	incidence	_	0	SENT_94	[p7l1230t236r1490b285],
2	of	IN	O	of	advmod	7	SENT_94	[p7l1509t236r1569b285],
3	anemia	NN	O	anemia	pobj	2	SENT_94	[p7l1578t239r1776b285],
4	in	IN	O	in	_	0	SENT_94	[p7l1794t239r1848b285],
5	leprosy	NNP	O	leprosy	nn	6	SENT_94	[p7l137t311r331b375],
6	patients	NNS	O	patient	prep_in	3	SENT_94	[p7l347t314r558b374],
7	treated	VBN	O	treat	dep	1	SENT_94	[p7l576t311r761b360],
8	with	IN	O	with	_	0	SENT_94	[p7l777t311r896b360],
9	dapsone	NN	O	dapsone	prep_with	7	SENT_94	[p7l914t311r1149b374],
10	.	.	O	.	_	0	SENT_94	[p7l914t311r1149b374],
11	]	SYM	O	]	dep	1	SENT_94	[p7l1163t315r1195b375],

1	Med	NNP	ORGANIZATION	Med	nn	3	SENT_95	[p7l1212t311r1322b360],
2	Assoc	NNP	ORGANIZATION	Assoc	nn	3	SENT_95	[p7l1337t314r1477b360],
3	Thai	NNP	O	Thai	_	0	SENT_95	[p7l1497t311r1613b360],
4	1984	CD	DATE	1984	num	3	SENT_95	[p7l1632t315r1761b367],
5	;	:	O	;	_	0	SENT_95	[p7l1632t315r1761b367],
6	67	CD	NUMBER	67	num	8	SENT_95	[p7l139t387r214b434],
7	:	:	O	:	_	0	SENT_95	[p7l139t387r214b434],
8	404-07	CD	NUMBER	404-07	dep	3	SENT_95	[p7l233t387r416b435],
9	.	.	O	.	_	0	SENT_95	[p7l233t387r416b435],

1	Carson	NNP	ORGANIZATION	Carson	nn	2	SENT_96	[p7l140t471r333b517],
2	PE	NNP	ORGANIZATION	PE	_	0	SENT_96	[p7l356t471r442b524],
3	,	,	O	,	_	0	SENT_96	[p7l356t471r442b524],
4	Flanagan	NNP	PERSON	Flanagan	nn	5	SENT_96	[p7l468t468r718b532],
5	CL	NN	O	cl	appos	2	SENT_96	[p7l740t471r828b524],
6	,	,	O	,	_	0	SENT_96	[p7l740t471r828b524],
7	Icl	NN	O	icl	appos	2	SENT_96	[p7l853t468r992b517],
8	<	JJR	O	<	dep	7	SENT_96	[p7l853t468r992b517],
9	es	CD	NUMBER	es	num	10	SENT_96	[p7l853t468r992b517],
10	CE	NN	O	ce	dep	2	SENT_96	[p7l1015t471r1107b524],
11	,	,	O	,	_	0	SENT_96	[p7l1015t471r1107b524],
12	Alving	NNP	PERSON	Alving	nn	13	SENT_96	[p7l1129t468r1309b532],
13	A.	NNP	O	A.	appos	10	SENT_96	[p7l1328t471r1385b517],
14	Enzymatic	JJ	O	enzymatic	amod	15	SENT_96	[p7l1410t471r1698b532],
15	deﬁciency	NN	O	deﬁciency	dep	2	SENT_96	[p7l139t541r416b605],
16	in	IN	O	in	_	0	SENT_96	[p7l434t544r489b589],
17	primaquine-sensitive	JJ	O	primaquine-sensitive	amod	18	SENT_96	[p7l509t544r1095b604],
18	erythrocytes	NNS	O	erythrocyte	prep_in	15	SENT_96	[p7l1117t541r1466b605],
19	.	.	O	.	_	0	SENT_96	[p7l1117t541r1466b605],

1	Science	NNP	O	Science	_	0	SENT_97	[p7l1493t542r1680b590],
2	1956	CD	DATE	1956	num	1	SENT_97	[p7l1701t544r1836b597],
3	;	:	O	;	_	0	SENT_97	[p7l1701t544r1836b597],
4	124	CD	NUMBER	124	num	6	SENT_97	[p7l139t618r245b662],
5	:	:	O	:	_	0	SENT_97	[p7l139t618r245b662],
6	484-85	CD	NUMBER	484-85	dep	1	SENT_97	[p7l266t616r470b662],
7	.	.	O	.	_	0	SENT_97	[p7l266t616r470b662],

1	Luzzatto	NNP	PERSON	Luzzatto	nn	2	SENT_98	[p7l141t702r372b747],
2	L	NNP	PERSON	L	_	0	SENT_98	[p7l396t702r439b754],
3	,	,	O	,	_	0	SENT_98	[p7l396t702r439b754],
4	Mehta	NNP	PERSON	Mehta	nn	5	SENT_98	[p7l464t698r636b747],
5	A	NNP	O	A	appos	2	SENT_98	[p7l654t701r711b754],
6	,	,	O	,	_	0	SENT_98	[p7l654t701r711b754],
7	Vulliamy	NNP	PERSON	Vulliamy	nn	8	SENT_98	[p7l733t698r984b762],
8	T.	NNP	O	T.	appos	2	SENT_98	[p7l1001t701r1045b747],
9	Glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	11	SENT_98	[p7l1070t698r1650b761],
10	dehydrogenase	NN	O	dehydrogenase	nn	11	SENT_98	[p7l139t771r553b835],
11	deﬁciency	NN	O	deﬁciency	dep	8	SENT_98	[p7l574t770r859b834],
12	.	.	O	.	_	0	SENT_98	[p7l574t770r859b834],

1	In	IN	O	in	dep	4	SENT_99	[p7l884t775r955b819],
2	:	:	O	:	_	0	SENT_99	[p7l884t775r955b819],
3	Scriver	NN	PERSON	scriver	nn	4	SENT_99	[p7l983t774r1172b820],
4	C	NN	O	c	_	0	SENT_99	[p7l1193t774r1246b827],
5	,	,	O	,	_	0	SENT_99	[p7l1193t774r1246b827],
6	Beaudet	NNP	PERSON	Beaudet	nn	7	SENT_99	[p7l1272t771r1494b820],
7	A	NNP	O	A	appos	4	SENT_99	[p7l1511t774r1568b827],
8	,	,	O	,	_	0	SENT_99	[p7l1511t774r1568b827],
9	Sly	NNP	O	Sly	nn	10	SENT_99	[p7l1594t771r1674b835],
10	W	NNP	O	W	appos	4	SENT_99	[p7l1691t775r1758b827],
11	,	,	O	,	_	0	SENT_99	[p7l1691t775r1758b827],
12	Valle	NNP	ORGANIZATION	Valle	nn	13	SENT_99	[p7l137t843r271b893],
13	D	NNP	ORGANIZATION	D	appos	4	SENT_99	[p7l294t848r351b900],
14	,	,	O	,	_	0	SENT_99	[p7l294t848r351b900],
15	eds	NNS	O	ed	appos	4	SENT_99	[p7l375t843r479b892],
16	.	.	O	.	_	0	SENT_99	[p7l375t843r479b892],

1	The	DT	O	the	det	5	SENT_100	[p7l501t843r606b892],
2	metabolic	JJ	O	metabolic	amod	5	SENT_100	[p7l626t843r897b892],
3	and	CC	O	and	_	0	SENT_100	[p7l917t843r1019b892],
4	molecular	JJ	O	molecular	amod	5	SENT_100	[p7l1038t843r1316b892],
5	bases	NNS	O	basis	_	0	SENT_100	[p7l1334t843r1482b892],
6	of	IN	O	of	_	0	SENT_100	[p7l1504t843r1565b892],
7	inherited	VBN	O	inherit	amod	11	SENT_100	[p7l1576t843r1829b892],
8	disease	NN	O	disease	nn	11	SENT_100	[p7l139t918r351b974],
9	,	,	O	,	_	0	SENT_100	[p7l139t918r351b974],
10	8th	JJ	ORDINAL	8th	amod	11	SENT_100	[p7l375t918r462b967],
11	edn	NN	O	edn	prep_of	5	SENT_100	[p7l483t918r597b967],
12	.	.	O	.	_	0	SENT_100	[p7l483t918r597b967],

1	New	NNP	LOCATION	New	nn	2	SENT_101	[p7l622t922r743b967],
2	York	NNP	LOCATION	York	_	0	SENT_101	[p7l761t918r899b967],
3	:	:	O	:	_	0	SENT_101	[p7l761t918r899b967],
4	McGraw-Hill	NNP	ORGANIZATION	McGraw-Hill	dep	2	SENT_101	[p7l924t918r1312b974],
5	,	,	O	,	_	0	SENT_101	[p7l924t918r1312b974],
6	2001	CD	DATE	2001	num	8	SENT_101	[p7l1337t922r1472b967],
7	:	:	O	:	_	0	SENT_101	[p7l1337t922r1472b967],
8	4517-53	CD	NUMBER	4517-53	appos	4	SENT_101	[p7l1494t921r1724b968],
9	.	.	O	.	_	0	SENT_101	[p7l1494t921r1724b968],

1	Bienzle	NNP	O	Bienzle	nn	2	SENT_102	[p7l141t1000r343b1049],
2	U	NNP	O	U	_	0	SENT_102	[p7l367t1005r426b1056],
3	,	,	O	,	_	0	SENT_102	[p7l367t1005r426b1056],
4	Lucas	NNP	ORGANIZATION	Lucas	nn	8	SENT_102	[p7l452t1005r602b1049],
5	AO	JJ	ORGANIZATION	ao	amod	8	SENT_102	[p7l623t1004r729b1057],
6	,	,	O	,	_	0	SENT_102	[p7l623t1004r729b1057],
7	Ayeni	NNP	PERSON	Ayeni	dep	8	SENT_102	[p7l750t1003r909b1064],
8	O	NNP	PERSON	O	conj_and	2	SENT_102	[p7l930t1004r989b1057],
9	,	,	O	,	_	0	SENT_102	[p7l930t1004r989b1057],
10	Luzzatto	NNP	PERSON	Luzzatto	nn	13	SENT_102	[p7l1014t1005r1245b1049],
11	L.	NNP	O	L.	nn	13	SENT_102	[p7l1269t1005r1312b1049],
12	Glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	13	SENT_102	[p7l1337t1000r1917b1064],
13	dehydrogenase	NN	O	dehydrogenase	conj_and	2	SENT_102	[p7l139t1074r553b1138],
14	and	CC	O	and	_	0	SENT_102	[p7l574t1074r676b1123],
15	malaria	NN	O	malaria	conj_and	2	SENT_102	[p7l694t1074r917b1123],
16	:	:	O	:	_	0	SENT_102	[p7l694t1074r917b1123],
17	greater	JJR	O	greater	amod	18	SENT_102	[p7l941t1084r1134b1138],
18	resistance	NN	O	resistance	dep	2	SENT_102	[p7l1153t1077r1428b1123],
19	of	IN	O	of	_	0	SENT_102	[p7l1449t1074r1510b1123],
20	females	NNS	O	female	prep_of	18	SENT_102	[p7l1521t1074r1733b1123],
21	heterozygous	JJ	O	heterozygous	amod	20	SENT_102	[p7l137t1147r505b1211],
22	for	IN	O	for	_	0	SENT_102	[p7l526t1147r605b1196],
23	enzyme	NN	O	enzyme	nn	24	SENT_102	[p7l624t1163r838b1211],
24	deﬁciency	NN	O	deﬁciency	prep_for	21	SENT_102	[p7l859t1147r1136b1211],
25	and	CC	O	and	_	0	SENT_102	[p7l1156t1147r1257b1196],
26	of	IN	O	of	amod	20	SENT_102	[p7l1277t1147r1337b1196],
27	males	NNS	O	male	pobj	26	SENT_102	[p7l1348t1147r1508b1196],
28	with	IN	O	with	_	0	SENT_102	[p7l1529t1147r1650b1196],
29	non-deﬁcient	JJ	O	non-deﬁcient	amod	30	SENT_102	[p7l138t1218r507b1267],
30	Variant	JJ	O	variant	prep_with	18	SENT_102	[p7l524t1221r729b1267],
31	.	.	O	.	_	0	SENT_102	[p7l524t1221r729b1267],

1	Lancet	NNP	O	Lancet	_	0	SENT_103	[p7l755t1223r925b1267],
2	1972	CD	DATE	1972	num	1	SENT_103	[p7l945t1221r1076b1275],
3	;	:	O	;	_	0	SENT_103	[p7l945t1221r1076b1275],
4	299	CD	NUMBER	299	num	6	SENT_103	[p7l1101t1223r1210b1267],
5	:	:	O	:	_	0	SENT_103	[p7l1101t1223r1210b1267],
6	107-10	CD	NUMBER	107-10	dep	1	SENT_103	[p7l1234t1221r1426b1269],
7	.	.	O	.	_	0	SENT_103	[p7l1234t1221r1426b1269],

1	Cappellini	NNP	PERSON	Cappellini	nn	2	SENT_104	[p7l140t1303r422b1366],
2	MD	NNP	O	MD	_	0	SENT_104	[p7l444t1307r561b1359],
3	,	,	O	,	_	0	SENT_104	[p7l444t1307r561b1359],
4	Fiorelli	NNP	PERSON	Fiorelli	nn	5	SENT_104	[p7l587t1303r780b1352],
5	G.	NNP	O	G.	appos	2	SENT_104	[p7l802t1306r860b1352],
6	Glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	8	SENT_104	[p7l885t1303r1465b1366],
7	dehydrogenase	NN	O	dehydrogenase	nn	8	SENT_104	[p7l1486t1303r1900b1367],
8	deﬁciency	NN	O	deﬁciency	dep	5	SENT_104	[p7l139t1375r423b1439],
9	.	.	O	.	_	0	SENT_104	[p7l139t1375r423b1439],

1	Lancet	NNP	O	Lancet	_	0	SENT_105	[p7l449t1380r619b1424],
2	2008	CD	DATE	2008	num	1	SENT_105	[p7l639t1380r781b1432],
3	;	:	O	;	_	0	SENT_105	[p7l639t1380r781b1432],
4	371	CD	NUMBER	371	num	6	SENT_105	[p7l805t1378r910b1425],
5	:	:	O	:	_	0	SENT_105	[p7l805t1378r910b1425],
6	64-74	CD	NUMBER	64-74	dep	1	SENT_105	[p7l934t1378r1098b1426],
7	.	.	O	.	_	0	SENT_105	[p7l934t1378r1098b1426],

1	Degowin	NNP	O	Degowin	nn	2	SENT_106	[p7l141t1462r386b1523],
2	RL	NNP	O	RL	_	0	SENT_106	[p7l409t1464r495b1515],
3	,	,	O	,	_	0	SENT_106	[p7l409t1464r495b1515],
4	Eppes	NNP	PERSON	Eppes	nn	5	SENT_106	[p7l521t1462r681b1523],
5	RB	NN	O	rb	appos	2	SENT_106	[p7l706t1464r800b1515],
6	,	,	O	,	_	0	SENT_106	[p7l706t1464r800b1515],
7	Powell	NNP	PERSON	Powell	nn	8	SENT_106	[p7l825t1459r1003b1508],
8	RD	NNP	O	RD	appos	2	SENT_106	[p7l1026t1464r1126b1515],
9	,	,	O	,	_	0	SENT_106	[p7l1026t1464r1126b1515],
10	Carson	NNP	ORGANIZATION	Carson	nn	11	SENT_106	[p7l1151t1462r1344b1508],
11	PE	NNP	ORGANIZATION	PE	appos	2	SENT_106	[p7l1366t1462r1453b1508],
12	.	.	O	.	_	0	SENT_106	[p7l1366t1462r1453b1508],

1	The	DT	O	the	det	3	SENT_107	[p7l1474t1459r1579b1508],
2	haemolytic	JJ	O	haemolytic	amod	3	SENT_107	[p7l1599t1459r1903b1523],
3	effects	NNS	O	effect	_	0	SENT_107	[p7l139t1532r313b1581],
4	of	IN	O	of	_	0	SENT_107	[p7l336t1532r396b1581],
5	diaphenylsulfone	NN	O	diaphenylsulfone	nn	8	SENT_107	[p7l408t1531r886b1596],
6	(	CD	NUMBER	(	num	8	SENT_107	[p7l911t1535r1075b1596],
7	DDS	NN	O	dd	nn	8	SENT_107	[p7l911t1535r1075b1596],
8	)	NN	O	)	prep_of	3	SENT_107	[p7l911t1535r1075b1596],
9	in	IN	O	in	_	0	SENT_107	[p7l1099t1535r1154b1580],
10	normal	JJ	O	normal	amod	11	SENT_107	[p7l1174t1532r1374b1581],
11	subjects	NNS	O	subject	prep_in	3	SENT_107	[p7l1396t1532r1616b1596],
12	and	CC	O	and	_	0	SENT_107	[p7l1639t1532r1740b1581],
13	in	IN	O	in	_	0	SENT_107	[p7l1759t1535r1813b1580],
14	those	DT	O	those	conj_and	11	SENT_107	[p7l1832t1532r1979b1581],
15	with	IN	O	with	_	0	SENT_107	[p7l137t1604r258b1653],
16	glucose-6-phosphate-dehydrogenase	NN	O	glucose-6-phosphate-dehydrogenase	nn	17	SENT_107	[p7l279t1604r1281b1669],
17	deﬁciency	NN	O	deﬁciency	prep_with	14	SENT_107	[p7l1302t1604r1587b1668],
18	.	.	O	.	_	0	SENT_107	[p7l1302t1604r1587b1668],

1	Bull	NNP	MISC	Bull	nn	4	SENT_108	[p7l142t1678r246b1727],
2	World	NNP	MISC	World	nn	4	SENT_108	[p7l271t1678r423b1727],
3	Health	NNP	MISC	Health	nn	4	SENT_108	[p7l445t1678r622b1727],
4	Organ	NNP	MISC	Organ	_	0	SENT_108	[p7l646t1682r809b1742],
5	1966	CD	DATE	1966	num	4	SENT_108	[p7l830t1682r966b1734],
6	;	:	O	;	_	0	SENT_108	[p7l830t1682r966b1734],
7	35	CD	NUMBER	35	num	9	SENT_108	[p7l990t1680r1066b1727],
8	:	:	O	:	_	0	SENT_108	[p7l990t1680r1066b1727],
9	165-79	CD	NUMBER	165-79	dep	4	SENT_108	[p7l1091t1681r1288b1729],
10	.	.	O	.	_	0	SENT_108	[p7l1091t1681r1288b1729],

1	Betl	NN	O	betl	_	0	SENT_109	[p7l141t1759r292b1808],
2	<	JJR	O	<	dep	1	SENT_109	[p7l141t1759r292b1808],
3	e	SYM	O	e	dep	4	SENT_109	[p7l141t1759r292b1808],
4	K	NNP	O	K	dep	1	SENT_109	[p7l315t1764r367b1816],
5	,	,	O	,	_	0	SENT_109	[p7l315t1764r367b1816],
6	Brewer	NNP	O	Brewer	nn	8	SENT_109	[p7l392t1764r587b1809],
7	G	NNP	O	G	nn	8	SENT_109	[p7l608t1763r691b1822],
8	]	NNS	O	]	appos	4	SENT_109	[p7l608t1763r691b1822],
9	,	,	O	,	_	0	SENT_109	[p7l608t1763r691b1822],
10	Kirkman	NNP	PERSON	Kirkman	nn	11	SENT_109	[p7l716t1759r958b1808],
11	HN	NNP	O	HN	appos	4	SENT_109	[p7l981t1764r1093b1816],
12	,	,	O	,	_	0	SENT_109	[p7l981t1764r1093b1816],
13	et	FW	O	et	nn	14	SENT_109	[p7l1116t1769r1164b1808],
14	al.	FW	O	al.	appos	4	SENT_109	[p7l1184t1759r1243b1808],
15	.	.	O	.	_	0	SENT_109	[p7l1184t1759r1243b1808],

1	Standardization	NN	O	standardization	_	0	SENT_110	[p7l1270t1759r1707b1808],
2	of	IN	O	of	_	0	SENT_110	[p7l1727t1759r1788b1808],
3	procedures	NNS	O	procedure	prep_of	1	SENT_110	[p7l138t1834r444b1898],
4	for	IN	O	for	_	0	SENT_110	[p7l465t1834r544b1883],
5	the	DT	O	the	det	6	SENT_110	[p7l562t1834r648b1883],
6	study	NN	O	study	prep_for	3	SENT_110	[p7l670t1834r817b1898],
7	of	IN	O	of	_	0	SENT_110	[p7l836t1834r897b1883],
8	glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	9	SENT_110	[p7l909t1834r1474b1898],
9	dehydrogenase	NN	O	dehydrogenase	prep_of	1	SENT_110	[p7l1495t1834r1924b1898],
10	.	.	O	.	_	0	SENT_110	[p7l1495t1834r1924b1898],

1	World	NNP	MISC	World	nn	6	SENT_111	[p7l145t1907r297b1956],
2	Health	NNP	MISC	Health	nn	6	SENT_111	[p7l319t1907r496b1956],
3	Organ	NN	MISC	organ	nn	6	SENT_111	[p7l520t1911r682b1971],
4	Tech	NNP	MISC	Tech	nn	6	SENT_111	[p7l706t1907r818b1955],
5	Rep	NNP	MISC	Rep	nn	6	SENT_111	[p7l841t1911r934b1970],
6	Ser	NNP	DATE	Ser	_	0	SENT_111	[p7l959t1910r1042b1956],
7	1967	CD	DATE	1967	num	6	SENT_111	[p7l1059t1910r1191b1963],
8	;	:	O	;	_	0	SENT_111	[p7l1059t1910r1191b1963],
9	366	CD	NUMBER	366	num	11	SENT_111	[p7l1215t1911r1324b1956],
10	:	:	O	:	_	0	SENT_111	[p7l1215t1911r1324b1956],
11	1-53	CD	NUMBER	1-53	dep	6	SENT_111	[p7l1349t1910r1485b1956],
12	.	.	O	.	_	0	SENT_111	[p7l1349t1910r1485b1956],

1	Sulo	NNP	O	Sulo	nn	2	SENT_112	[p7l142t1989r259b2038],
2	I	NNP	O	I	_	0	SENT_112	[p7l281t1994r316b2052],
3	,	,	O	,	_	0	SENT_112	[p7l281t1994r316b2052],
4	Chimpeni	NNP	PERSON	Chimpeni	nn	5	SENT_112	[p7l340t1989r617b2053],
5	P	NN	PERSON	p	appos	2	SENT_112	[p7l640t1994r688b2045],
6	,	,	O	,	_	0	SENT_112	[p7l640t1994r688b2045],
7	I-Iatcher	NN	O	i-iatcher	nn	8	SENT_112	[p7l713t1989r935b2038],
8	I	NN	O	i	appos	2	SENT_112	[p7l955t1994r990b2052],
9	,	,	O	,	_	0	SENT_112	[p7l955t1994r990b2052],
10	et	FW	O	et	nn	11	SENT_112	[p7l1013t1999r1061b2038],
11	al.	FW	O	al.	appos	2	SENT_112	[p7l1080t1989r1139b2038],
12	.	.	O	.	_	0	SENT_112	[p7l1080t1989r1139b2038],

1	Chlorproguanil-dapsone	JJ	O	chlorproguanil-dapsone	_	0	SENT_113	[p7l1164t1989r1839b2054],
2	versus	CC	O	versus	prep	1	SENT_113	[p7l137t2080r312b2112],
3	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	dep	2	SENT_113	[p7l336t2063r1103b2127],
4	for	IN	O	for	_	0	SENT_113	[p7l1123t2063r1202b2112],
5	sequential	JJ	O	sequential	amod	6	SENT_113	[p7l1222t2063r1505b2127],
6	episodes	NNS	O	episode	prep_for	3	SENT_113	[p7l1526t2063r1761b2127],
7	of	IN	O	of	_	0	SENT_113	[p7l1783t2063r1844b2112],
8	uncomplicated	JJ	O	uncomplicated	amod	10	SENT_113	[p7l137t2136r550b2199],
9	falciparum	NN	O	falciparum	nn	10	SENT_113	[p7l569t2135r871b2199],
10	malaria	NN	O	malaria	prep_of	6	SENT_113	[p7l890t2136r1099b2185],
11	in	IN	O	in	_	0	SENT_113	[p7l1119t2139r1174b2184],
12	Kenya	NNP	LOCATION	Kenya	prep_in	10	SENT_113	[p7l1196t2140r1361b2200],
13	and	CC	O	and	_	0	SENT_113	[p7l1381t2136r1483b2185],
14	Malawi	NNP	LOCATION	Malawi	conj_and	12	SENT_113	[p7l1504t2136r1715b2185],
15	:	:	O	:	_	0	SENT_113	[p7l1504t2136r1715b2185],
16	a	DT	O	a	det	19	SENT_113	[p7l139t2226r166b2257],
17	randomised	JJ	O	randomised	amod	19	SENT_113	[p7l186t2208r517b2257],
18	clinical	JJ	O	clinical	amod	19	SENT_113	[p7l537t2208r733b2257],
19	trial	NN	O	trial	dep	1	SENT_113	[p7l753t2208r877b2257],
20	.	.	O	.	_	0	SENT_113	[p7l753t2208r877b2257],

1	Lancet	NNP	O	Lancet	_	0	SENT_114	[p7l903t2213r1073b2257],
2	2002	CD	DATE	2002	num	1	SENT_114	[p7l1093t2212r1235b2265],
3	;	:	O	;	_	0	SENT_114	[p7l1093t2212r1235b2265],
4	360	CD	NUMBER	360	num	6	SENT_114	[p7l1259t2212r1369b2258],
5	:	:	O	:	_	0	SENT_114	[p7l1259t2212r1369b2258],
6	1136-43	CD	NUMBER	1136-43	dep	1	SENT_114	[p7l1393t2212r1619b2257],
7	.	.	O	.	_	0	SENT_114	[p7l1393t2212r1619b2257],

1	Alloueche	NNP	MISC	Alloueche	nn	2	SENT_115	[p7l137t2293r414b2342],
2	A	NNP	MISC	A	_	0	SENT_115	[p7l433t2296r490b2349],
3	,	,	O	,	_	0	SENT_115	[p7l433t2296r490b2349],
4	Bailey	NNP	PERSON	Bailey	nn	5	SENT_115	[p7l515t2293r680b2357],
5	W	NNP	PERSON	W	appos	2	SENT_115	[p7l698t2297r765b2349],
6	,	,	O	,	_	0	SENT_115	[p7l698t2297r765b2349],
7	Barton	NNP	PERSON	Barton	nn	8	SENT_115	[p7l791t2297r974b2342],
8	S	NNP	O	S	appos	2	SENT_115	[p7l998t2296r1043b2349],
9	,	,	O	,	_	0	SENT_115	[p7l998t2296r1043b2349],
10	et	FW	O	et	nn	11	SENT_115	[p7l1066t2303r1114b2342],
11	al.	FW	O	al.	appos	2	SENT_115	[p7l1134t2293r1192b2342],
12	.	.	O	.	_	0	SENT_115	[p7l1134t2293r1192b2342],

1	Comparison	NN	O	comparison	_	0	SENT_116	[p7l1217t2296r1556b2356],
2	of	IN	O	of	_	0	SENT_116	[p7l1577t2293r1638b2342],
3	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	1	SENT_116	[p7l139t2365r800b2430],
4	with	IN	O	with	_	0	SENT_116	[p7l818t2365r940b2414],
5	sulfadoxine-pyrimethamine	NN	O	sulfadoxine-pyrimethamine	prep_with	3	SENT_116	[p7l962t2365r1729b2429],
6	for	IN	O	for	_	0	SENT_116	[p7l1749t2365r1828b2414],
7	the	DT	O	the	det	8	SENT_116	[p7l1846t2365r1931b2414],
8	treatment	NN	O	treatment	prep_for	5	SENT_116	[p7l137t2449r410b2488],
9	of	IN	O	of	_	0	SENT_116	[p7l430t2439r490b2488],
10	uncomplicated	JJ	O	uncomplicated	amod	12	SENT_116	[p7l500t2439r913b2503],
11	falciparum	NN	O	falciparum	nn	12	SENT_116	[p7l932t2439r1234b2503],
12	malaria	NN	O	malaria	prep_of	8	SENT_116	[p7l1253t2439r1462b2488],
13	in	IN	O	in	_	0	SENT_116	[p7l1481t2442r1536b2487],
14	young	JJ	O	young	amod	16	SENT_116	[p7l1554t2456r1726b2503],
15	African	JJ	MISC	african	amod	16	SENT_116	[p7l1745t2439r1951b2488],
16	children	NNS	O	child	prep_in	12	SENT_116	[p7l139t2512r382b2561],
17	:	:	O	:	_	0	SENT_116	[p7l139t2512r382b2561],
18	double-blind	JJ	O	double-blind	amod	21	SENT_116	[p7l406t2512r757b2561],
19	randomised	JJ	O	randomised	amod	21	SENT_116	[p7l776t2512r1107b2561],
20	controlled	JJ	O	controlled	amod	21	SENT_116	[p7l1127t2512r1406b2561],
21	trial	NN	O	trial	dep	1	SENT_116	[p7l1424t2512r1548b2561],
22	.	.	O	.	_	0	SENT_116	[p7l1424t2512r1548b2561],

1	Lancet	NNP	O	Lancet	_	0	SENT_117	[p7l1574t2516r1745b2561],
2	2004	CD	DATE	2004	num	1	SENT_117	[p7l1764t2516r1903b2569],
3	;	:	O	;	_	0	SENT_117	[p7l1764t2516r1903b2569],
4	363	CD	NUMBER	363	num	6	SENT_117	[p7l139t2589r249b2634],
5	:	:	O	:	_	0	SENT_117	[p7l139t2589r249b2634],
6	1843-48	CD	NUMBER	1843-48	dep	1	SENT_117	[p7l273t2589r502b2634],
7	.	.	O	.	_	0	SENT_117	[p7l273t2589r502b2634],

1	Review	NN	O	review	_	0	SENT_118	[p7l141t2673r335b2719],
2	of	IN	O	of	_	0	SENT_118	[p7l354t2670r415b2719],
3	the	DT	O	the	det	4	SENT_118	[p7l424t2670r510b2719],
4	safety	NN	O	safety	prep_of	1	SENT_118	[p7l532t2670r689b2734],
5	of	IN	O	of	_	0	SENT_118	[p7l709t2670r769b2719],
6	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_of	4	SENT_118	[p7l781t2670r1441b2734],
7	in	IN	O	in	_	0	SENT_118	[p7l1461t2673r1516b2718],
8	the	DT	O	the	det	9	SENT_118	[p7l1535t2670r1621b2719],
9	treatment	NN	O	treatment	prep_in	1	SENT_118	[p7l1640t2680r1913b2719],
10	of	IN	O	of	_	0	SENT_118	[p7l1933t2670r1993b2719],
11	uncomplicated	JJ	O	uncomplicated	amod	13	SENT_118	[p7l137t2743r550b2806],
12	falciparum	NN	O	falciparum	nn	13	SENT_118	[p7l569t2743r871b2806],
13	malaria	NN	O	malaria	prep_of	9	SENT_118	[p7l890t2743r1099b2792],
14	in	IN	O	in	_	0	SENT_118	[p7l1119t2746r1174b2791],
15	Africa	NNP	LOCATION	Africa	prep_in	13	SENT_118	[p7l1192t2743r1374b2792],
16	.	.	O	.	_	0	SENT_118	[p7l1192t2743r1374b2792],

1	Report	NNP	O	Report	nsubj	6	SENT_119	[p7l1399t2747r1581b2806],
2	of	IN	O	of	_	0	SENT_119	[p7l1601t2743r1661b2792],
3	a	DT	O	a	det	5	SENT_119	[p7l1673t2760r1700b2792],
4	technical	JJ	O	technical	amod	5	SENT_119	[p7l1719t2743r1968b2792],
5	consultation	NN	O	consultation	prep_of	1	SENT_119	[p7l139t2815r481b2864],
6	convened	VBN	O	convene	_	0	SENT_119	[p7l502t2815r764b2864],
7	by	IN	O	by	_	0	SENT_119	[p7l782t2815r845b2879],
8	WHO	WP	ORGANIZATION	who	prep_by	6	SENT_119	[p7l863t2819r1041b2871],
9	,	,	O	,	_	0	SENT_119	[p7l863t2819r1041b2871],
10	Geneva	NNP	LOCATION	Geneva	dobj	6	SENT_119	[p7l1066t2819r1282b2871],
11	,	,	O	,	_	0	SENT_119	[p7l1066t2819r1282b2871],
12	1-2	CD	NUMBER	1-2	appos	10	SENT_119	[p7l1307t2820r1393b2863],
13	Iuly	JJ	O	iuly	amod	12	SENT_119	[p7l1417t2815r1521b2879],
14	2004	CD	DATE	2004	tmod	13	SENT_119	[p7l1541t2819r1679b2864],
15	.	.	O	.	_	0	SENT_119	[p7l1541t2819r1679b2864],

1	http://malaria.who.int/docs/LapDap.pdf	NN	O	http://malaria.who.int/docs/lapdap.pdf	nsubj	3	SENT_120	[p7l137t2889r1275b2952],
2	(	CD	NUMBER	(	num	1	SENT_120	[p7l1290t2889r1545b2953],
3	accessed	VBN	O	access	_	0	SENT_120	[p7l1290t2889r1545b2953],
4	April	NNP	DATE	April	tmod	3	SENT_120	[p7l1563t2889r1700b2952],
5	30	CD	DATE	30	num	4	SENT_120	[p7l1723t2893r1798b2945],
6	,	,	DATE	,	_	0	SENT_120	[p7l1723t2893r1798b2945],
7	2010	CD	DATE	2010	num	4	SENT_120	[p7l1822t2893r1979b2953],
8	)	NN	O	)	dep	4	SENT_120	[p7l1822t2893r1979b2953],
9	.	.	O	.	_	0	SENT_120	[p7l1822t2893r1979b2953],

1	Update	NNP	O	Update	_	0	SENT_121	[p7l141t2971r329b3035],
2	on	IN	O	on	_	0	SENT_121	[p7l347t2989r413b3020],
3	GSK	NNP	ORGANIZATION	GSK	poss	6	SENT_121	[p7l431t2975r591b3020],
4	’s	POS	O	’s	_	0	SENT_121	[p7l431t2975r591b3020],
5	malaria	NN	O	malaria	nn	6	SENT_121	[p7l610t2971r807b3020],
6	treatments	NNS	O	treatment	prep_on	1	SENT_121	[p7l822t2981r1118b3020],
7	:	:	O	:	_	0	SENT_121	[p7l822t2981r1118b3020],
8	Dacart	NNP	PERSON	Dacart	dep	1	SENT_121	[p7l1140t2976r1309b3020],
9	and	CC	O	and	_	0	SENT_121	[p7l1326t2971r1423b3020],
10	Lapdap	NNP	O	Lapdap	conj_and	8	SENT_121	[p7l1441t2971r1641b3035],
11	.	.	O	.	_	0	SENT_121	[p7l1441t2971r1641b3035],

1	http://wvvw	NN	O	http://wvvw	_	0	SENT_122	[p7l1659t2971r1972b3035],
2	.	.	O	.	_	0	SENT_122	[p7l1659t2971r1972b3035],

1	gsk.com/media/pressreleases	NNS	O	gsk.com/media/pressreleases	_	0	SENT_123	[p7l139t3045r915b3109],
2	/	:	O	/	punct	3	SENT_123	[p7l921t3050r941b3109],
3	2008	CD	DATE	2008	dep	1	SENT_123	[p7l946t3049r1092b3109],
4	/	:	O	/	punct	3	SENT_123	[p7l946t3049r1092b3109],
5	2008_pressrelease_0014	CD	NUMBER	2008_pressrelease_0014	dep	3	SENT_123	[p7l1097t3045r1842b3109],
6	.	.	O	.	_	0	SENT_123	[p7l1097t3045r1842b3109],

1	htrn	NN	O	htrn	nn	2	SENT_124	[p7l1097t3045r1842b3109],
2	(	NN	O	(	nsubj	3	SENT_124	[p7l142t3118r383b3182],
3	accessed	VBN	O	access	_	0	SENT_124	[p7l142t3118r383b3182],
4	April	NNP	DATE	April	tmod	3	SENT_124	[p7l397t3118r528b3181],
5	30	CD	DATE	30	num	4	SENT_124	[p7l547t3122r618b3174],
6	,	,	DATE	,	_	0	SENT_124	[p7l547t3122r618b3174],
7	2010	CD	DATE	2010	num	4	SENT_124	[p7l638t3122r786b3182],
8	)	NN	O	)	dep	4	SENT_124	[p7l638t3122r786b3182],
9	.	.	O	.	_	0	SENT_124	[p7l638t3122r786b3182],

1	www	NN	O	www	_	0	SENT_125	[p8l6t91r500b138],
2	.	.	O	.	_	0	SENT_125	[p8l6t91r500b138],

1	the	DT	O	the	det	2	SENT_126	[p8l6t91r500b138],
2	|	NN	O	|	dep	6	SENT_126	[p8l6t91r500b138],
3	ancet.com	NNP	O	ancet.com	nn	4	SENT_126	[p8l6t91r500b138],
4	Vol	NNP	O	Vol	dep	2	SENT_126	[p8l540t91r621b138],
5	376	CD	NUMBER	376	num	6	SENT_126	[p8l639t90r735b144],
6	August	NNP	DATE	August	_	0	SENT_126	[p8l777t94r965b152],
7	28	CD	DATE	28	num	6	SENT_126	[p8l982t90r1061b146],
8	,	,	DATE	,	_	0	SENT_126	[p8l982t90r1061b146],
9	2010	CD	DATE	2010	num	11	SENT_126	[p8l1079t97r1209b138],
10	Owusu-Agyei	NNP	O	Owusu-Agyei	nn	11	SENT_126	[p8l10t158r302b208],
11	S	NN	O	s	appos	6	SENT_126	[p8l320t158r355b201],
12	,	,	O	,	_	0	SENT_126	[p8l320t158r355b201],
13	Asante	NNP	O	Asante	nn	14	SENT_126	[p8l372t158r521b195],
14	KP	NNP	O	KP	appos	6	SENT_126	[p8l538t159r611b201],
15	,	,	O	,	_	0	SENT_126	[p8l538t159r611b201],
16	Owusu	NNP	PERSON	Owusu	nn	17	SENT_126	[p8l629t158r784b195],
17	R	NNP	O	R	appos	6	SENT_126	[p8l800t159r841b201],
18	,	,	O	,	_	0	SENT_126	[p8l800t159r841b201],
19	et	FW	O	et	nn	20	SENT_126	[p8l859t163r897b195],
20	al.	FW	O	al.	appos	6	SENT_126	[p8l912t155r958b195],
21	.	.	O	.	_	0	SENT_126	[p8l912t155r958b195],

1	An	DT	O	a	det	3	SENT_127	[p8l974t158r1038b194],
2	open	JJ	O	open	amod	3	SENT_127	[p8l1054t169r1161b207],
3	label	NN	O	label	_	0	SENT_127	[p8l1175t155r1288b201],
4	,	,	O	,	_	0	SENT_127	[p8l1175t155r1288b201],
5	randomised	JJ	O	randomised	amod	6	SENT_127	[p8l9t215r271b255],
6	trial	NN	O	trial	appos	3	SENT_127	[p8l284t215r371b255],
7	of	IN	O	of	_	0	SENT_127	[p8l386t215r435b255],
8	artesunate	NN	O	artesunate	prep_of	6	SENT_127	[p8l442t215r997b267],
9	+	CC	O	+	_	0	SENT_127	[p8l442t215r997b267],
10	amodiaquine	NN	O	amodiaquine	conj_+	6	SENT_127	[p8l442t215r997b267],
11	,	,	O	,	_	0	SENT_127	[p8l442t215r997b267],
12	artesunate	NN	O	artesunate	conj_+	10	SENT_127	[p8l1015t223r1269b255],
13	+	CC	O	+	_	0	SENT_127	[p8l1015t223r1269b255],
14	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	conj_+	10	SENT_127	[p8l9t274r529b326],
15	and	CC	O	and	_	0	SENT_127	[p8l545t273r625b313],
16	artemether-lumefantrine	NN	O	artemether-lumefantrine	conj_and	10	SENT_127	[p8l640t273r1180b313],
17	for	IN	O	for	_	0	SENT_127	[p8l1195t273r1257b313],
18	the	DT	O	the	det	19	SENT_127	[p8l1270t274r1339b313],
19	treatment	NN	O	treatment	prep_for	16	SENT_127	[p8l8t340r223b372],
20	of	IN	O	of	_	0	SENT_127	[p8l238t332r286b372],
21	uncomplicated	JJ	O	uncomplicated	amod	22	SENT_127	[p8l292t332r618b384],
22	malaria	NN	O	malaria	prep_of	19	SENT_127	[p8l632t332r807b372],
23	.	.	O	.	_	0	SENT_127	[p8l632t332r807b372],

1	PLoS	NNP	O	PLoS	_	0	SENT_128	[p8l827t335r934b372],
2	One	CD	NUMBER	one	num	1	SENT_128	[p8l953t336r1035b372],
3	2008	CD	DATE	2008	num	5	SENT_128	[p8l1050t336r1162b378],
4	;	:	O	;	_	0	SENT_128	[p8l1050t336r1162b378],
5	3	CD	NUMBER	3	dep	1	SENT_128	[p8l1180t336r1215b372],
6	:	:	O	:	_	0	SENT_128	[p8l1180t336r1215b372],
7	e2530	NN	O	e2530	dep	1	SENT_128	[p8l1232t335r1369b372],
8	.	.	O	.	_	0	SENT_128	[p8l1232t335r1369b372],

1	Byrd	NNP	PERSON	Byrd	_	0	SENT_129	[p8l11t400r109b452],
2	SR	JJ	O	sr	dep	1	SENT_129	[p8l127t403r196b445],
3	,	,	O	,	_	0	SENT_129	[p8l127t403r196b445],
4	Gelber	NNP	PERSON	Gelber	nn	5	SENT_129	[p8l215t400r359b440],
5	RH	NNP	O	RH	appos	2	SENT_129	[p8l375t404r460b439],
6	.	.	O	.	_	0	SENT_129	[p8l375t404r460b439],

1	Effect	NN	O	effect	_	0	SENT_130	[p8l479t400r601b440],
2	of	IN	O	of	_	0	SENT_130	[p8l616t400r664b440],
3	dapsone	NN	O	dapsone	prep_of	1	SENT_130	[p8l672t400r852b451],
4	on	IN	O	on	_	0	SENT_130	[p8l868t414r922b440],
5	haemoglobin	NN	O	haemoglobin	nn	6	SENT_130	[p8l936t400r1224b452],
6	concentration	NN	O	concentration	prep_on	1	SENT_130	[p8l10t461r310b498],
7	in	IN	O	in	_	0	SENT_130	[p8l324t461r368b498],
8	patients	NNS	O	patient	prep_in	1	SENT_130	[p8l382t461r553b510],
9	with	IN	O	with	_	0	SENT_130	[p8l568t458r665b498],
10	leprosy	NNP	O	leprosy	prep_with	8	SENT_130	[p8l679t458r841b510],
11	.	.	O	.	_	0	SENT_130	[p8l679t458r841b510],

1	Lepr	NNP	O	Lepr	nn	2	SENT_131	[p8l861t462r951b510],
2	Rev	NN	O	rev	_	0	SENT_131	[p8l966t462r1038b498],
3	1991	CD	DATE	1991	num	2	SENT_131	[p8l1053t462r1155b504],
4	;	:	O	;	_	0	SENT_131	[p8l1053t462r1155b504],
5	62	CD	NUMBER	62	num	7	SENT_131	[p8l1174t462r1234b498],
6	:	:	O	:	_	0	SENT_131	[p8l1174t462r1234b498],
7	171-78	CD	NUMBER	171-78	dep	2	SENT_131	[p8l1252t461r1399b499],
8	.	.	O	.	_	0	SENT_131	[p8l1252t461r1399b499],

1	Woodruﬁf	JJ	O	woodruﬁf	amod	2	SENT_132	[p8l8t526r224b566],
2	AW	NN	O	aw	dep	21	SENT_132	[p8l230t529r312b572],
3	,	,	O	,	_	0	SENT_132	[p8l230t529r312b572],
4	Ridley	NNP	PERSON	Ridley	nn	5	SENT_132	[p8l331t526r466b578],
5	DS	NN	PERSON	d	appos	2	SENT_132	[p8l482t529r557b571],
6	,	,	O	,	_	0	SENT_132	[p8l482t529r557b571],
7	Rowland	NNP	ORGANIZATION	Rowland	nn	8	SENT_132	[p8l576t526r765b566],
8	HAK	NNP	ORGANIZATION	HAK	appos	2	SENT_132	[p8l781t529r901b571],
9	,	,	O	,	_	0	SENT_132	[p8l781t529r901b571],
10	Harries	NNP	ORGANIZATION	Harries	nn	11	SENT_132	[p8l920t528r1081b566],
11	IR	NNP	ORGANIZATION	IR	appos	2	SENT_132	[p8l1099t530r1160b577],
12	,	,	O	,	_	0	SENT_132	[p8l1099t530r1160b577],
13	Hall	NNP	O	Hall	nn	14	SENT_132	[p8l1179t526r1269b566],
14	A	NNP	O	A	appos	2	SENT_132	[p8l1283t529r1328b571],
15	,	,	O	,	_	0	SENT_132	[p8l1283t529r1328b571],
16	Heaf	NNP	LOCATION	Heaf	nn	17	SENT_132	[p8l11t584r122b624],
17	P	NN	O	p	appos	2	SENT_132	[p8l131t588r227b635],
18	]	CD	NUMBER	]	num	21	SENT_132	[p8l131t588r227b635],
19	D.	NNP	O	D.	nn	21	SENT_132	[p8l131t588r227b635],
20	Drug	NNP	O	Drug	nn	21	SENT_132	[p8l247t588r357b637],
21	prevention	NN	O	prevention	_	0	SENT_132	[p8l371t587r607b636],
22	of	IN	O	of	_	0	SENT_132	[p8l622t584r670b624],
23	malaria	NN	O	malaria	prep_of	21	SENT_132	[p8l677t585r853b624],
24	.	.	O	.	_	0	SENT_132	[p8l677t585r853b624],

1	Br	NNP	O	Br	nsubj	2	SENT_133	[p8l873t588r923b624],
2	Med	VBD	O	med	_	0	SENT_133	[p8l936t585r1059b637],
3	]	CD	NUMBER	]	num	7	SENT_133	[p8l936t585r1059b637],
4	(	CD	NUMBER	(	num	7	SENT_133	[p8l1078t585r1182b637],
5	Clin	NNP	PERSON	Clin	nn	7	SENT_133	[p8l1078t585r1182b637],
6	Res	NNP	PERSON	Res	nn	7	SENT_133	[p8l1199t588r1266b624],
7	Ed	NNP	PERSON	Ed	dobj	2	SENT_133	[p8l1283t585r1353b637],
8	)	CD	NUMBER	)	num	9	SENT_133	[p8l1283t585r1353b637],
9	1981	CD	DATE	1981	dep	7	SENT_133	[p8l1372t588r1474b630],
10	;	:	O	;	_	0	SENT_133	[p8l1372t588r1474b630],
11	2.82	CD	NUMBER	2.82	num	13	SENT_133	[p8l10t647r97b683],
12	:	:	O	:	_	0	SENT_133	[p8l10t647r97b683],
13	988-89	CD	NUMBER	988-89	dep	7	SENT_133	[p8l114t647r279b684],
14	.	.	O	.	_	0	SENT_133	[p8l114t647r279b684],

1	Ponnampalam	NNP	PERSON	Ponnampalam	nn	2	SENT_134	[p8l11t711r330b762],
2	IT	NNP	O	IT	_	0	SENT_134	[p8l346t713r398b762],
3	.	.	O	.	_	0	SENT_134	[p8l346t713r398b762],

1	Haemoglobinuria	NN	PERSON	haemoglobinurium	_	0	SENT_135	[p8l417t711r804b763],
2	after	IN	O	after	_	0	SENT_135	[p8l819t711r917b751],
3	a	DT	O	a	det	6	SENT_135	[p8l931t725r953b751],
4	single	JJ	O	single	amod	6	SENT_135	[p8l969t711r1097b763],
5	dose	NN	O	dose	nn	6	SENT_135	[p8l1113t711r1210b751],
6	treatment	NN	O	treatment	prep_after	1	SENT_135	[p8l1225t719r1439b751],
7	with	IN	O	with	_	0	SENT_135	[p8l8t769r104b809],
8	dapsone	NN	O	dapsone	prep_with	6	SENT_135	[p8l119t769r299b821],
9	and	CC	O	and	_	0	SENT_135	[p8l315t769r395b809],
10	pyrimethamine	NN	O	pyrimethamine	conj_and	8	SENT_135	[p8l409t769r747b821],
11	for	IN	O	for	_	0	SENT_135	[p8l762t769r824b809],
12	falciparum	NN	O	falciparum	nn	13	SENT_135	[p8l838t769r1076b821],
13	malaria	NN	O	malaria	prep_for	1	SENT_135	[p8l1091t769r1255b809],
14	in	IN	O	in	_	0	SENT_135	[p8l1270t772r1313b809],
15	a	DT	O	a	det	16	SENT_135	[p8l1329t783r1350b809],
16	patient	NN	O	patient	prep_in	1	SENT_135	[p8l9t832r160b881],
17	with	IN	O	with	_	0	SENT_135	[p8l173t829r269b869],
18	glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	20	SENT_135	[p8l285t829r729b881],
19	dehydrogenase	NN	O	dehydrogenase	nn	20	SENT_135	[p8l745t829r1071b881],
20	deﬁciency	NN	O	deﬁciency	prep_with	16	SENT_135	[p8l1087t829r1311b881],
21	.	.	O	.	_	0	SENT_135	[p8l1087t829r1311b881],

1	Trop	NNP	O	Trop	nn	3	SENT_136	[p8l13t890r100b939],
2	Geogr	NNP	O	Geogr	nn	3	SENT_136	[p8l119t891r238b940],
3	Med	NNP	O	Med	_	0	SENT_136	[p8l251t888r340b928],
4	1981	CD	DATE	1981	num	3	SENT_136	[p8l355t891r457b933],
5	;	:	O	;	_	0	SENT_136	[p8l355t891r457b933],
6	33	CD	NUMBER	33	num	8	SENT_136	[p8l475t891r536b928],
7	:	:	O	:	_	0	SENT_136	[p8l475t891r536b928],
8	401-02	CD	NUMBER	401-02	dep	3	SENT_136	[p8l551t891r710b928],
9	.	.	O	.	_	0	SENT_136	[p8l551t891r710b928],

1	Bukirwa	NN	O	bukirwa	nn	2	SENT_137	[p8l11t954r191b994],
2	H	NN	O	h	_	0	SENT_137	[p8l207t958r258b1000],
3	,	,	O	,	_	0	SENT_137	[p8l207t958r258b1000],
4	Garner	NNP	PERSON	Garner	nn	5	SENT_137	[p8l277t957r430b994],
5	P	NN	PERSON	p	appos	2	SENT_137	[p8l446t958r484b1000],
6	,	,	O	,	_	0	SENT_137	[p8l446t958r484b1000],
7	Critchley	NNP	PERSON	Critchley	appos	5	SENT_137	[p8l502t954r696b1006],
8	]	CD	NUMBER	]	num	7	SENT_137	[p8l711t958r738b1005],
9	.	.	O	.	_	0	SENT_137	[p8l711t958r738b1005],

1	Chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	_	0	SENT_138	[p8l757t954r1287b1007],
2	for	IN	O	for	_	0	SENT_138	[p8l1302t954r1365b994],
3	treating	VBG	O	treat	prepc_for	1	SENT_138	[p8l8t1016r178b1066],
4	uncomplicated	JJ	O	uncomplicated	amod	5	SENT_138	[p8l192t1014r517b1066],
5	malaria	NN	O	malaria	dobj	3	SENT_138	[p8l531t1014r706b1054],
6	.	.	O	.	_	0	SENT_138	[p8l531t1014r706b1054],

1	Cochrane	NNP	ORGANIZATION	Cochrane	nn	4	SENT_139	[p8l727t1014r920b1054],
2	Database	NNP	ORGANIZATION	Database	nn	4	SENT_139	[p8l937t1014r1126b1054],
3	Syst	NNP	ORGANIZATION	Syst	nn	4	SENT_139	[p8l1144t1017r1223b1065],
4	Rev	NN	O	rev	_	0	SENT_139	[p8l1240t1018r1312b1053],
5	2004	CD	DATE	2004	num	4	SENT_139	[p8l1327t1017r1436b1059],
6	;	:	O	;	_	0	SENT_139	[p8l1327t1017r1436b1059],
7	4	CD	NUMBER	4	dep	4	SENT_139	[p8l9t1076r44b1112],
8	:	:	O	:	_	0	SENT_139	[p8l9t1076r44b1112],
9	CD004387	NN	O	cd004387	dep	7	SENT_139	[p8l63t1075r285b1113],
10	.	.	O	.	_	0	SENT_139	[p8l63t1075r285b1113],

1	Fanello	NNP	MISC	Fanello	nn	2	SENT_140	[p8l11t1139r168b1179],
2	CI	NNP	MISC	CI	_	0	SENT_140	[p8l185t1142r248b1184],
3	,	,	O	,	_	0	SENT_140	[p8l185t1142r248b1184],
4	Karema	NNP	PERSON	Karema	nn	5	SENT_140	[p8l268t1143r438b1179],
5	C	NNP	PERSON	C	appos	2	SENT_140	[p8l455t1142r498b1185],
6	,	,	O	,	_	0	SENT_140	[p8l455t1142r498b1185],
7	Avellino	NNP	LOCATION	Avellino	nn	8	SENT_140	[p8l515t1139r694b1179],
8	P	NN	O	p	appos	2	SENT_140	[p8l712t1143r751b1185],
9	,	,	O	,	_	0	SENT_140	[p8l712t1143r751b1185],
10	et	FW	O	et	nn	11	SENT_140	[p8l769t1147r808b1179],
11	al.	FW	O	al.	appos	2	SENT_140	[p8l823t1139r870b1179],
12	.	.	O	.	_	0	SENT_140	[p8l823t1139r870b1179],

1	High	JJ	O	high	amod	2	SENT_141	[p8l890t1139r1001b1191],
2	risk	NN	O	risk	_	0	SENT_141	[p8l1016t1139r1100b1179],
3	of	IN	O	of	_	0	SENT_141	[p8l1115t1139r1164b1179],
4	severe	JJ	O	severe	amod	5	SENT_141	[p8l1174t1153r1309b1179],
5	anaemia	NN	O	anaemia	prep_of	2	SENT_141	[p8l10t1200r196b1237],
6	after	IN	O	after	_	0	SENT_141	[p8l213t1197r312b1237],
7	chlorproguanil-dapsone	NN	O	chlorproguanil-dapsone	prep_after	5	SENT_141	[p8l327t1198r1118b1250],
8	+	CC	O	+	_	0	SENT_141	[p8l327t1198r1118b1250],
9	artesunate	NN	O	artesunate	nn	11	SENT_141	[p8l327t1198r1118b1250],
10	antimalarial	JJ	O	antimalarial	amod	11	SENT_141	[p8l1134t1198r1401b1237],
11	treatment	NN	O	treatment	conj_+	2	SENT_141	[p8l8t1264r226b1296],
12	in	IN	O	in	_	0	SENT_141	[p8l241t1259r285b1296],
13	patients	NNS	O	patient	prep_in	11	SENT_141	[p8l300t1259r474b1308],
14	with	IN	O	with	_	0	SENT_141	[p8l490t1256r588b1296],
15	G6PD	NN	O	g6pd	prep_with	13	SENT_141	[p8l605t1259r736b1296],
16	(	CD	NUMBER	(	dep	2	SENT_141	[p8l757t1259r843b1309],
17	A	DT	O	a	det	20	SENT_141	[p8l757t1259r843b1309],
18	—	NN	O	—	nn	20	SENT_141	[p8l757t1259r843b1309],
19	)	NN	O	)	nn	20	SENT_141	[p8l757t1259r843b1309],
20	deﬁciency	NN	O	deﬁciency	dep	16	SENT_141	[p8l862t1256r1090b1308],
21	.	.	O	.	_	0	SENT_141	[p8l862t1256r1090b1308],

1	PloS	NNP	O	PloS	_	0	SENT_142	[p8l1111t1256r1204b1296],
2	One	CD	NUMBER	one	num	1	SENT_142	[p8l1224t1260r1307b1296],
3	2008	CD	DATE	2008	num	5	SENT_142	[p8l1323t1260r1437b1302],
4	;	:	O	;	_	0	SENT_142	[p8l1323t1260r1437b1302],
5	3	CD	NUMBER	3	dep	1	SENT_142	[p8l10t1320r45b1356],
6	:	:	O	:	_	0	SENT_142	[p8l10t1320r45b1356],
7	e4031	NN	O	e4031	dep	1	SENT_142	[p8l63t1320r194b1356],
8	.	.	O	.	_	0	SENT_142	[p8l63t1320r194b1356],

1	Premji	NNP	PERSON	Premji	nn	2	SENT_143	[p8l11t1385r157b1434],
2	Z	NNP	O	Z	_	0	SENT_143	[p8l174t1385r216b1428],
3	,	,	O	,	_	0	SENT_143	[p8l174t1385r216b1428],
4	Umeh	NNP	PERSON	Umeh	nn	5	SENT_143	[p8l235t1382r372b1422],
5	RE	NNP	O	RE	appos	2	SENT_143	[p8l389t1385r460b1428],
6	,	,	O	,	_	0	SENT_143	[p8l389t1385r460b1428],
7	Owusu-Agyei	NNP	O	Owusu-Agyei	nn	8	SENT_143	[p8l479t1385r771b1435],
8	S	NNP	O	S	appos	2	SENT_143	[p8l788t1385r824b1428],
9	,	,	O	,	_	0	SENT_143	[p8l788t1385r824b1428],
10	et	FW	O	et	nn	11	SENT_143	[p8l841t1390r880b1422],
11	al.	FW	O	al.	appos	2	SENT_143	[p8l894t1382r940b1422],
12	.	.	O	.	_	0	SENT_143	[p8l894t1382r940b1422],

1	Chlorproguanildapsone-artesunate	JJ	O	chlorproguanildapsone-artesunate	nsubj	9	SENT_144	[p8l959t1382r1307b1435, p8l10t1442r432b1494],
2	versus	CC	O	versus	prep	1	SENT_144	[p8l446t1456r585b1482],
3	artemether-lumefantrine	NN	O	artemether-lumefantrine	dep	2	SENT_144	[p8l602t1442r1153b1482],
4	:	:	O	:	_	0	SENT_144	[p8l602t1442r1153b1482],
5	a	DT	O	a	dep	1	SENT_144	[p8l1171t1456r1193b1482],
6	randomized	VBN	O	randomize	partmod	5	SENT_144	[p8l1207t1442r1482b1487],
7	,	,	O	,	_	0	SENT_144	[p8l1207t1442r1482b1487],
8	double-blind	JJ	O	double-blind	amod	9	SENT_144	[p8l10t1501r286b1540],
9	phase	NN	O	phase	_	0	SENT_144	[p8l300t1501r425b1552],
10	III	CD	NUMBER	iii	num	11	SENT_144	[p8l443t1505r495b1540],
11	trial	NN	O	trial	dobj	9	SENT_144	[p8l511t1501r598b1540],
12	in	IN	O	in	_	0	SENT_144	[p8l612t1503r656b1540],
13	African	JJ	MISC	african	amod	14	SENT_144	[p8l670t1501r832b1540],
14	children	NNS	O	child	prep_in	11	SENT_144	[p8l847t1501r1027b1541],
15	and	CC	O	and	_	0	SENT_144	[p8l1043t1501r1123b1540],
16	adolescents	NNS	O	adolescent	conj_and	14	SENT_144	[p8l1137t1501r1386b1540],
17	with	IN	O	with	_	0	SENT_144	[p8l1401t1501r1497b1540],
18	uncomplicated	JJ	O	uncomplicated	amod	20	SENT_144	[p8l8t1559r333b1611],
19	Plasmodiamfalcipamm	NN	O	plasmodiamfalcipamm	nn	20	SENT_144	[p8l351t1559r848b1612],
20	malaria	NN	O	malaria	prep_with	9	SENT_144	[p8l862t1559r1037b1599],
21	.	.	O	.	_	0	SENT_144	[p8l862t1559r1037b1599],

1	PloS	NNP	O	PloS	_	0	SENT_145	[p8l1057t1559r1149b1599],
2	One	CD	NUMBER	one	num	1	SENT_145	[p8l1168t1563r1250b1599],
3	2009	CD	DATE	2009	num	5	SENT_145	[p8l1266t1563r1377b1605],
4	;	:	O	;	_	0	SENT_145	[p8l1266t1563r1377b1605],
5	4	CD	NUMBER	4	dep	1	SENT_145	[p8l9t1622r44b1658],
6	:	:	O	:	_	0	SENT_145	[p8l9t1622r44b1658],
7	e6682	NN	O	e6682	dep	1	SENT_145	[p8l62t1622r199b1658],
8	.	.	O	.	_	0	SENT_145	[p8l62t1622r199b1658],

1	Kremsner	NNP	PERSON	Kremsner	nn	2	SENT_146	[p8l11t1689r228b1726],
2	PG	NNP	O	PG	_	0	SENT_146	[p8l244t1688r321b1731],
3	,	,	O	,	_	0	SENT_146	[p8l244t1688r321b1731],
4	Krishna	NNP	PERSON	Krishna	nn	5	SENT_146	[p8l341t1686r511b1726],
5	S.	NNP	O	S.	appos	2	SENT_146	[p8l529t1689r564b1726],
6	Antimalarial	JJ	O	antimalarial	amod	7	SENT_146	[p8l580t1686r855b1726],
7	combinations	NNS	O	combination	dep	5	SENT_146	[p8l870t1686r1179b1726],
8	.	.	O	.	_	0	SENT_146	[p8l870t1686r1179b1726],

1	Lancet	NNP	O	Lancet	_	0	SENT_147	[p8l1199t1689r1332b1726],
2	2004	CD	DATE	2004	num	1	SENT_147	[p8l1347t1689r1457b1731],
3	;	:	O	;	_	0	SENT_147	[p8l1347t1689r1457b1731],

1	Krattiger	NNP	O	Krattiger	nn	2	SENT_148	[p8l11t1815r202b1865],
2	A	NNP	O	A	_	0	SENT_148	[p8l215t1816r260b1858],
3	,	,	O	,	_	0	SENT_148	[p8l215t1816r260b1858],
4	Mahoney	NNP	ORGANIZATION	Mahoney	nn	5	SENT_148	[p8l279t1813r480b1865],
5	RT	NN	ORGANIZATION	rt	appos	2	SENT_148	[p8l495t1815r562b1858],
6	,	,	O	,	_	0	SENT_148	[p8l495t1815r562b1858],
7	Nelsen	NNP	PERSON	Nelsen	nn	8	SENT_148	[p8l581t1813r729b1853],
8	L	NNP	O	L	appos	2	SENT_148	[p8l746t1817r781b1858],
9	,	,	O	,	_	0	SENT_148	[p8l746t1817r781b1858],
10	et	FW	O	et	nn	11	SENT_148	[p8l798t1821r836b1853],
11	al.	FW	O	al.	appos	2	SENT_148	[p8l851t1813r897b1853],
12	.	.	O	.	_	0	SENT_148	[p8l851t1813r897b1853],

1	Executive	NNP	O	Executive	nn	2	SENT_149	[p8l916t1815r1119b1853],
2	guide	NN	O	guide	_	0	SENT_149	[p8l1135t1813r1255b1865],
3	to	TO	O	to	_	0	SENT_149	[p8l1269t1821r1309b1853],
4	intellectual	JJ	O	intellectual	amod	6	SENT_149	[p8l9t1871r250b1911],
5	property	NN	O	property	nn	6	SENT_149	[p8l264t1879r448b1923],
6	management	NN	O	management	prep_to	2	SENT_149	[p8l462t1879r752b1924],
7	in	IN	O	in	_	0	SENT_149	[p8l766t1874r809b1911],
8	health	NN	O	health	nn	11	SENT_149	[p8l823t1871r959b1911],
9	and	CC	O	and	_	0	SENT_149	[p8l974t1871r1054b1911],
10	agricultural	JJ	O	agricultural	nn	11	SENT_149	[p8l1069t1871r1321b1924],
11	innovation	NN	O	innovation	prep_in	6	SENT_149	[p8l9t1934r253b1971],
12	:	:	O	:	_	0	SENT_149	[p8l9t1934r253b1971],
13	a	DT	O	a	det	14	SENT_149	[p8l271t1945r293b1971],
14	handbook	NN	O	handbook	dep	2	SENT_149	[p8l307t1931r525b1971],
15	of	IN	O	of	_	0	SENT_149	[p8l539t1931r588b1971],
16	best	JJS	O	best	amod	17	SENT_149	[p8l594t1931r684b1971],
17	practices	NNS	O	practice	prep_of	14	SENT_149	[p8l697t1934r899b1983],
18	.	.	O	.	_	0	SENT_149	[p8l697t1934r899b1983],

1	MIHR	NNP	O	MIHR	_	0	SENT_150	[p8l918t1935r1069b1971],
2	:	:	O	:	_	0	SENT_150	[p8l918t1935r1069b1971],
3	Oxford	NNP	LOCATION	Oxford	dep	1	SENT_150	[p8l1088t1931r1248b1977],
4	,	,	O	,	_	0	SENT_150	[p8l1088t1931r1248b1977],
5	and	CC	O	and	_	0	SENT_150	[p8l1266t1931r1346b1971],
6	PIPRA	NNP	O	PIPRA	dep	1	SENT_150	[p8l11t1993r169b2030],
7	:	:	O	:	_	0	SENT_150	[p8l11t1993r169b2030],
8	Davis	NNP	PERSON	Davis	nn	12	SENT_150	[p8l189t1993r318b2036],
9	,	,	O	,	_	0	SENT_150	[p8l189t1993r318b2036],
10	CA	NNP	LOCATION	CA	appos	12	SENT_150	[p8l336t1993r414b2036],
11	,	,	O	,	_	0	SENT_150	[p8l336t1993r414b2036],
12	USA	NNP	LOCATION	USA	dep	1	SENT_150	[p8l433t1993r545b2036],
13	,	,	O	,	_	0	SENT_150	[p8l433t1993r545b2036],
14	2007	CD	DATE	2007	dep	12	SENT_150	[p8l563t1993r662b2031],
15	.	.	O	.	_	0	SENT_150	[p8l563t1993r662b2031],

1	Fanello	NNP	MISC	Fanello	nn	2	SENT_151	[p8l11t2056r165b2096],
2	CI	NNP	MISC	CI	_	0	SENT_151	[p8l182t2059r244b2102],
3	,	,	O	,	_	0	SENT_151	[p8l182t2059r244b2102],
4	Karema	NNP	PERSON	Karema	nn	5	SENT_151	[p8l263t2060r431b2096],
5	C	NNP	O	C	appos	2	SENT_151	[p8l447t2059r490b2102],
6	,	,	O	,	_	0	SENT_151	[p8l447t2059r490b2102],
7	Ngamije	NNP	O	Ngamije	nn	8	SENT_151	[p8l508t2059r692b2109],
8	D	NNP	O	D	appos	2	SENT_151	[p8l710t2060r755b2102],
9	,	,	O	,	_	0	SENT_151	[p8l710t2060r755b2102],
10	et	FW	O	et	nn	11	SENT_151	[p8l773t2064r811b2096],
11	al.	FW	O	al.	appos	2	SENT_151	[p8l826t2056r872b2096],
12	.	.	O	.	_	0	SENT_151	[p8l826t2056r872b2096],

1	A	DT	O	a	det	3	SENT_152	[p8l888t2059r923b2095],
2	randomised	JJ	O	randomised	amod	3	SENT_152	[p8l937t2056r1198b2096],
3	trial	NN	O	trial	nsubj	5	SENT_152	[p8l1212t2056r1299b2096],
4	to	TO	O	to	aux	5	SENT_152	[p8l1313t2064r1353b2096],
5	assess	VB	O	assess	_	0	SENT_152	[p8l10t2130r141b2156],
6	the	DT	O	the	det	7	SENT_152	[p8l157t2116r225b2156],
7	efficacy	NN	O	efficacy	dobj	5	SENT_152	[p8l241t2116r402b2168],
8	and	CC	O	and	_	0	SENT_152	[p8l416t2116r497b2156],
9	safety	NN	O	safety	dobj	5	SENT_152	[p8l512t2116r635b2168],
10	of	IN	O	of	_	0	SENT_152	[p8l650t2116r698b2156],
11	chlorproguanil/dapsone	NN	O	chlorproguanil/dapsone	prep_of	7	SENT_152	[p8l706t2116r1490b2168],
12	+	CC	O	+	_	0	SENT_152	[p8l706t2116r1490b2168],
13	artesunate	NN	O	artesunate	conj_+	7	SENT_152	[p8l706t2116r1490b2168],
14	for	IN	O	for	_	0	SENT_152	[p8l9t2174r71b2214],
15	the	DT	O	the	det	16	SENT_152	[p8l84t2175r152b2214],
16	treatment	NN	O	treatment	prep_for	13	SENT_152	[p8l166t2182r381b2214],
17	of	IN	O	of	_	0	SENT_152	[p8l396t2174r444b2214],
18	uncomplicated	JJ	O	uncomplicated	amod	20	SENT_152	[p8l451t2175r776b2226],
19	Plasmodiumfalciparum	NN	MISC	plasmodiumfalciparum	nn	20	SENT_152	[p8l793t2174r1291b2227],
20	malaria	NN	O	malaria	prep_of	16	SENT_152	[p8l1304t2175r1479b2214],
21	.	.	O	.	_	0	SENT_152	[p8l1304t2175r1479b2214],

1	Trans	NNP	O	Trans	nn	6	SENT_153	[p8l13t2236r124b2273],
2	R	NNP	O	R	nn	6	SENT_153	[p8l141t2237r171b2272],
3	Soc	NNP	O	Soc	nn	6	SENT_153	[p8l189t2236r258b2273],
4	Trop	NNP	O	Trop	nn	6	SENT_153	[p8l275t2236r362b2285],
5	Med	NNP	O	Med	nn	6	SENT_153	[p8l378t2233r467b2273],
6	Hyg	NNP	O	Hyg	_	0	SENT_153	[p8l484t2237r571b2286],
7	2008	CD	DATE	2008	num	6	SENT_153	[p8l583t2237r695b2279],
8	;	:	O	;	_	0	SENT_153	[p8l583t2237r695b2279],
9	102	CD	NUMBER	102	num	11	SENT_153	[p8l713t2237r796b2273],
10	:	:	O	:	_	0	SENT_153	[p8l713t2237r796b2273],
11	412-20	CD	NUMBER	412-20	dep	6	SENT_153	[p8l811t2237r970b2273],
12	.	.	O	.	_	0	SENT_153	[p8l811t2237r970b2273],

1	Ialloh	NNP	MISC	Ialloh	nn	4	SENT_154	[p8l10t2301r133b2351],
2	A	NNP	MISC	A	nn	4	SENT_154	[p8l147t2303r192b2346],
3	,	,	O	,	_	0	SENT_154	[p8l147t2303r192b2346],
4	Tantular	NNP	PERSON	Tantular	nsubj	8	SENT_154	[p8l208t2301r391b2340],
5	IS	VBZ	O	be	cop	8	SENT_154	[p8l407t2303r463b2346],
6	,	,	O	,	_	0	SENT_154	[p8l407t2303r463b2346],
7	Pusarawati	NNP	O	Pusarawati	nn	8	SENT_154	[p8l482t2303r718b2340],
8	S	NNP	O	S	_	0	SENT_154	[p8l736t2303r772b2346],
9	,	,	O	,	_	0	SENT_154	[p8l736t2303r772b2346],
10	et	FW	O	et	nn	11	SENT_154	[p8l789t2309r827b2340],
11	al.	FW	O	al.	appos	8	SENT_154	[p8l842t2301r888b2340],
12	.	.	O	.	_	0	SENT_154	[p8l842t2301r888b2340],

1	Rapid	JJ	O	rapid	amod	3	SENT_155	[p8l907t2301r1031b2352],
2	epidemiologic	JJ	O	epidemiologic	amod	3	SENT_155	[p8l1046t2301r1354b2353],
3	assessment	NN	O	assessment	_	0	SENT_155	[p8l10t2367r260b2399],
4	of	IN	O	of	_	0	SENT_155	[p8l275t2359r323b2399],
5	glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	7	SENT_155	[p8l331t2359r775b2412],
6	dehydrogenase	NN	O	dehydrogenase	nn	7	SENT_155	[p8l791t2359r1117b2412],
7	deﬁciency	NN	O	deﬁciency	prep_of	3	SENT_155	[p8l1133t2359r1351b2411],
8	in	IN	O	in	_	0	SENT_155	[p8l1365t2362r1408b2399],
9	malaria	NN	O	malaria	npadvmod	11	SENT_155	[p8l9t2419r377b2459],
10	—	CD	NUMBER	—	num	9	SENT_155	[p8l9t2419r377b2459],
11	endemic	JJ	O	endemic	amod	12	SENT_155	[p8l9t2419r377b2459],
12	areas	NNS	O	area	prep_in	7	SENT_155	[p8l393t2433r502b2459],
13	in	IN	O	in	_	0	SENT_155	[p8l518t2422r562b2458],
14	Southeast	NNP	LOCATION	Southeast	nn	15	SENT_155	[p8l580t2419r790b2459],
15	Asia	NNP	LOCATION	Asia	prep_in	12	SENT_155	[p8l803t2422r898b2459],
16	using	VBG	O	use	partmod	3	SENT_155	[p8l912t2422r1035b2471],
17	a	DT	O	a	det	20	SENT_155	[p8l1050t2433r1071b2459],
18	novel	JJ	O	novel	amod	20	SENT_155	[p8l1086t2419r1202b2459],
19	diagnostic	JJ	O	diagnostic	amod	20	SENT_155	[p8l1218t2419r1440b2471],
20	kit	NN	O	kit	dobj	16	SENT_155	[p8l8t2478r75b2517],
21	.	.	O	.	_	0	SENT_155	[p8l8t2478r75b2517],

1	Trop	NNP	O	Trop	nn	4	SENT_156	[p8l96t2480r183b2529],
2	Med	NNP	O	Med	nn	4	SENT_156	[p8l200t2478r289b2517],
3	Int	NNP	O	Int	nn	4	SENT_156	[p8l305t2481r365b2517],
4	Health	NNP	O	Health	_	0	SENT_156	[p8l382t2478r521b2517],
5	2004	CD	DATE	2004	num	4	SENT_156	[p8l537t2481r646b2523],
6	;	:	O	;	_	0	SENT_156	[p8l537t2481r646b2523],
7	9	CD	NUMBER	9	num	9	SENT_156	[p8l664t2481r699b2517],
8	:	:	O	:	_	0	SENT_156	[p8l664t2481r699b2517],
9	615-23	CD	NUMBER	615-23	dep	4	SENT_156	[p8l716t2480r876b2517],
10	.	.	O	.	_	0	SENT_156	[p8l716t2480r876b2517],

